id	sid	tid	token	lemma	pos
admet-1078	1	1	therapeutic	therapeutic	ADJ
admet-1078	1	2	potential	potential	NOUN
admet-1078	1	3	of	of	ADP
admet-1078	1	4	interferon	interferon	ADJ
admet-1078	1	5	-	-	PUNCT
admet-1078	1	6	gamma	gamma	NOUN
admet-1078	1	7	in	in	ADP
admet-1078	1	8	tuberculosis	tuberculosis	NOUN
admet-1078	1	9	doi	doi	NOUN
admet-1078	1	10	:	:	PUNCT
admet-1078	1	11	http://dx.doi.org/10.5599/admet.1078	http://dx.doi.org/10.5599/admet.1078	PROPN
admet-1078	1	12	63	63	NUM
admet-1078	1	13	admet	admet	PROPN
admet-1078	1	14	&	&	CCONJ
admet-1078	1	15	dmpk	dmpk	PROPN
admet-1078	1	16	10(1	10(1	NUM
admet-1078	1	17	)	)	PUNCT
admet-1078	1	18	(	(	PUNCT
admet-1078	1	19	2022	2022	NUM
admet-1078	1	20	)	)	PUNCT
admet-1078	1	21	63	63	NUM
admet-1078	1	22	-	-	SYM
admet-1078	1	23	73	73	NUM
admet-1078	1	24	;	;	PUNCT
admet-1078	1	25	doi	doi	NOUN
admet-1078	1	26	:	:	PUNCT
admet-1078	1	27	https://doi.org/10.5599/admet.1078	https://doi.org/10.5599/admet.1078	NOUN
admet-1078	1	28	open	open	ADJ
admet-1078	1	29	access	access	NOUN
admet-1078	1	30	:	:	PUNCT
admet-1078	1	31	issn	issn	PROPN
admet-1078	1	32	:	:	PUNCT
admet-1078	1	33	1848	1848	NUM
admet-1078	1	34	-	-	SYM
admet-1078	1	35	7718	7718	NUM
admet-1078	1	36	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-1078	1	37	review	review	VERB
admet-1078	1	38	therapeutic	therapeutic	ADJ
admet-1078	1	39	potential	potential	NOUN
admet-1078	1	40	of	of	ADP
admet-1078	1	41	interferon	interferon	ADJ
admet-1078	1	42	-	-	PUNCT
admet-1078	1	43	gamma	gamma	NOUN
admet-1078	1	44	in	in	ADP
admet-1078	1	45	tuberculosis	tuberculosis	NOUN
admet-1078	1	46	svetlana	svetlana	PROPN
admet-1078	1	47	a.	a.	PROPN
admet-1078	1	48	berns1	berns1	PROPN
admet-1078	1	49	,	,	PUNCT
admet-1078	1	50	julia	julia	PROPN
admet-1078	1	51	a.	a.	PROPN
admet-1078	1	52	isakova2	isakova2	PROPN
admet-1078	1	53	and	and	CCONJ
admet-1078	1	54	polina	polina	PROPN
admet-1078	1	55	i.	i.	PROPN
admet-1078	1	56	pekhtereva3	pekhtereva3	PROPN
admet-1078	1	57	,	,	PUNCT
admet-1078	1	58	*	*	SYM
admet-1078	1	59	1	1	NUM
admet-1078	1	60	federal	federal	ADJ
admet-1078	1	61	state	state	NOUN
admet-1078	1	62	institution	institution	PROPN
admet-1078	1	63	national	national	PROPN
admet-1078	1	64	medical	medical	PROPN
admet-1078	1	65	research	research	NOUN
admet-1078	1	66	center	center	NOUN
admet-1078	1	67	for	for	ADP
admet-1078	1	68	therapy	therapy	NOUN
admet-1078	1	69	and	and	CCONJ
admet-1078	1	70	preventive	preventive	ADJ
admet-1078	1	71	medicine	medicine	NOUN
admet-1078	1	72	of	of	ADP
admet-1078	1	73	the	the	DET
admet-1078	1	74	ministry	ministry	PROPN
admet-1078	1	75	of	of	ADP
admet-1078	1	76	healthcare	healthcare	PROPN
admet-1078	1	77	of	of	ADP
admet-1078	1	78	the	the	DET
admet-1078	1	79	russian	russian	PROPN
admet-1078	1	80	federation	federation	PROPN
admet-1078	1	81	,	,	PUNCT
admet-1078	1	82	svberns@yandex.ru	svberns@yandex.ru	ADV
admet-1078	1	83	2	2	NUM
admet-1078	1	84	spp	spp	NOUN
admet-1078	1	85	“	"	PUNCT
admet-1078	1	86	pharmaclon	pharmaclon	NOUN
admet-1078	1	87	”	"	PUNCT
admet-1078	1	88	ltd	ltd	PROPN
admet-1078	1	89	.	.	PROPN
admet-1078	1	90	,	,	PUNCT
admet-1078	1	91	moscow	moscow	PROPN
admet-1078	1	92	,	,	PUNCT
admet-1078	1	93	russia	russia	PROPN
admet-1078	1	94	,	,	PUNCT
admet-1078	1	95	julia.is.alex@gmail.com	julia.is.alex@gmail.com	NOUN
admet-1078	1	96	3	3	NUM
admet-1078	1	97	spp	spp	NOUN
admet-1078	1	98	“	"	PUNCT
admet-1078	1	99	pharmaclon	pharmaclon	NOUN
admet-1078	1	100	”	"	PUNCT
admet-1078	1	101	ltd	ltd	PROPN
admet-1078	1	102	.	.	PROPN
admet-1078	1	103	,	,	PUNCT
admet-1078	1	104	moscow	moscow	PROPN
admet-1078	1	105	,	,	PUNCT
admet-1078	1	106	russia	russia	PROPN
admet-1078	1	107	,	,	PUNCT
admet-1078	1	108	pekhterevapolina@gmail.com	pekhterevapolina@gmail.com	X
admet-1078	2	1	*	*	PUNCT
admet-1078	2	2	corresponding	correspond	VERB
admet-1078	2	3	author	author	NOUN
admet-1078	2	4	:	:	PUNCT
admet-1078	2	5	polina	polina	PROPN
admet-1078	2	6	i.	i.	PROPN
admet-1078	2	7	pekhtereva	pekhtereva	PROPN
admet-1078	2	8	;	;	PUNCT
admet-1078	2	9	e	e	X
admet-1078	2	10	-	-	NOUN
admet-1078	2	11	mail	mail	NOUN
admet-1078	2	12	:	:	PUNCT
admet-1078	2	13	pekhterevapolina@gmail.com	pekhterevapolina@gmail.com	X
admet-1078	2	14	;	;	PUNCT
admet-1078	2	15	tel	tel	PROPN
admet-1078	2	16	.	.	PUNCT
admet-1078	2	17	:	:	PUNCT
admet-1078	3	1	+7	+7	ADJ
admet-1078	3	2	-	-	ADJ
admet-1078	3	3	909	909	NUM
admet-1078	3	4	-	-	PUNCT
admet-1078	3	5	675	675	NUM
admet-1078	3	6	-	-	PUNCT
admet-1078	3	7	9643	9643	NUM
admet-1078	3	8	received	receive	VERB
admet-1078	3	9	:	:	PUNCT
admet-1078	3	10	august	august	PROPN
admet-1078	3	11	11	11	NUM
admet-1078	3	12	,	,	PUNCT
admet-1078	3	13	2021	2021	NUM
admet-1078	3	14	;	;	PUNCT
admet-1078	3	15	revised	revise	VERB
admet-1078	3	16	:	:	PUNCT
admet-1078	3	17	november	november	PROPN
admet-1078	3	18	27	27	NUM
admet-1078	3	19	,	,	PUNCT
admet-1078	3	20	2021	2021	NUM
admet-1078	3	21	;	;	PUNCT
admet-1078	3	22	published	publish	VERB
admet-1078	3	23	:	:	PUNCT
admet-1078	3	24	january	january	PROPN
admet-1078	3	25	14	14	NUM
admet-1078	3	26	,	,	PUNCT
admet-1078	3	27	2021	2021	NUM
admet-1078	3	28	abstract	abstract	ADJ
admet-1078	3	29	tuberculosis	tuberculosis	NOUN
admet-1078	3	30	is	be	AUX
admet-1078	3	31	one	one	NUM
admet-1078	3	32	of	of	ADP
admet-1078	3	33	the	the	DET
admet-1078	3	34	critical	critical	ADJ
admet-1078	3	35	health	health	NOUN
admet-1078	3	36	problems	problem	NOUN
admet-1078	3	37	worldwide	worldwide	ADV
admet-1078	3	38	.	.	PUNCT
admet-1078	4	1	the	the	DET
admet-1078	4	2	search	search	NOUN
admet-1078	4	3	for	for	ADP
admet-1078	4	4	ways	way	NOUN
admet-1078	4	5	to	to	PART
admet-1078	4	6	improve	improve	VERB
admet-1078	4	7	the	the	DET
admet-1078	4	8	results	result	NOUN
admet-1078	4	9	of	of	ADP
admet-1078	4	10	tuberculosis	tuberculosis	NOUN
admet-1078	4	11	treatment	treatment	NOUN
admet-1078	4	12	and	and	CCONJ
admet-1078	4	13	overcome	overcome	VERB
admet-1078	4	14	drug	drug	NOUN
admet-1078	4	15	resistance	resistance	NOUN
admet-1078	4	16	lies	lie	VERB
admet-1078	4	17	in	in	ADP
admet-1078	4	18	understanding	understand	VERB
admet-1078	4	19	the	the	DET
admet-1078	4	20	pathogenesis	pathogenesis	NOUN
admet-1078	4	21	of	of	ADP
admet-1078	4	22	the	the	DET
admet-1078	4	23	development	development	NOUN
admet-1078	4	24	of	of	ADP
admet-1078	4	25	the	the	DET
admet-1078	4	26	infectious	infectious	ADJ
admet-1078	4	27	process	process	NOUN
admet-1078	4	28	.	.	PUNCT
admet-1078	5	1	the	the	DET
admet-1078	5	2	interferon	interferon	ADJ
admet-1078	5	3	system	system	NOUN
admet-1078	5	4	,	,	PUNCT
admet-1078	5	5	particularly	particularly	ADV
admet-1078	5	6	the	the	DET
admet-1078	5	7	role	role	NOUN
admet-1078	5	8	of	of	ADP
admet-1078	5	9	interferon	interferon	ADJ
admet-1078	5	10	-	-	PUNCT
admet-1078	5	11	gamma	gamma	NOUN
admet-1078	5	12	,	,	PUNCT
admet-1078	5	13	has	have	AUX
admet-1078	5	14	been	be	AUX
admet-1078	5	15	identified	identify	VERB
admet-1078	5	16	as	as	ADP
admet-1078	5	17	the	the	DET
admet-1078	5	18	main	main	ADJ
admet-1078	5	19	link	link	NOUN
admet-1078	5	20	in	in	ADP
admet-1078	5	21	the	the	DET
admet-1078	5	22	immune	immune	ADJ
admet-1078	5	23	response	response	NOUN
admet-1078	5	24	in	in	ADP
admet-1078	5	25	tuberculosis	tuberculosis	NOUN
admet-1078	5	26	.	.	PUNCT
admet-1078	6	1	the	the	DET
admet-1078	6	2	clinical	clinical	ADJ
admet-1078	6	3	efficacy	efficacy	NOUN
admet-1078	6	4	of	of	ADP
admet-1078	6	5	interferon	interferon	ADJ
admet-1078	6	6	-	-	PUNCT
admet-1078	6	7	gamma	gamma	NOUN
admet-1078	6	8	has	have	AUX
admet-1078	6	9	been	be	AUX
admet-1078	6	10	studied	study	VERB
admet-1078	6	11	and	and	CCONJ
admet-1078	6	12	evaluated	evaluate	VERB
admet-1078	6	13	in	in	ADP
admet-1078	6	14	clinical	clinical	ADJ
admet-1078	6	15	trials	trial	NOUN
admet-1078	6	16	since	since	SCONJ
admet-1078	6	17	the	the	DET
admet-1078	6	18	end	end	NOUN
admet-1078	6	19	of	of	ADP
admet-1078	6	20	the	the	DET
admet-1078	6	21	last	last	ADJ
admet-1078	6	22	century	century	NOUN
admet-1078	6	23	.	.	PUNCT
admet-1078	7	1	there	there	PRON
admet-1078	7	2	was	be	AUX
admet-1078	7	3	obtained	obtain	VERB
admet-1078	7	4	evidence	evidence	NOUN
admet-1078	7	5	of	of	ADP
admet-1078	7	6	the	the	DET
admet-1078	7	7	clinical	clinical	ADJ
admet-1078	7	8	efficacy	efficacy	NOUN
admet-1078	7	9	of	of	ADP
admet-1078	7	10	interferon	interferon	ADJ
admet-1078	7	11	-	-	PUNCT
admet-1078	7	12	gamma	gamma	NOUN
admet-1078	7	13	as	as	ADP
admet-1078	7	14	part	part	NOUN
admet-1078	7	15	of	of	ADP
admet-1078	7	16	complex	complex	ADJ
admet-1078	7	17	therapy	therapy	NOUN
admet-1078	7	18	.	.	PUNCT
admet-1078	8	1	recent	recent	ADJ
admet-1078	8	2	experimental	experimental	ADJ
admet-1078	8	3	data	datum	NOUN
admet-1078	8	4	make	make	VERB
admet-1078	8	5	it	it	PRON
admet-1078	8	6	possible	possible	ADJ
admet-1078	8	7	to	to	PART
admet-1078	8	8	consider	consider	VERB
admet-1078	8	9	interferon	interferon	ADJ
admet-1078	8	10	-	-	PUNCT
admet-1078	8	11	gamma	gamma	NOUN
admet-1078	8	12	as	as	ADP
admet-1078	8	13	a	a	DET
admet-1078	8	14	promising	promising	ADJ
admet-1078	8	15	therapeutic	therapeutic	ADJ
admet-1078	8	16	option	option	NOUN
admet-1078	8	17	for	for	ADP
admet-1078	8	18	the	the	DET
admet-1078	8	19	treatment	treatment	NOUN
admet-1078	8	20	of	of	ADP
admet-1078	8	21	multidrug	multidrug	NOUN
admet-1078	8	22	-	-	PUNCT
admet-1078	8	23	resistant	resistant	ADJ
admet-1078	8	24	tuberculosis	tuberculosis	NOUN
admet-1078	8	25	as	as	ADP
admet-1078	8	26	part	part	NOUN
admet-1078	8	27	of	of	ADP
admet-1078	8	28	complex	complex	ADJ
admet-1078	8	29	therapy	therapy	NOUN
admet-1078	8	30	worthy	worthy	ADJ
admet-1078	8	31	of	of	ADP
admet-1078	8	32	further	further	ADJ
admet-1078	8	33	studies	study	NOUN
admet-1078	8	34	.	.	PUNCT
admet-1078	9	1	©	©	X
admet-1078	9	2	2021	2021	NUM
admet-1078	9	3	by	by	ADP
admet-1078	9	4	the	the	DET
admet-1078	9	5	authors	author	NOUN
admet-1078	9	6	.	.	PUNCT
admet-1078	10	1	this	this	DET
admet-1078	10	2	article	article	NOUN
admet-1078	10	3	is	be	AUX
admet-1078	10	4	an	an	DET
admet-1078	10	5	open	open	ADJ
admet-1078	10	6	-	-	PUNCT
admet-1078	10	7	access	access	NOUN
admet-1078	10	8	article	article	NOUN
admet-1078	10	9	distributed	distribute	VERB
admet-1078	10	10	under	under	ADP
admet-1078	10	11	the	the	DET
admet-1078	10	12	terms	term	NOUN
admet-1078	10	13	and	and	CCONJ
admet-1078	10	14	conditions	condition	NOUN
admet-1078	10	15	of	of	ADP
admet-1078	10	16	the	the	DET
admet-1078	10	17	creative	creative	ADJ
admet-1078	10	18	commons	common	NOUN
admet-1078	10	19	attribution	attribution	NOUN
admet-1078	10	20	license	license	NOUN
admet-1078	10	21	(	(	PUNCT
admet-1078	10	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-1078	10	23	)	)	PUNCT
admet-1078	10	24	.	.	PUNCT
admet-1078	11	1	keywords	keyword	VERB
admet-1078	11	2	interferon	interferon	ADJ
admet-1078	11	3	gamma	gamma	NOUN
admet-1078	11	4	;	;	PUNCT
admet-1078	11	5	mrd	mrd	PROPN
admet-1078	11	6	-	-	PUNCT
admet-1078	11	7	tb	tb	NOUN
admet-1078	11	8	;	;	PUNCT
admet-1078	11	9	immunotherapy	immunotherapy	NOUN
admet-1078	11	10	;	;	PUNCT
admet-1078	11	11	ifn	ifn	PROPN
admet-1078	11	12	-	-	PUNCT
admet-1078	11	13	γ	γ	NOUN
admet-1078	11	14	;	;	PUNCT
admet-1078	11	15	complex	complex	ADJ
admet-1078	11	16	treatment	treatment	NOUN
admet-1078	11	17	.	.	PUNCT
admet-1078	12	1	introduction	introduction	NOUN
admet-1078	12	2	the	the	DET
admet-1078	12	3	problem	problem	NOUN
admet-1078	12	4	of	of	ADP
admet-1078	12	5	resistance	resistance	NOUN
admet-1078	12	6	of	of	ADP
admet-1078	12	7	microorganisms	microorganism	NOUN
admet-1078	12	8	to	to	ADP
admet-1078	12	9	antimicrobial	antimicrobial	ADJ
admet-1078	12	10	drugs	drug	NOUN
admet-1078	12	11	and	and	CCONJ
admet-1078	12	12	,	,	PUNCT
admet-1078	12	13	consequently	consequently	ADV
admet-1078	12	14	,	,	PUNCT
admet-1078	12	15	issues	issue	NOUN
admet-1078	12	16	related	relate	VERB
admet-1078	12	17	to	to	ADP
admet-1078	12	18	the	the	DET
admet-1078	12	19	ineffectiveness	ineffectiveness	NOUN
admet-1078	12	20	of	of	ADP
admet-1078	12	21	treatment	treatment	NOUN
admet-1078	12	22	remain	remain	VERB
admet-1078	12	23	one	one	NUM
admet-1078	12	24	of	of	ADP
admet-1078	12	25	the	the	DET
admet-1078	12	26	most	most	ADV
admet-1078	12	27	urgent	urgent	ADJ
admet-1078	12	28	in	in	ADP
admet-1078	12	29	medicine	medicine	NOUN
admet-1078	12	30	.	.	PUNCT
admet-1078	13	1	the	the	DET
admet-1078	13	2	world	world	PROPN
admet-1078	13	3	health	health	PROPN
admet-1078	13	4	organization	organization	NOUN
admet-1078	13	5	(	(	PUNCT
admet-1078	13	6	who	who	PRON
admet-1078	13	7	)	)	PUNCT
admet-1078	13	8	developed	develop	VERB
admet-1078	13	9	and	and	CCONJ
admet-1078	13	10	published	publish	VERB
admet-1078	13	11	in	in	ADP
admet-1078	13	12	2001	2001	NUM
admet-1078	13	13	the	the	DET
admet-1078	13	14	who	who	PRON
admet-1078	13	15	global	global	ADJ
admet-1078	13	16	strategy	strategy	NOUN
admet-1078	13	17	for	for	ADP
admet-1078	13	18	containing	contain	VERB
admet-1078	13	19	antimicrobial	antimicrobial	ADJ
admet-1078	13	20	resistance	resistance	NOUN
admet-1078	13	21	,	,	PUNCT
admet-1078	13	22	which	which	PRON
admet-1078	13	23	recommends	recommend	VERB
admet-1078	13	24	considering	consider	VERB
admet-1078	13	25	this	this	DET
admet-1078	13	26	problem	problem	NOUN
admet-1078	13	27	as	as	ADP
admet-1078	13	28	one	one	NUM
admet-1078	13	29	of	of	ADP
admet-1078	13	30	the	the	DET
admet-1078	13	31	priorities	priority	NOUN
admet-1078	13	32	of	of	ADP
admet-1078	13	33	national	national	ADJ
admet-1078	13	34	health	health	NOUN
admet-1078	13	35	systems	system	NOUN
admet-1078	13	36	[	[	X
admet-1078	13	37	1	1	NUM
admet-1078	13	38	]	]	PUNCT
admet-1078	13	39	.	.	PUNCT
admet-1078	14	1	the	the	DET
admet-1078	14	2	significance	significance	NOUN
admet-1078	14	3	of	of	ADP
admet-1078	14	4	the	the	DET
admet-1078	14	5	problem	problem	NOUN
admet-1078	14	6	of	of	ADP
admet-1078	14	7	antibiotic	antibiotic	ADJ
admet-1078	14	8	resistance	resistance	NOUN
admet-1078	14	9	is	be	AUX
admet-1078	14	10	determined	determine	VERB
admet-1078	14	11	by	by	ADP
admet-1078	14	12	the	the	DET
admet-1078	14	13	widespread	widespread	ADJ
admet-1078	14	14	prevalence	prevalence	NOUN
admet-1078	14	15	of	of	ADP
admet-1078	14	16	resistant	resistant	ADJ
admet-1078	14	17	microorganisms	microorganism	NOUN
admet-1078	14	18	in	in	ADP
admet-1078	14	19	inpatient	inpatient	NOUN
admet-1078	14	20	departments	department	NOUN
admet-1078	14	21	and	and	CCONJ
admet-1078	14	22	the	the	DET
admet-1078	14	23	wide	wide	ADJ
admet-1078	14	24	access	access	NOUN
admet-1078	14	25	to	to	ADP
admet-1078	14	26	drugs	drug	NOUN
admet-1078	14	27	used	use	VERB
admet-1078	14	28	for	for	ADP
admet-1078	14	29	the	the	DET
admet-1078	14	30	treatment	treatment	NOUN
admet-1078	14	31	of	of	ADP
admet-1078	14	32	multi	multi	ADJ
admet-1078	14	33	-	-	ADJ
admet-1078	14	34	resistant	resistant	ADJ
admet-1078	14	35	strains	strain	NOUN
admet-1078	15	1	[	[	X
admet-1078	15	2	2	2	NUM
admet-1078	15	3	]	]	PUNCT
admet-1078	15	4	.	.	PUNCT
admet-1078	16	1	a	a	DET
admet-1078	16	2	decrease	decrease	NOUN
admet-1078	16	3	in	in	ADP
admet-1078	16	4	the	the	DET
admet-1078	16	5	effectiveness	effectiveness	NOUN
admet-1078	16	6	of	of	ADP
admet-1078	16	7	therapy	therapy	NOUN
admet-1078	16	8	ultimately	ultimately	ADV
admet-1078	16	9	requires	require	VERB
admet-1078	16	10	the	the	DET
admet-1078	16	11	use	use	NOUN
admet-1078	16	12	of	of	ADP
admet-1078	16	13	more	more	ADV
admet-1078	16	14	expensive	expensive	ADJ
admet-1078	16	15	drugs	drug	NOUN
admet-1078	16	16	and	and	CCONJ
admet-1078	16	17	an	an	DET
admet-1078	16	18	increase	increase	NOUN
admet-1078	16	19	in	in	ADP
admet-1078	16	20	the	the	DET
admet-1078	16	21	duration	duration	NOUN
admet-1078	16	22	of	of	ADP
admet-1078	16	23	treatment	treatment	NOUN
admet-1078	16	24	,	,	PUNCT
admet-1078	16	25	which	which	PRON
admet-1078	16	26	leads	lead	VERB
admet-1078	16	27	to	to	ADP
admet-1078	16	28	hospitalization	hospitalization	NOUN
admet-1078	16	29	time	time	NOUN
admet-1078	16	30	increase	increase	NOUN
admet-1078	16	31	,	,	PUNCT
admet-1078	16	32	economic	economic	ADJ
admet-1078	16	33	losses	loss	NOUN
admet-1078	16	34	,	,	PUNCT
admet-1078	16	35	and	and	CCONJ
admet-1078	16	36	mortality	mortality	NOUN
admet-1078	16	37	risk	risk	NOUN
admet-1078	16	38	[	[	X
admet-1078	16	39	3	3	NUM
admet-1078	16	40	]	]	PUNCT
admet-1078	16	41	.	.	PUNCT
admet-1078	17	1	tuberculosis	tuberculosis	NOUN
admet-1078	17	2	(	(	PUNCT
admet-1078	17	3	tb	tb	NOUN
admet-1078	17	4	)	)	PUNCT
admet-1078	17	5	is	be	AUX
admet-1078	17	6	a	a	DET
admet-1078	17	7	socially	socially	ADV
admet-1078	17	8	significant	significant	ADJ
admet-1078	17	9	disease	disease	NOUN
admet-1078	17	10	and	and	CCONJ
admet-1078	17	11	the	the	DET
admet-1078	17	12	deadliest	deadly	ADJ
admet-1078	17	13	infection	infection	NOUN
admet-1078	17	14	,	,	PUNCT
admet-1078	17	15	continuing	continue	VERB
admet-1078	17	16	to	to	PART
admet-1078	17	17	be	be	AUX
admet-1078	17	18	the	the	DET
admet-1078	17	19	most	most	ADV
admet-1078	17	20	pressing	press	VERB
admet-1078	17	21	challenge	challenge	NOUN
admet-1078	17	22	for	for	ADP
admet-1078	17	23	the	the	DET
admet-1078	17	24	healthcare	healthcare	NOUN
admet-1078	17	25	system	system	NOUN
admet-1078	17	26	around	around	ADP
admet-1078	17	27	the	the	DET
admet-1078	17	28	world	world	NOUN
admet-1078	17	29	.	.	PUNCT
admet-1078	18	1	according	accord	VERB
admet-1078	18	2	to	to	ADP
admet-1078	18	3	who	who	PRON
admet-1078	18	4	,	,	PUNCT
admet-1078	18	5	tb	tb	X
admet-1078	18	6	is	be	AUX
admet-1078	18	7	the	the	DET
admet-1078	18	8	ninth	ninth	ADJ
admet-1078	18	9	leading	lead	VERB
admet-1078	18	10	cause	cause	NOUN
admet-1078	18	11	of	of	ADP
admet-1078	18	12	death	death	NOUN
admet-1078	18	13	in	in	ADP
admet-1078	18	14	the	the	DET
admet-1078	18	15	world	world	NOUN
admet-1078	18	16	,	,	PUNCT
admet-1078	18	17	having	having	AUX
admet-1078	18	18	been	be	AUX
admet-1078	18	19	the	the	DET
admet-1078	18	20	leading	lead	VERB
admet-1078	18	21	cause	cause	NOUN
admet-1078	18	22	of	of	ADP
admet-1078	18	23	death	death	NOUN
admet-1078	18	24	from	from	ADP
admet-1078	18	25	any	any	DET
admet-1078	18	26	single	single	ADJ
admet-1078	18	27	infectious	infectious	ADJ
admet-1078	18	28	agent	agent	NOUN
admet-1078	18	29	,	,	PUNCT
admet-1078	18	30	ahead	ahead	ADV
admet-1078	18	31	of	of	ADP
admet-1078	18	32	human	human	ADJ
admet-1078	18	33	immunodeficiency	immunodeficiency	NOUN
admet-1078	18	34	virus	virus	NOUN
admet-1078	18	35	(	(	PUNCT
admet-1078	18	36	hiv	hiv	PROPN
admet-1078	18	37	)	)	PUNCT
admet-1078	18	38	/	/	PUNCT
admet-1078	18	39	acquired	acquire	VERB
admet-1078	18	40	immunodeficiency	immunodeficiency	NOUN
admet-1078	18	41	syndrome	syndrome	NOUN
admet-1078	18	42	(	(	PUNCT
admet-1078	18	43	aids	aids	PROPN
admet-1078	18	44	)	)	PUNCT
admet-1078	18	45	,	,	PUNCT
admet-1078	18	46	till	till	SCONJ
admet-1078	18	47	2020	2020	NUM
admet-1078	18	48	,	,	PUNCT
admet-1078	18	49	when	when	SCONJ
admet-1078	18	50	http://dx.doi.org/10.5599/admet.1078	http://dx.doi.org/10.5599/admet.1078	PROPN
admet-1078	18	51	https://doi.org/10.5599/admet.1078	https://doi.org/10.5599/admet.1078	PROPN
admet-1078	18	52	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	PROPN
admet-1078	18	53	mailto:svberns@yandex.ru	mailto:svberns@yandex.ru	VERB
admet-1078	18	54	mailto:julia.is.alex@gmail.com	mailto:julia.is.alex@gmail.com	X
admet-1078	18	55	mailto:pekhterevapolina@gmail.com	mailto:pekhterevapolina@gmail.com	PROPN
admet-1078	18	56	mailto:pekhterevapolina@gmail.com	mailto:pekhterevapolina@gmail.com	PROPN
admet-1078	19	1	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-1078	19	2	svetlana	svetlana	PROPN
admet-1078	19	3	a.	a.	PROPN
admet-1078	19	4	berns	berns	PROPN
admet-1078	19	5	et	et	PROPN
admet-1078	19	6	al	al	PROPN
admet-1078	19	7	.	.	PROPN
admet-1078	19	8	admet	admet	PROPN
admet-1078	19	9	&	&	CCONJ
admet-1078	19	10	dmpk	dmpk	PROPN
admet-1078	19	11	10(1	10(1	NUM
admet-1078	19	12	)	)	PUNCT
admet-1078	19	13	(	(	PUNCT
admet-1078	19	14	2022	2022	NUM
admet-1078	19	15	)	)	PUNCT
admet-1078	19	16	63	63	NUM
admet-1078	19	17	-	-	SYM
admet-1078	19	18	73	73	NUM
admet-1078	19	19	64	64	NUM
admet-1078	19	20	covid-19	covid-19	PROPN
admet-1078	19	21	occupied	occupy	VERB
admet-1078	19	22	this	this	DET
admet-1078	19	23	place	place	NOUN
admet-1078	19	24	[	[	X
admet-1078	19	25	4	4	NUM
admet-1078	19	26	]	]	PUNCT
admet-1078	19	27	.	.	PUNCT
admet-1078	20	1	in	in	ADP
admet-1078	20	2	2019	2019	NUM
admet-1078	20	3	,	,	PUNCT
admet-1078	20	4	who	who	PRON
admet-1078	20	5	estimates	estimate	VERB
admet-1078	20	6	that	that	SCONJ
admet-1078	20	7	1.21	1.21	NUM
admet-1078	20	8	million	million	NUM
admet-1078	20	9	hiv	hiv	NOUN
admet-1078	20	10	-	-	PUNCT
admet-1078	20	11	negative	negative	ADJ
admet-1078	20	12	people	people	NOUN
admet-1078	20	13	died	die	VERB
admet-1078	20	14	from	from	ADP
admet-1078	20	15	tb	tb	PROPN
admet-1078	20	16	(	(	PUNCT
admet-1078	20	17	less	less	ADJ
admet-1078	20	18	than	than	ADP
admet-1078	20	19	1.7	1.7	NUM
admet-1078	20	20	million	million	NUM
admet-1078	20	21	deaths	death	NOUN
admet-1078	20	22	in	in	ADP
admet-1078	20	23	2000	2000	NUM
admet-1078	20	24	)	)	PUNCT
admet-1078	20	25	,	,	PUNCT
admet-1078	20	26	and	and	CCONJ
admet-1078	20	27	208,000	208,000	NUM
admet-1078	20	28	deaths	death	NOUN
admet-1078	20	29	were	be	AUX
admet-1078	20	30	reported	report	VERB
admet-1078	20	31	among	among	ADP
admet-1078	20	32	hiv	hiv	PROPN
admet-1078	20	33	-	-	PUNCT
admet-1078	20	34	positive	positive	ADJ
admet-1078	20	35	people	people	NOUN
admet-1078	21	1	[	[	X
admet-1078	21	2	5	5	NUM
admet-1078	21	3	]	]	PUNCT
admet-1078	21	4	.	.	PUNCT
admet-1078	22	1	thus	thus	ADV
admet-1078	22	2	,	,	PUNCT
admet-1078	22	3	global	global	ADJ
admet-1078	22	4	tb	tb	ADP
admet-1078	22	5	deaths	death	NOUN
admet-1078	22	6	have	have	AUX
admet-1078	22	7	been	be	AUX
admet-1078	22	8	reduced	reduce	VERB
admet-1078	22	9	by	by	ADP
admet-1078	22	10	35	35	NUM
admet-1078	22	11	%	%	NOUN
admet-1078	22	12	from	from	ADP
admet-1078	22	13	2015	2015	NUM
admet-1078	22	14	to	to	ADP
admet-1078	22	15	2020	2020	NUM
admet-1078	22	16	.	.	PUNCT
admet-1078	23	1	the	the	DET
admet-1078	23	2	incidence	incidence	NOUN
admet-1078	23	3	of	of	ADP
admet-1078	23	4	tb	tb	NOUN
admet-1078	23	5	has	have	AUX
admet-1078	23	6	decreased	decrease	VERB
admet-1078	23	7	by	by	ADP
admet-1078	23	8	20	20	NUM
admet-1078	23	9	%	%	NOUN
admet-1078	23	10	over	over	ADP
admet-1078	23	11	the	the	DET
admet-1078	23	12	same	same	ADJ
admet-1078	23	13	period	period	NOUN
admet-1078	23	14	.	.	PUNCT
admet-1078	24	1	in	in	ADP
admet-1078	24	2	this	this	DET
admet-1078	24	3	way	way	NOUN
admet-1078	24	4	,	,	PUNCT
admet-1078	24	5	there	there	PRON
admet-1078	24	6	are	be	VERB
admet-1078	24	7	notable	notable	ADJ
admet-1078	24	8	successes	success	NOUN
admet-1078	24	9	in	in	ADP
admet-1078	24	10	the	the	DET
admet-1078	24	11	fight	fight	NOUN
admet-1078	24	12	against	against	ADP
admet-1078	24	13	this	this	DET
admet-1078	24	14	infectious	infectious	ADJ
admet-1078	24	15	disease	disease	NOUN
admet-1078	24	16	,	,	PUNCT
admet-1078	24	17	but	but	CCONJ
admet-1078	24	18	so	so	ADV
admet-1078	24	19	far	far	ADV
admet-1078	24	20	,	,	PUNCT
admet-1078	24	21	not	not	PART
admet-1078	24	22	enough	enough	ADJ
admet-1078	24	23	to	to	PART
admet-1078	24	24	achieve	achieve	VERB
admet-1078	24	25	the	the	DET
admet-1078	24	26	global	global	ADJ
admet-1078	24	27	goals	goal	NOUN
admet-1078	24	28	set	set	VERB
admet-1078	24	29	by	by	ADP
admet-1078	24	30	the	the	DET
admet-1078	24	31	who	who	PRON
admet-1078	24	32	[	[	X
admet-1078	24	33	5	5	NUM
admet-1078	24	34	]	]	PUNCT
admet-1078	24	35	.	.	PUNCT
admet-1078	25	1	most	most	ADJ
admet-1078	25	2	tb	tb	ADP
admet-1078	25	3	deaths	death	NOUN
admet-1078	25	4	can	can	AUX
admet-1078	25	5	be	be	AUX
admet-1078	25	6	prevented	prevent	VERB
admet-1078	25	7	with	with	ADP
admet-1078	25	8	early	early	ADJ
admet-1078	25	9	diagnosis	diagnosis	NOUN
admet-1078	25	10	and	and	CCONJ
admet-1078	25	11	appropriate	appropriate	ADJ
admet-1078	25	12	treatment	treatment	NOUN
admet-1078	25	13	.	.	PUNCT
admet-1078	26	1	millions	million	NOUN
admet-1078	26	2	of	of	ADP
admet-1078	26	3	people	people	NOUN
admet-1078	26	4	are	be	AUX
admet-1078	26	5	diagnosed	diagnose	VERB
admet-1078	26	6	and	and	CCONJ
admet-1078	26	7	successfully	successfully	ADV
admet-1078	26	8	treated	treat	VERB
admet-1078	26	9	with	with	ADP
admet-1078	26	10	tb	tb	NOUN
admet-1078	26	11	each	each	DET
admet-1078	26	12	year	year	NOUN
admet-1078	26	13	,	,	PUNCT
admet-1078	26	14	but	but	CCONJ
admet-1078	26	15	there	there	PRON
admet-1078	26	16	are	be	VERB
admet-1078	26	17	still	still	ADV
admet-1078	26	18	significant	significant	ADJ
admet-1078	26	19	gaps	gap	NOUN
admet-1078	26	20	in	in	ADP
admet-1078	26	21	the	the	DET
admet-1078	26	22	detection	detection	NOUN
admet-1078	26	23	and	and	CCONJ
admet-1078	26	24	therapy	therapy	NOUN
admet-1078	26	25	of	of	ADP
admet-1078	26	26	the	the	DET
admet-1078	26	27	disease	disease	NOUN
admet-1078	26	28	.	.	PUNCT
admet-1078	27	1	the	the	DET
admet-1078	27	2	situation	situation	NOUN
admet-1078	27	3	may	may	AUX
admet-1078	27	4	be	be	AUX
admet-1078	27	5	aggravated	aggravate	VERB
admet-1078	27	6	by	by	ADP
admet-1078	27	7	the	the	DET
admet-1078	27	8	epidemic	epidemic	NOUN
admet-1078	27	9	threat	threat	NOUN
admet-1078	27	10	of	of	ADP
admet-1078	27	11	covid-19	covid-19	PROPN
admet-1078	27	12	,	,	PUNCT
admet-1078	27	13	in	in	ADP
admet-1078	27	14	particular	particular	ADJ
admet-1078	27	15	,	,	PUNCT
admet-1078	27	16	due	due	ADP
admet-1078	27	17	to	to	ADP
admet-1078	27	18	the	the	DET
admet-1078	27	19	redistribution	redistribution	NOUN
admet-1078	27	20	of	of	ADP
admet-1078	27	21	human	human	ADJ
admet-1078	27	22	,	,	PUNCT
admet-1078	27	23	financial	financial	ADJ
admet-1078	27	24	,	,	PUNCT
admet-1078	27	25	and	and	CCONJ
admet-1078	27	26	other	other	ADJ
admet-1078	27	27	resources	resource	NOUN
admet-1078	27	28	not	not	PART
admet-1078	27	29	in	in	ADP
admet-1078	27	30	favour	favour	NOUN
admet-1078	27	31	of	of	ADP
admet-1078	27	32	diagnosis	diagnosis	NOUN
admet-1078	27	33	and	and	CCONJ
admet-1078	27	34	treatment	treatment	NOUN
admet-1078	27	35	of	of	ADP
admet-1078	27	36	tuberculosis	tuberculosis	NOUN
admet-1078	27	37	.	.	PUNCT
admet-1078	28	1	the	the	DET
admet-1078	28	2	number	number	NOUN
admet-1078	28	3	of	of	ADP
admet-1078	28	4	medical	medical	ADJ
admet-1078	28	5	institutions	institution	NOUN
admet-1078	28	6	providing	provide	VERB
admet-1078	28	7	inpatient	inpatient	NOUN
admet-1078	28	8	and	and	CCONJ
admet-1078	28	9	outpatient	outpatient	NOUN
admet-1078	28	10	care	care	NOUN
admet-1078	28	11	for	for	ADP
admet-1078	28	12	tb	tb	ADP
admet-1078	28	13	patients	patient	NOUN
admet-1078	28	14	has	have	AUX
admet-1078	28	15	decreased	decrease	VERB
admet-1078	28	16	,	,	PUNCT
admet-1078	28	17	and	and	CCONJ
admet-1078	28	18	there	there	PRON
admet-1078	28	19	are	be	VERB
admet-1078	28	20	overlaps	overlap	NOUN
admet-1078	28	21	in	in	ADP
admet-1078	28	22	data	datum	NOUN
admet-1078	28	23	collection	collection	NOUN
admet-1078	28	24	and	and	CCONJ
admet-1078	28	25	reporting	report	VERB
admet-1078	28	26	[	[	X
admet-1078	28	27	5	5	NUM
admet-1078	28	28	]	]	PUNCT
admet-1078	28	29	.	.	PUNCT
admet-1078	29	1	in	in	ADP
admet-1078	29	2	conditions	condition	NOUN
admet-1078	29	3	of	of	ADP
admet-1078	29	4	unstable	unstable	ADJ
admet-1078	29	5	drug	drug	NOUN
admet-1078	29	6	supply	supply	NOUN
admet-1078	29	7	,	,	PUNCT
admet-1078	29	8	underdeveloped	underdeveloped	ADJ
admet-1078	29	9	infrastructure	infrastructure	NOUN
admet-1078	29	10	,	,	PUNCT
admet-1078	29	11	and	and	CCONJ
admet-1078	29	12	limited	limited	ADJ
admet-1078	29	13	resources	resource	NOUN
admet-1078	29	14	[	[	X
admet-1078	29	15	6	6	NUM
admet-1078	29	16	]	]	PUNCT
admet-1078	29	17	,	,	PUNCT
admet-1078	29	18	the	the	DET
admet-1078	29	19	threat	threat	NOUN
admet-1078	29	20	of	of	ADP
admet-1078	29	21	drug	drug	NOUN
admet-1078	29	22	-	-	PUNCT
admet-1078	29	23	resistant	resistant	ADJ
admet-1078	29	24	tb	tb	X
admet-1078	29	25	remains	remain	VERB
admet-1078	29	26	.	.	PUNCT
admet-1078	30	1	according	accord	VERB
admet-1078	30	2	to	to	ADP
admet-1078	30	3	who	who	PRON
admet-1078	30	4	estimates	estimate	VERB
admet-1078	30	5	,	,	PUNCT
admet-1078	30	6	in	in	ADP
admet-1078	30	7	2019	2019	NUM
admet-1078	30	8	,	,	PUNCT
admet-1078	30	9	in	in	ADP
admet-1078	30	10	the	the	DET
admet-1078	30	11	world	world	NOUN
admet-1078	30	12	,	,	PUNCT
admet-1078	30	13	3.3	3.3	NUM
admet-1078	30	14	%	%	NOUN
admet-1078	30	15	(	(	PUNCT
admet-1078	30	16	95	95	NUM
admet-1078	30	17	%	%	NOUN
admet-1078	30	18	confidence	confidence	NOUN
admet-1078	30	19	interval	interval	NOUN
admet-1078	30	20	(	(	PUNCT
admet-1078	30	21	ci	ci	NOUN
admet-1078	30	22	):	):	PUNCT
admet-1078	30	23	2.3–4.3	2.3–4.3	NUM
admet-1078	30	24	%	%	NOUN
admet-1078	30	25	)	)	PUNCT
admet-1078	30	26	of	of	ADP
admet-1078	30	27	newly	newly	ADV
admet-1078	30	28	diagnosed	diagnose	VERB
admet-1078	30	29	tb	tb	ADP
admet-1078	30	30	cases	case	NOUN
admet-1078	30	31	and	and	CCONJ
admet-1078	30	32	18	18	NUM
admet-1078	30	33	%	%	NOUN
admet-1078	30	34	(	(	PUNCT
admet-1078	30	35	95	95	NUM
admet-1078	30	36	%	%	NOUN
admet-1078	30	37	ci	ci	NOUN
admet-1078	30	38	:	:	PUNCT
admet-1078	30	39	9.7–27	9.7–27	NUM
admet-1078	30	40	%	%	NOUN
admet-1078	30	41	)	)	PUNCT
admet-1078	30	42	of	of	ADP
admet-1078	30	43	previously	previously	ADV
admet-1078	30	44	treated	treat	VERB
admet-1078	30	45	patients	patient	NOUN
admet-1078	30	46	have	have	AUX
admet-1078	30	47	been	be	AUX
admet-1078	30	48	identified	identify	VERB
admet-1078	30	49	as	as	ADP
admet-1078	30	50	resistant	resistant	ADJ
admet-1078	30	51	to	to	ADP
admet-1078	30	52	rifampicin	rifampicin	VERB
admet-1078	30	53	(	(	PUNCT
admet-1078	30	54	rr	rr	NOUN
admet-1078	30	55	-	-	PUNCT
admet-1078	30	56	tb	tb	NOUN
admet-1078	30	57	)	)	PUNCT
admet-1078	30	58	,	,	PUNCT
admet-1078	30	59	the	the	DET
admet-1078	30	60	most	most	ADV
admet-1078	30	61	effective	effective	ADJ
admet-1078	30	62	first	first	ADJ
admet-1078	30	63	-	-	PUNCT
admet-1078	30	64	line	line	NOUN
admet-1078	30	65	drug	drug	NOUN
admet-1078	30	66	,	,	PUNCT
admet-1078	30	67	or	or	CCONJ
admet-1078	30	68	multidrug	multidrug	NOUN
admet-1078	30	69	-	-	PUNCT
admet-1078	30	70	resistant	resistant	ADJ
admet-1078	30	71	tb	tb	X
admet-1078	30	72	(	(	PUNCT
admet-1078	30	73	mdr	mdr	PROPN
admet-1078	30	74	-	-	NOUN
admet-1078	30	75	tb	tb	NOUN
admet-1078	30	76	)	)	PUNCT
admet-1078	30	77	.	.	PUNCT
admet-1078	31	1	among	among	ADP
admet-1078	31	2	them	they	PRON
admet-1078	31	3	,	,	PUNCT
admet-1078	31	4	20.1	20.1	NUM
admet-1078	31	5	%	%	NOUN
admet-1078	31	6	(	(	PUNCT
admet-1078	31	7	95	95	NUM
admet-1078	31	8	%	%	NOUN
admet-1078	31	9	ci	ci	NOUN
admet-1078	31	10	:	:	PUNCT
admet-1078	31	11	15.5	15.5	NUM
admet-1078	31	12	-	-	SYM
admet-1078	31	13	25.0	25.0	NUM
admet-1078	31	14	%	%	NOUN
admet-1078	31	15	)	)	PUNCT
admet-1078	31	16	were	be	AUX
admet-1078	31	17	also	also	ADV
admet-1078	31	18	resistant	resistant	ADJ
admet-1078	31	19	to	to	ADP
admet-1078	31	20	fluoroquinolones	fluoroquinolone	NOUN
admet-1078	31	21	,	,	PUNCT
admet-1078	31	22	the	the	DET
admet-1078	31	23	drugs	drug	NOUN
admet-1078	31	24	of	of	ADP
admet-1078	31	25	choice	choice	NOUN
admet-1078	31	26	in	in	ADP
admet-1078	31	27	establishing	establish	VERB
admet-1078	31	28	resistance	resistance	NOUN
admet-1078	31	29	to	to	ADP
admet-1078	31	30	rifampicin	rifampicin	NOUN
admet-1078	31	31	or	or	CCONJ
admet-1078	31	32	isoniazid	isoniazid	NOUN
admet-1078	31	33	.	.	PUNCT
admet-1078	32	1	it	it	PRON
admet-1078	32	2	is	be	AUX
admet-1078	32	3	alarming	alarm	VERB
admet-1078	32	4	that	that	SCONJ
admet-1078	32	5	about	about	ADP
admet-1078	32	6	half	half	NOUN
admet-1078	32	7	of	of	ADP
admet-1078	32	8	these	these	DET
admet-1078	32	9	cases	case	NOUN
admet-1078	32	10	are	be	AUX
admet-1078	32	11	registered	register	VERB
admet-1078	32	12	in	in	ADP
admet-1078	32	13	india	india	PROPN
admet-1078	32	14	,	,	PUNCT
admet-1078	32	15	china	china	PROPN
admet-1078	32	16	and	and	CCONJ
admet-1078	32	17	the	the	DET
admet-1078	32	18	russian	russian	PROPN
admet-1078	32	19	federation	federation	PROPN
admet-1078	33	1	[	[	X
admet-1078	33	2	5	5	NUM
admet-1078	33	3	]	]	PUNCT
admet-1078	33	4	.	.	PUNCT
admet-1078	34	1	the	the	DET
admet-1078	34	2	problem	problem	NOUN
admet-1078	34	3	of	of	ADP
admet-1078	34	4	overcoming	overcome	VERB
admet-1078	34	5	drug	drug	NOUN
admet-1078	34	6	resistance	resistance	NOUN
admet-1078	34	7	to	to	ADP
admet-1078	34	8	tb	tb	NOUN
admet-1078	34	9	is	be	AUX
admet-1078	34	10	also	also	ADV
admet-1078	34	11	complicated	complicated	ADJ
admet-1078	34	12	because	because	SCONJ
admet-1078	34	13	chemotherapy	chemotherapy	NOUN
admet-1078	34	14	itself	itself	PRON
admet-1078	34	15	has	have	VERB
admet-1078	34	16	an	an	DET
admet-1078	34	17	antimicrobial	antimicrobial	ADJ
admet-1078	34	18	effect	effect	NOUN
admet-1078	34	19	and	and	CCONJ
admet-1078	34	20	suppresses	suppress	VERB
admet-1078	34	21	the	the	DET
admet-1078	34	22	immune	immune	ADJ
admet-1078	34	23	system	system	NOUN
admet-1078	34	24	's	's	PART
admet-1078	34	25	activity	activity	NOUN
admet-1078	34	26	and	and	CCONJ
admet-1078	34	27	can	can	AUX
admet-1078	34	28	aggravate	aggravate	VERB
admet-1078	34	29	the	the	DET
admet-1078	34	30	patient	patient	NOUN
admet-1078	34	31	's	's	PART
admet-1078	34	32	immunological	immunological	ADJ
admet-1078	34	33	reactivity	reactivity	NOUN
admet-1078	34	34	.	.	PUNCT
admet-1078	35	1	impaired	impair	VERB
admet-1078	35	2	immune	immune	ADJ
admet-1078	35	3	response	response	NOUN
admet-1078	35	4	in	in	ADP
admet-1078	35	5	tb	tb	ADP
admet-1078	35	6	patients	patient	NOUN
admet-1078	35	7	can	can	AUX
admet-1078	35	8	be	be	AUX
admet-1078	35	9	corrected	correct	VERB
admet-1078	35	10	by	by	ADP
admet-1078	35	11	immunotherapy	immunotherapy	NOUN
admet-1078	35	12	.	.	PUNCT
admet-1078	36	1	the	the	DET
admet-1078	36	2	correction	correction	NOUN
admet-1078	36	3	of	of	ADP
admet-1078	36	4	the	the	DET
admet-1078	36	5	immune	immune	ADJ
admet-1078	36	6	status	status	NOUN
admet-1078	36	7	in	in	ADP
admet-1078	36	8	mdr	mdr	PROPN
admet-1078	36	9	-	-	PROPN
admet-1078	36	10	tb	tb	ADP
admet-1078	36	11	patients	patient	NOUN
admet-1078	36	12	is	be	AUX
admet-1078	36	13	of	of	ADP
admet-1078	36	14	particular	particular	ADJ
admet-1078	36	15	importance	importance	NOUN
admet-1078	36	16	because	because	SCONJ
admet-1078	36	17	these	these	DET
admet-1078	36	18	patients	patient	NOUN
admet-1078	36	19	initially	initially	ADV
admet-1078	36	20	have	have	VERB
admet-1078	36	21	a	a	DET
admet-1078	36	22	worse	bad	ADJ
admet-1078	36	23	prognosis	prognosis	NOUN
admet-1078	36	24	and	and	CCONJ
admet-1078	36	25	a	a	DET
admet-1078	36	26	more	more	ADV
admet-1078	36	27	severe	severe	ADJ
admet-1078	36	28	course	course	NOUN
admet-1078	36	29	of	of	ADP
admet-1078	36	30	the	the	DET
admet-1078	36	31	disease	disease	NOUN
admet-1078	36	32	[	[	X
admet-1078	36	33	7	7	NUM
admet-1078	36	34	]	]	PUNCT
admet-1078	36	35	.	.	PUNCT
admet-1078	37	1	in	in	ADP
admet-1078	37	2	such	such	ADJ
admet-1078	37	3	conditions	condition	NOUN
admet-1078	37	4	,	,	PUNCT
admet-1078	37	5	the	the	DET
admet-1078	37	6	possibility	possibility	NOUN
admet-1078	37	7	of	of	ADP
admet-1078	37	8	adjuvant	adjuvant	ADJ
admet-1078	37	9	immunotherapy	immunotherapy	NOUN
admet-1078	37	10	,	,	PUNCT
admet-1078	37	11	which	which	PRON
admet-1078	37	12	can	can	AUX
admet-1078	37	13	change	change	VERB
admet-1078	37	14	the	the	DET
admet-1078	37	15	course	course	NOUN
admet-1078	37	16	of	of	ADP
admet-1078	37	17	the	the	DET
admet-1078	37	18	disease	disease	NOUN
admet-1078	37	19	and	and	CCONJ
admet-1078	37	20	alleviate	alleviate	VERB
admet-1078	37	21	the	the	DET
admet-1078	37	22	patient	patient	NOUN
admet-1078	37	23	's	's	PART
admet-1078	37	24	condition	condition	NOUN
admet-1078	37	25	,	,	PUNCT
admet-1078	37	26	gains	gain	VERB
admet-1078	37	27	a	a	DET
admet-1078	37	28	special	special	ADJ
admet-1078	37	29	role	role	NOUN
admet-1078	37	30	.	.	PUNCT
admet-1078	38	1	one	one	NUM
admet-1078	38	2	of	of	ADP
admet-1078	38	3	the	the	DET
admet-1078	38	4	ways	way	NOUN
admet-1078	38	5	of	of	ADP
admet-1078	38	6	such	such	ADJ
admet-1078	38	7	therapy	therapy	NOUN
admet-1078	38	8	is	be	AUX
admet-1078	38	9	to	to	PART
admet-1078	38	10	regulate	regulate	VERB
admet-1078	38	11	the	the	DET
admet-1078	38	12	body	body	NOUN
admet-1078	38	13	's	's	PART
admet-1078	38	14	immune	immune	ADJ
admet-1078	38	15	response	response	NOUN
admet-1078	38	16	.	.	PUNCT
admet-1078	39	1	features	feature	NOUN
admet-1078	39	2	of	of	ADP
admet-1078	39	3	the	the	DET
admet-1078	39	4	formation	formation	NOUN
admet-1078	39	5	of	of	ADP
admet-1078	39	6	the	the	DET
admet-1078	39	7	immune	immune	ADJ
admet-1078	39	8	response	response	NOUN
admet-1078	39	9	in	in	ADP
admet-1078	39	10	bacterial	bacterial	ADJ
admet-1078	39	11	infection	infection	NOUN
admet-1078	39	12	returning	return	VERB
admet-1078	39	13	to	to	ADP
admet-1078	39	14	the	the	DET
admet-1078	39	15	pathophysiological	pathophysiological	ADJ
admet-1078	39	16	background	background	NOUN
admet-1078	39	17	of	of	ADP
admet-1078	39	18	the	the	DET
admet-1078	39	19	immune	immune	ADJ
admet-1078	39	20	response	response	NOUN
admet-1078	39	21	in	in	ADP
admet-1078	39	22	bacterial	bacterial	ADJ
admet-1078	39	23	infection	infection	NOUN
admet-1078	39	24	,	,	PUNCT
admet-1078	39	25	it	it	PRON
admet-1078	39	26	is	be	AUX
admet-1078	39	27	known	know	VERB
admet-1078	39	28	that	that	SCONJ
admet-1078	39	29	when	when	SCONJ
admet-1078	39	30	the	the	DET
admet-1078	39	31	pathogen	pathogen	NOUN
admet-1078	39	32	enters	enter	VERB
admet-1078	39	33	the	the	DET
admet-1078	39	34	human	human	ADJ
admet-1078	39	35	body	body	NOUN
admet-1078	39	36	for	for	ADP
admet-1078	39	37	the	the	DET
admet-1078	39	38	first	first	ADJ
admet-1078	39	39	time	time	NOUN
admet-1078	39	40	,	,	PUNCT
admet-1078	39	41	the	the	DET
admet-1078	39	42	innate	innate	ADJ
admet-1078	39	43	and	and	CCONJ
admet-1078	39	44	adaptive	adaptive	ADJ
admet-1078	39	45	immune	immune	ADJ
admet-1078	39	46	response	response	NOUN
admet-1078	39	47	mechanisms	mechanism	NOUN
admet-1078	39	48	get	get	AUX
admet-1078	39	49	activated	activate	VERB
admet-1078	39	50	[	[	PUNCT
admet-1078	39	51	8	8	NUM
admet-1078	39	52	]	]	PUNCT
admet-1078	39	53	.	.	PUNCT
admet-1078	40	1	in	in	ADP
admet-1078	40	2	case	case	NOUN
admet-1078	40	3	of	of	ADP
admet-1078	40	4	repeated	repeat	VERB
admet-1078	40	5	exposure	exposure	NOUN
admet-1078	40	6	to	to	ADP
admet-1078	40	7	the	the	DET
admet-1078	40	8	same	same	ADJ
admet-1078	40	9	pathogen	pathogen	NOUN
admet-1078	40	10	,	,	PUNCT
admet-1078	40	11	i.	i.	PROPN
admet-1078	40	12	e.	e.	PROPN
admet-1078	40	13	upon	upon	SCONJ
admet-1078	40	14	reinfection	reinfection	NOUN
admet-1078	40	15	,	,	PUNCT
admet-1078	40	16	the	the	DET
admet-1078	40	17	removal	removal	NOUN
admet-1078	40	18	of	of	ADP
admet-1078	40	19	the	the	DET
admet-1078	40	20	pathogen	pathogen	NOUN
admet-1078	40	21	can	can	AUX
admet-1078	40	22	occur	occur	VERB
admet-1078	40	23	at	at	ADP
admet-1078	40	24	a	a	DET
admet-1078	40	25	higher	high	ADJ
admet-1078	40	26	rate	rate	NOUN
admet-1078	40	27	due	due	ADP
admet-1078	40	28	to	to	ADP
admet-1078	40	29	protective	protective	ADJ
admet-1078	40	30	immunity	immunity	NOUN
admet-1078	40	31	and	and	CCONJ
admet-1078	40	32	immunological	immunological	ADJ
admet-1078	40	33	memory	memory	NOUN
admet-1078	40	34	[	[	X
admet-1078	40	35	9	9	NUM
admet-1078	40	36	]	]	PUNCT
admet-1078	40	37	.	.	PUNCT
admet-1078	41	1	the	the	DET
admet-1078	41	2	important	important	ADJ
admet-1078	41	3	role	role	NOUN
admet-1078	41	4	of	of	ADP
admet-1078	41	5	interferons	interferon	NOUN
admet-1078	41	6	(	(	PUNCT
admet-1078	41	7	ifns	ifns	NOUN
admet-1078	41	8	)	)	PUNCT
admet-1078	41	9	in	in	ADP
admet-1078	41	10	the	the	DET
admet-1078	41	11	implementation	implementation	NOUN
admet-1078	41	12	of	of	ADP
admet-1078	41	13	the	the	DET
admet-1078	41	14	immune	immune	ADJ
admet-1078	41	15	response	response	NOUN
admet-1078	41	16	process	process	NOUN
admet-1078	41	17	was	be	AUX
admet-1078	41	18	proven	prove	VERB
admet-1078	41	19	back	back	ADP
admet-1078	41	20	long	long	ADV
admet-1078	41	21	ago	ago	ADV
admet-1078	41	22	[	[	X
admet-1078	41	23	10,11	10,11	NOUN
admet-1078	41	24	]	]	PUNCT
admet-1078	41	25	.	.	PUNCT
admet-1078	42	1	the	the	DET
admet-1078	42	2	search	search	NOUN
admet-1078	42	3	for	for	ADP
admet-1078	42	4	new	new	ADJ
admet-1078	42	5	ways	way	NOUN
admet-1078	42	6	to	to	PART
admet-1078	42	7	overcome	overcome	VERB
admet-1078	42	8	drug	drug	NOUN
admet-1078	42	9	resistance	resistance	NOUN
admet-1078	42	10	in	in	ADP
admet-1078	42	11	patients	patient	NOUN
admet-1078	42	12	with	with	ADP
admet-1078	42	13	mdrtb	mdrtb	NOUN
admet-1078	42	14	aimed	aim	VERB
admet-1078	42	15	at	at	ADP
admet-1078	42	16	the	the	DET
admet-1078	42	17	role	role	NOUN
admet-1078	42	18	of	of	ADP
admet-1078	42	19	ifn	ifn	NOUN
admet-1078	42	20	as	as	ADP
admet-1078	42	21	an	an	DET
admet-1078	42	22	immunomodulator	immunomodulator	NOUN
admet-1078	42	23	in	in	ADP
admet-1078	42	24	the	the	DET
admet-1078	42	25	complex	complex	ADJ
admet-1078	42	26	therapy	therapy	NOUN
admet-1078	42	27	of	of	ADP
admet-1078	42	28	tb	tb	PROPN
admet-1078	42	29	.	.	PUNCT
admet-1078	43	1	the	the	DET
admet-1078	43	2	ifn	ifn	PROPN
admet-1078	43	3	system	system	NOUN
admet-1078	43	4	includes	include	VERB
admet-1078	43	5	the	the	DET
admet-1078	43	6	ifn	ifn	PROPN
admet-1078	43	7	cytokines	cytokine	VERB
admet-1078	43	8	themselves	themselves	PRON
admet-1078	43	9	,	,	PUNCT
admet-1078	43	10	transcriptional	transcriptional	ADJ
admet-1078	43	11	activators	activator	NOUN
admet-1078	43	12	and	and	CCONJ
admet-1078	43	13	repressors	repressor	NOUN
admet-1078	43	14	,	,	PUNCT
admet-1078	43	15	cellular	cellular	ADJ
admet-1078	43	16	receptors	receptor	NOUN
admet-1078	43	17	and	and	CCONJ
admet-1078	43	18	enzyme	enzyme	NOUN
admet-1078	43	19	systems	system	NOUN
admet-1078	43	20	activated	activate	VERB
admet-1078	43	21	by	by	ADP
admet-1078	43	22	them	they	PRON
admet-1078	43	23	.	.	PUNCT
admet-1078	44	1	ifns	ifns	PROPN
admet-1078	44	2	increase	increase	VERB
admet-1078	44	3	the	the	DET
admet-1078	44	4	resistance	resistance	NOUN
admet-1078	44	5	of	of	ADP
admet-1078	44	6	cells	cell	NOUN
admet-1078	44	7	to	to	ADP
admet-1078	44	8	infectious	infectious	ADJ
admet-1078	44	9	agents	agent	NOUN
admet-1078	44	10	and	and	CCONJ
admet-1078	44	11	propagate	propagate	VERB
admet-1078	44	12	signals	signal	NOUN
admet-1078	44	13	to	to	ADP
admet-1078	44	14	other	other	ADJ
admet-1078	44	15	cells	cell	NOUN
admet-1078	44	16	that	that	PRON
admet-1078	44	17	have	have	AUX
admet-1078	44	18	not	not	PART
admet-1078	44	19	previously	previously	ADV
admet-1078	44	20	had	have	VERB
admet-1078	44	21	contact	contact	NOUN
admet-1078	44	22	with	with	ADP
admet-1078	44	23	either	either	CCONJ
admet-1078	44	24	the	the	DET
admet-1078	44	25	antigen	antigen	NOUN
admet-1078	44	26	or	or	CCONJ
admet-1078	44	27	ifn	ifn	PROPN
admet-1078	44	28	.	.	PUNCT
admet-1078	45	1	all	all	DET
admet-1078	45	2	ifns	ifns	NOUN
admet-1078	45	3	are	be	AUX
admet-1078	45	4	divided	divide	VERB
admet-1078	45	5	into	into	ADP
admet-1078	45	6	3	3	NUM
admet-1078	45	7	types	type	NOUN
admet-1078	45	8	:	:	PUNCT
admet-1078	45	9	ifn	ifn	PROPN
admet-1078	45	10	of	of	ADP
admet-1078	45	11	type	type	NOUN
admet-1078	46	1	i	i	PRON
admet-1078	46	2	(	(	PUNCT
admet-1078	46	3	-α	-α	ADV
admet-1078	46	4	,	,	PUNCT
admet-1078	46	5	-β	-β	VERB
admet-1078	46	6	,	,	PUNCT
admet-1078	46	7	-κ	-κ	ADV
admet-1078	46	8	,	,	PUNCT
admet-1078	46	9	-ε	-ε	ADV
admet-1078	46	10	,	,	PUNCT
admet-1078	46	11	-ω	-ω	X
admet-1078	46	12	,	,	PUNCT
admet-1078	46	13	-τ	-τ	PUNCT
admet-1078	46	14	)	)	PUNCT
admet-1078	47	1	[	[	X
admet-1078	47	2	12	12	NUM
admet-1078	47	3	]	]	PUNCT
admet-1078	47	4	,	,	PUNCT
admet-1078	47	5	type	type	NOUN
admet-1078	47	6	ii	ii	PROPN
admet-1078	47	7	(	(	PUNCT
admet-1078	47	8	-γ	-γ	NOUN
admet-1078	47	9	)	)	PUNCT
admet-1078	48	1	[	[	X
admet-1078	48	2	13	13	NUM
admet-1078	48	3	]	]	PUNCT
admet-1078	48	4	and	and	CCONJ
admet-1078	48	5	type	type	NOUN
admet-1078	48	6	iii	iii	PROPN
admet-1078	48	7	(	(	PUNCT
admet-1078	48	8	-λ1	-λ1	NOUN
admet-1078	48	9	-	-	PUNCT
admet-1078	48	10	4	4	NUM
admet-1078	48	11	,	,	PUNCT
admet-1078	48	12	-£1	-£1	NOUN
admet-1078	48	13	-	-	PUNCT
admet-1078	48	14	3	3	NUM
admet-1078	48	15	)	)	PUNCT
admet-1078	49	1	[	[	X
admet-1078	49	2	14	14	NUM
admet-1078	49	3	]	]	PUNCT
admet-1078	49	4	.	.	PUNCT
admet-1078	50	1	at	at	ADP
admet-1078	50	2	an	an	DET
admet-1078	50	3	early	early	ADJ
admet-1078	50	4	stage	stage	NOUN
admet-1078	50	5	of	of	ADP
admet-1078	50	6	infection	infection	NOUN
admet-1078	50	7	(	(	PUNCT
admet-1078	50	8	several	several	ADJ
admet-1078	50	9	hours	hour	NOUN
admet-1078	50	10	)	)	PUNCT
admet-1078	50	11	,	,	PUNCT
admet-1078	50	12	ifns	ifns	NOUN
admet-1078	50	13	of	of	ADP
admet-1078	50	14	types	type	NOUN
admet-1078	50	15	i	i	PRON
admet-1078	50	16	and	and	CCONJ
admet-1078	50	17	ii	ii	PROPN
admet-1078	50	18	are	be	AUX
admet-1078	50	19	produced	produce	VERB
admet-1078	50	20	as	as	ADP
admet-1078	50	21	the	the	DET
admet-1078	50	22	first	first	ADJ
admet-1078	50	23	line	line	NOUN
admet-1078	50	24	of	of	ADP
admet-1078	50	25	immune	immune	ADJ
admet-1078	50	26	defense	defense	NOUN
admet-1078	50	27	in	in	ADP
admet-1078	50	28	order	order	NOUN
admet-1078	50	29	to	to	PART
admet-1078	50	30	attract	attract	VERB
admet-1078	50	31	the	the	DET
admet-1078	50	32	largest	large	ADJ
admet-1078	50	33	number	number	NOUN
admet-1078	50	34	of	of	ADP
admet-1078	50	35	dendritic	dendritic	ADJ
admet-1078	50	36	cells	cell	NOUN
admet-1078	50	37	and	and	CCONJ
admet-1078	50	38	macrophages	macrophage	NOUN
admet-1078	50	39	to	to	ADP
admet-1078	50	40	the	the	DET
admet-1078	50	41	site	site	NOUN
admet-1078	50	42	of	of	ADP
admet-1078	50	43	injury	injury	NOUN
admet-1078	50	44	,	,	PUNCT
admet-1078	50	45	which	which	PRON
admet-1078	50	46	trigger	trigger	VERB
admet-1078	50	47	active	active	ADJ
admet-1078	50	48	phagocytosis	phagocytosis	NOUN
admet-1078	50	49	and	and	CCONJ
admet-1078	50	50	inactivate	inactivate	VERB
admet-1078	50	51	the	the	DET
admet-1078	50	52	pathogen	pathogen	NOUN
admet-1078	50	53	.	.	PUNCT
admet-1078	51	1	however	however	ADV
admet-1078	51	2	,	,	PUNCT
admet-1078	51	3	if	if	SCONJ
admet-1078	51	4	there	there	PRON
admet-1078	51	5	is	be	VERB
admet-1078	51	6	a	a	DET
admet-1078	51	7	defect	defect	NOUN
admet-1078	51	8	in	in	ADP
admet-1078	51	9	the	the	DET
admet-1078	51	10	admet	admet	PROPN
admet-1078	51	11	&	&	CCONJ
admet-1078	51	12	dmpk	dmpk	PROPN
admet-1078	51	13	10(1	10(1	NUM
admet-1078	51	14	)	)	PUNCT
admet-1078	51	15	(	(	PUNCT
admet-1078	51	16	2022	2022	NUM
admet-1078	51	17	)	)	PUNCT
admet-1078	51	18	63	63	NUM
admet-1078	51	19	-	-	SYM
admet-1078	51	20	73	73	NUM
admet-1078	51	21	therapeutic	therapeutic	ADJ
admet-1078	51	22	potential	potential	NOUN
admet-1078	51	23	of	of	ADP
admet-1078	51	24	interferon	interferon	ADJ
admet-1078	51	25	-	-	PUNCT
admet-1078	51	26	gamma	gamma	NOUN
admet-1078	51	27	in	in	ADP
admet-1078	51	28	tuberculosis	tuberculosis	NOUN
admet-1078	51	29	doi	doi	NOUN
admet-1078	51	30	:	:	PUNCT
admet-1078	51	31	http://dx.doi.org/10.5599/admet.1078	http://dx.doi.org/10.5599/admet.1078	PROPN
admet-1078	51	32	65	65	NUM
admet-1078	51	33	immune	immune	ADJ
admet-1078	51	34	mechanism	mechanism	NOUN
admet-1078	51	35	,	,	PUNCT
admet-1078	51	36	attracted	attract	VERB
admet-1078	51	37	macrophages	macrophage	NOUN
admet-1078	51	38	can	can	AUX
admet-1078	51	39	promote	promote	VERB
admet-1078	51	40	infection	infection	NOUN
admet-1078	51	41	,	,	PUNCT
admet-1078	51	42	providing	provide	VERB
admet-1078	51	43	the	the	DET
admet-1078	51	44	microorganism	microorganism	NOUN
admet-1078	51	45	with	with	ADP
admet-1078	51	46	a	a	DET
admet-1078	51	47	target	target	NOUN
admet-1078	51	48	for	for	ADP
admet-1078	51	49	intracellular	intracellular	ADJ
admet-1078	51	50	growth	growth	NOUN
admet-1078	51	51	and	and	CCONJ
admet-1078	51	52	spread	spread	VERB
admet-1078	51	53	[	[	X
admet-1078	51	54	15,16	15,16	NUM
admet-1078	51	55	]	]	PUNCT
admet-1078	51	56	.	.	PUNCT
admet-1078	52	1	in	in	ADP
admet-1078	52	2	this	this	DET
admet-1078	52	3	case	case	NOUN
admet-1078	52	4	,	,	PUNCT
admet-1078	52	5	type	type	NOUN
admet-1078	52	6	i	i	PRON
admet-1078	52	7	ifns	ifns	NOUN
admet-1078	52	8	can	can	AUX
admet-1078	52	9	contribute	contribute	VERB
admet-1078	52	10	to	to	ADP
admet-1078	52	11	the	the	DET
admet-1078	52	12	development	development	NOUN
admet-1078	52	13	of	of	ADP
admet-1078	52	14	tb	tb	NOUN
admet-1078	52	15	by	by	ADP
admet-1078	52	16	inducing	induce	VERB
admet-1078	52	17	il-10	il-10	X
admet-1078	52	18	and	and	CCONJ
admet-1078	52	19	deactivating	deactivate	VERB
admet-1078	52	20	macrophages	macrophage	NOUN
admet-1078	52	21	[	[	X
admet-1078	52	22	17,18	17,18	NUM
admet-1078	52	23	]	]	PUNCT
admet-1078	52	24	.	.	PUNCT
admet-1078	53	1	the	the	DET
admet-1078	53	2	immune	immune	ADJ
admet-1078	53	3	defense	defense	NOUN
admet-1078	53	4	of	of	ADP
admet-1078	53	5	the	the	DET
admet-1078	53	6	first	first	ADJ
admet-1078	53	7	level	level	NOUN
admet-1078	53	8	will	will	AUX
admet-1078	53	9	be	be	AUX
admet-1078	53	10	broken	break	VERB
admet-1078	53	11	and	and	CCONJ
admet-1078	53	12	the	the	DET
admet-1078	53	13	cellular	cellular	ADJ
admet-1078	53	14	response	response	NOUN
admet-1078	53	15	to	to	ADP
admet-1078	53	16	the	the	DET
admet-1078	53	17	antigen	antigen	NOUN
admet-1078	53	18	blocked	block	VERB
admet-1078	53	19	.	.	PUNCT
admet-1078	54	1	as	as	ADP
admet-1078	54	2	a	a	DET
admet-1078	54	3	result	result	NOUN
admet-1078	54	4	,	,	PUNCT
admet-1078	54	5	a	a	DET
admet-1078	54	6	latent	latent	NOUN
admet-1078	54	7	form	form	NOUN
admet-1078	54	8	of	of	ADP
admet-1078	54	9	tb	tb	NOUN
admet-1078	54	10	may	may	AUX
admet-1078	54	11	develop	develop	VERB
admet-1078	54	12	[	[	X
admet-1078	54	13	19	19	NUM
admet-1078	54	14	]	]	PUNCT
admet-1078	54	15	.	.	PUNCT
admet-1078	55	1	the	the	DET
admet-1078	55	2	optimal	optimal	ADJ
admet-1078	55	3	immune	immune	ADJ
admet-1078	55	4	response	response	NOUN
admet-1078	55	5	is	be	AUX
admet-1078	55	6	formed	form	VERB
admet-1078	55	7	in	in	ADP
admet-1078	55	8	a	a	DET
admet-1078	55	9	few	few	ADJ
admet-1078	55	10	days	day	NOUN
admet-1078	55	11	after	after	ADP
admet-1078	55	12	infection	infection	NOUN
admet-1078	55	13	.	.	PUNCT
admet-1078	56	1	cd4	cd4	PROPN
admet-1078	56	2	+	+	PROPN
admet-1078	56	3	and	and	CCONJ
admet-1078	56	4	cd8	cd8	PROPN
admet-1078	56	5	+	+	PROPN
admet-1078	56	6	effector	effector	NOUN
admet-1078	56	7	t	t	PROPN
admet-1078	56	8	cells	cell	NOUN
admet-1078	56	9	are	be	AUX
admet-1078	56	10	directed	direct	VERB
admet-1078	56	11	to	to	ADP
admet-1078	56	12	the	the	DET
admet-1078	56	13	affected	affected	ADJ
admet-1078	56	14	area	area	NOUN
admet-1078	56	15	and	and	CCONJ
admet-1078	56	16	start	start	VERB
admet-1078	56	17	inducing	induce	VERB
admet-1078	56	18	type	type	NOUN
admet-1078	56	19	ii	ii	PROPN
admet-1078	56	20	ifn	ifn	NOUN
admet-1078	56	21	,	,	PUNCT
admet-1078	56	22	strongly	strongly	ADV
admet-1078	56	23	shifting	shift	VERB
admet-1078	56	24	the	the	DET
admet-1078	56	25	balance	balance	NOUN
admet-1078	56	26	towards	towards	ADP
admet-1078	56	27	this	this	DET
admet-1078	56	28	class	class	NOUN
admet-1078	56	29	of	of	ADP
admet-1078	56	30	cytokines	cytokine	NOUN
admet-1078	56	31	[	[	X
admet-1078	56	32	15	15	NUM
admet-1078	56	33	]	]	PUNCT
admet-1078	56	34	and	and	CCONJ
admet-1078	56	35	reducing	reduce	VERB
admet-1078	56	36	the	the	DET
admet-1078	56	37	risk	risk	NOUN
admet-1078	56	38	of	of	ADP
admet-1078	56	39	developing	develop	VERB
admet-1078	56	40	an	an	DET
admet-1078	56	41	active	active	ADJ
admet-1078	56	42	tb	tb	NOUN
admet-1078	56	43	process	process	NOUN
admet-1078	56	44	[	[	X
admet-1078	56	45	20	20	NUM
admet-1078	56	46	]	]	PUNCT
admet-1078	56	47	.	.	PUNCT
admet-1078	57	1	it	it	PRON
admet-1078	57	2	was	be	AUX
admet-1078	57	3	found	find	VERB
admet-1078	57	4	that	that	SCONJ
admet-1078	57	5	cd4	cd4	PROPN
admet-1078	57	6	+	+	ADJ
admet-1078	57	7	lymphocyte	lymphocyte	ADJ
admet-1078	57	8	count	count	NOUN
admet-1078	57	9	below	below	ADP
admet-1078	57	10	100	100	NUM
admet-1078	57	11	cells	cell	NOUN
admet-1078	57	12	/	/	SYM
admet-1078	57	13	mm3	mm3	NOUN
admet-1078	57	14	before	before	ADP
admet-1078	57	15	treatment	treatment	NOUN
admet-1078	57	16	significantly	significantly	ADV
admet-1078	57	17	increases	increase	VERB
admet-1078	57	18	the	the	DET
admet-1078	57	19	likelihood	likelihood	NOUN
admet-1078	57	20	of	of	ADP
admet-1078	57	21	an	an	DET
admet-1078	57	22	unfavourable	unfavourable	ADJ
admet-1078	57	23	outcome	outcome	NOUN
admet-1078	57	24	of	of	ADP
admet-1078	57	25	generalized	generalized	ADJ
admet-1078	57	26	tuberculosis	tuberculosis	NOUN
admet-1078	57	27	in	in	ADP
admet-1078	57	28	hiv	hiv	PROPN
admet-1078	57	29	patients	patient	NOUN
admet-1078	58	1	[	[	X
admet-1078	58	2	21	21	NUM
admet-1078	58	3	]	]	PUNCT
admet-1078	58	4	.	.	PUNCT
admet-1078	59	1	at	at	ADV
admet-1078	59	2	least	least	ADV
admet-1078	59	3	10	10	NUM
admet-1078	59	4	genes	gene	NOUN
admet-1078	59	5	are	be	AUX
admet-1078	59	6	known	know	VERB
admet-1078	59	7	to	to	PART
admet-1078	59	8	be	be	AUX
admet-1078	59	9	associated	associate	VERB
admet-1078	59	10	with	with	ADP
admet-1078	59	11	increased	increase	VERB
admet-1078	59	12	susceptibility	susceptibility	NOUN
admet-1078	59	13	to	to	ADP
admet-1078	59	14	mycobacterial	mycobacterial	ADJ
admet-1078	59	15	infection	infection	NOUN
admet-1078	59	16	[	[	X
admet-1078	59	17	22	22	NUM
admet-1078	59	18	]	]	PUNCT
admet-1078	59	19	.	.	PUNCT
admet-1078	60	1	first	first	ADV
admet-1078	60	2	of	of	ADP
admet-1078	60	3	all	all	PRON
admet-1078	60	4	,	,	PUNCT
admet-1078	60	5	these	these	PRON
admet-1078	60	6	are	be	AUX
admet-1078	60	7	genes	gene	NOUN
admet-1078	60	8	encoding	encode	VERB
admet-1078	60	9	ifn	ifn	PROPN
admet-1078	60	10	-	-	PUNCT
admet-1078	60	11	γ	γ	NOUN
admet-1078	60	12	and	and	CCONJ
admet-1078	60	13	its	its	PRON
admet-1078	60	14	receptors	receptor	NOUN
admet-1078	60	15	,	,	PUNCT
admet-1078	60	16	as	as	ADV
admet-1078	60	17	well	well	ADV
admet-1078	60	18	as	as	ADP
admet-1078	60	19	cellular	cellular	ADJ
admet-1078	60	20	factors	factor	NOUN
admet-1078	60	21	stat1	stat1	NOUN
admet-1078	61	1	[	[	X
admet-1078	61	2	23	23	NUM
admet-1078	61	3	]	]	PUNCT
admet-1078	61	4	and	and	CCONJ
admet-1078	61	5	nfκb	nfκb	NOUN
admet-1078	61	6	[	[	X
admet-1078	61	7	24	24	NUM
admet-1078	61	8	]	]	PUNCT
admet-1078	61	9	,	,	PUNCT
admet-1078	61	10	directly	directly	ADV
admet-1078	61	11	related	relate	VERB
admet-1078	61	12	to	to	ADP
admet-1078	61	13	the	the	DET
admet-1078	61	14	mechanism	mechanism	NOUN
admet-1078	61	15	of	of	ADP
admet-1078	61	16	ifn	ifn	PROPN
admet-1078	61	17	-	-	PUNCT
admet-1078	61	18	γ	γ	NOUN
admet-1078	61	19	action	action	NOUN
admet-1078	61	20	on	on	ADP
admet-1078	61	21	the	the	DET
admet-1078	61	22	cell	cell	NOUN
admet-1078	61	23	:	:	PUNCT
admet-1078	61	24	antigen	antigen	PROPN
admet-1078	61	25	recognition	recognition	NOUN
admet-1078	61	26	,	,	PUNCT
admet-1078	61	27	the	the	DET
admet-1078	61	28	realization	realization	NOUN
admet-1078	61	29	of	of	ADP
admet-1078	61	30	an	an	DET
admet-1078	61	31	innate	innate	ADJ
admet-1078	61	32	immune	immune	ADJ
admet-1078	61	33	response	response	NOUN
admet-1078	61	34	,	,	PUNCT
admet-1078	61	35	and	and	CCONJ
admet-1078	61	36	oxidative	oxidative	ADJ
admet-1078	61	37	properties	property	NOUN
admet-1078	61	38	of	of	ADP
admet-1078	61	39	macrophages	macrophage	NOUN
admet-1078	61	40	[	[	X
admet-1078	61	41	25	25	NUM
admet-1078	61	42	]	]	PUNCT
admet-1078	61	43	,	,	PUNCT
admet-1078	61	44	and	and	CCONJ
admet-1078	61	45	necessary	necessary	ADJ
admet-1078	61	46	for	for	ADP
admet-1078	61	47	protection	protection	NOUN
admet-1078	61	48	against	against	ADP
admet-1078	61	49	tb	tb	ADP
admet-1078	61	50	[	[	X
admet-1078	61	51	26	26	NUM
admet-1078	61	52	]	]	PUNCT
admet-1078	61	53	and	and	CCONJ
admet-1078	61	54	other	other	ADJ
admet-1078	61	55	infectious	infectious	ADJ
admet-1078	61	56	diseases	disease	NOUN
admet-1078	61	57	,	,	PUNCT
admet-1078	61	58	since	since	SCONJ
admet-1078	61	59	they	they	PRON
admet-1078	61	60	determine	determine	VERB
admet-1078	61	61	nonspecific	nonspecific	ADJ
admet-1078	61	62	pathways	pathway	NOUN
admet-1078	61	63	of	of	ADP
admet-1078	61	64	action	action	NOUN
admet-1078	61	65	on	on	ADP
admet-1078	61	66	the	the	DET
admet-1078	61	67	pathogen	pathogen	NOUN
admet-1078	61	68	(	(	PUNCT
admet-1078	61	69	figure	figure	NOUN
admet-1078	61	70	1	1	NUM
admet-1078	61	71	)	)	PUNCT
admet-1078	61	72	.	.	PUNCT
admet-1078	62	1	figure	figure	NOUN
admet-1078	62	2	1	1	NUM
admet-1078	62	3	.	.	PUNCT
admet-1078	63	1	mechanism	mechanism	NOUN
admet-1078	63	2	of	of	ADP
admet-1078	63	3	ifn	ifn	PROPN
admet-1078	63	4	-	-	PUNCT
admet-1078	63	5	γ	γ	NOUN
admet-1078	63	6	action	action	NOUN
admet-1078	63	7	via	via	ADP
admet-1078	63	8	the	the	DET
admet-1078	63	9	immune	immune	ADJ
admet-1078	63	10	cells	cell	NOUN
admet-1078	63	11	http://dx.doi.org/10.5599/admet.1078	http://dx.doi.org/10.5599/admet.1078	VERB
admet-1078	63	12	svetlana	svetlana	PROPN
admet-1078	63	13	a.	a.	PROPN
admet-1078	63	14	berns	berns	PROPN
admet-1078	63	15	et	et	PROPN
admet-1078	63	16	al	al	PROPN
admet-1078	63	17	.	.	PROPN
admet-1078	63	18	admet	admet	PROPN
admet-1078	63	19	&	&	CCONJ
admet-1078	63	20	dmpk	dmpk	PROPN
admet-1078	63	21	10(1	10(1	NUM
admet-1078	63	22	)	)	PUNCT
admet-1078	63	23	(	(	PUNCT
admet-1078	63	24	2022	2022	NUM
admet-1078	63	25	)	)	PUNCT
admet-1078	63	26	63	63	NUM
admet-1078	63	27	-	-	SYM
admet-1078	63	28	73	73	NUM
admet-1078	63	29	66	66	NUM
admet-1078	63	30	disseminated	disseminate	VERB
admet-1078	63	31	forms	form	NOUN
admet-1078	63	32	of	of	ADP
admet-1078	63	33	infections	infection	NOUN
admet-1078	63	34	in	in	ADP
admet-1078	63	35	children	child	NOUN
admet-1078	63	36	often	often	ADV
admet-1078	63	37	arise	arise	VERB
admet-1078	63	38	due	due	ADP
admet-1078	63	39	to	to	ADP
admet-1078	63	40	congenital	congenital	ADJ
admet-1078	63	41	defects	defect	NOUN
admet-1078	63	42	in	in	ADP
admet-1078	63	43	the	the	DET
admet-1078	63	44	structure	structure	NOUN
admet-1078	63	45	of	of	ADP
admet-1078	63	46	the	the	DET
admet-1078	63	47	ifn	ifn	PROPN
admet-1078	63	48	-	-	PUNCT
admet-1078	63	49	γ	γ	NOUN
admet-1078	63	50	protein	protein	NOUN
admet-1078	63	51	[	[	X
admet-1078	63	52	27	27	NUM
admet-1078	63	53	]	]	PUNCT
admet-1078	63	54	.	.	PUNCT
admet-1078	64	1	the	the	DET
admet-1078	64	2	deficiency	deficiency	NOUN
admet-1078	64	3	of	of	ADP
admet-1078	64	4	genes	gene	NOUN
admet-1078	64	5	encoding	encode	VERB
admet-1078	64	6	protein	protein	NOUN
admet-1078	64	7	chains	chain	NOUN
admet-1078	64	8	of	of	ADP
admet-1078	64	9	receptors	receptor	NOUN
admet-1078	64	10	is	be	AUX
admet-1078	64	11	one	one	NUM
admet-1078	64	12	of	of	ADP
admet-1078	64	13	the	the	DET
admet-1078	64	14	most	most	ADV
admet-1078	64	15	common	common	ADJ
admet-1078	64	16	mutations	mutation	NOUN
admet-1078	64	17	that	that	PRON
admet-1078	64	18	cause	cause	VERB
admet-1078	64	19	increased	increase	VERB
admet-1078	64	20	susceptibility	susceptibility	NOUN
admet-1078	64	21	to	to	ADP
admet-1078	64	22	mycobacterial	mycobacterial	ADJ
admet-1078	64	23	infection	infection	NOUN
admet-1078	64	24	.	.	PUNCT
admet-1078	65	1	the	the	DET
admet-1078	65	2	ifnγr1	ifnγr1	PROPN
admet-1078	65	3	gene	gene	NOUN
admet-1078	65	4	accounts	account	VERB
admet-1078	65	5	for	for	ADP
admet-1078	65	6	39	39	NUM
admet-1078	65	7	%	%	NOUN
admet-1078	65	8	of	of	ADP
admet-1078	65	9	mutations	mutation	NOUN
admet-1078	65	10	[	[	X
admet-1078	65	11	28	28	NUM
admet-1078	65	12	]	]	PUNCT
admet-1078	65	13	.	.	PUNCT
admet-1078	66	1	for	for	ADP
admet-1078	66	2	reasons	reason	NOUN
admet-1078	66	3	still	still	ADV
admet-1078	66	4	unclear	unclear	ADJ
admet-1078	66	5	,	,	PUNCT
admet-1078	66	6	ifnγr2	ifnγr2	ADJ
admet-1078	66	7	deficiency	deficiency	NOUN
admet-1078	66	8	is	be	AUX
admet-1078	66	9	much	much	ADV
admet-1078	66	10	less	less	ADV
admet-1078	66	11	common	common	ADJ
admet-1078	66	12	[	[	X
admet-1078	66	13	29	29	NUM
admet-1078	66	14	]	]	PUNCT
admet-1078	66	15	.	.	PUNCT
admet-1078	67	1	in	in	ADP
admet-1078	67	2	patients	patient	NOUN
admet-1078	67	3	with	with	ADP
admet-1078	67	4	complete	complete	ADJ
admet-1078	67	5	deficiencies	deficiency	NOUN
admet-1078	67	6	of	of	ADP
admet-1078	67	7	any	any	PRON
admet-1078	67	8	of	of	ADP
admet-1078	67	9	these	these	DET
admet-1078	67	10	genes	gene	NOUN
admet-1078	67	11	,	,	PUNCT
admet-1078	67	12	there	there	PRON
admet-1078	67	13	is	be	VERB
admet-1078	67	14	an	an	DET
admet-1078	67	15	absence	absence	NOUN
admet-1078	67	16	or	or	CCONJ
admet-1078	67	17	incomplete	incomplete	ADJ
admet-1078	67	18	formation	formation	NOUN
admet-1078	67	19	of	of	ADP
admet-1078	67	20	granulomas	granuloma	NOUN
admet-1078	67	21	and	and	CCONJ
admet-1078	67	22	diffusely	diffusely	ADV
admet-1078	67	23	loaded	load	VERB
admet-1078	67	24	macrophages	macrophage	NOUN
admet-1078	67	25	[	[	X
admet-1078	67	26	30	30	NUM
admet-1078	67	27	]	]	PUNCT
admet-1078	67	28	.	.	PUNCT
admet-1078	68	1	features	feature	NOUN
admet-1078	68	2	of	of	ADP
admet-1078	68	3	the	the	DET
admet-1078	68	4	formation	formation	NOUN
admet-1078	68	5	of	of	ADP
admet-1078	68	6	bacterial	bacterial	ADJ
admet-1078	68	7	resistance	resistance	NOUN
admet-1078	68	8	the	the	DET
admet-1078	68	9	main	main	ADJ
admet-1078	68	10	mechanisms	mechanism	NOUN
admet-1078	68	11	of	of	ADP
admet-1078	68	12	the	the	DET
admet-1078	68	13	resistance	resistance	NOUN
admet-1078	68	14	development	development	NOUN
admet-1078	68	15	include	include	VERB
admet-1078	68	16	genetic	genetic	ADJ
admet-1078	68	17	changes	change	NOUN
admet-1078	68	18	that	that	PRON
admet-1078	68	19	ensure	ensure	VERB
admet-1078	68	20	the	the	DET
admet-1078	68	21	"	"	PUNCT
admet-1078	68	22	removal	removal	NOUN
admet-1078	68	23	of	of	ADP
admet-1078	68	24	the	the	DET
admet-1078	68	25	effect	effect	NOUN
admet-1078	68	26	"	"	PUNCT
admet-1078	68	27	of	of	ADP
admet-1078	68	28	the	the	DET
admet-1078	68	29	antibiotic	antibiotic	NOUN
admet-1078	68	30	(	(	PUNCT
admet-1078	68	31	change	change	NOUN
admet-1078	68	32	in	in	ADP
admet-1078	68	33	the	the	DET
admet-1078	68	34	target	target	NOUN
admet-1078	68	35	,	,	PUNCT
admet-1078	68	36	metabolism	metabolism	NOUN
admet-1078	68	37	,	,	PUNCT
admet-1078	68	38	method	method	NOUN
admet-1078	68	39	of	of	ADP
admet-1078	68	40	removing	remove	VERB
admet-1078	68	41	the	the	DET
admet-1078	68	42	antibiotic	antibiotic	NOUN
admet-1078	68	43	from	from	ADP
admet-1078	68	44	the	the	DET
admet-1078	68	45	cell	cell	NOUN
admet-1078	68	46	)	)	PUNCT
admet-1078	68	47	,	,	PUNCT
admet-1078	68	48	as	as	ADV
admet-1078	68	49	well	well	ADV
admet-1078	68	50	as	as	ADP
admet-1078	68	51	the	the	DET
admet-1078	68	52	isolation	isolation	NOUN
admet-1078	68	53	of	of	ADP
admet-1078	68	54	the	the	DET
admet-1078	68	55	microorganism	microorganism	NOUN
admet-1078	68	56	from	from	ADP
admet-1078	68	57	the	the	DET
admet-1078	68	58	drug	drug	NOUN
admet-1078	68	59	(	(	PUNCT
admet-1078	68	60	intracellular	intracellular	ADJ
admet-1078	68	61	localization	localization	NOUN
admet-1078	68	62	,	,	PUNCT
admet-1078	68	63	biofilm	biofilm	NOUN
admet-1078	68	64	formation	formation	NOUN
admet-1078	68	65	)	)	PUNCT
admet-1078	69	1	[	[	X
admet-1078	69	2	31	31	NUM
admet-1078	69	3	]	]	PUNCT
admet-1078	69	4	.	.	PUNCT
admet-1078	70	1	in	in	ADP
admet-1078	70	2	the	the	DET
admet-1078	70	3	case	case	NOUN
admet-1078	70	4	of	of	ADP
admet-1078	70	5	m.	m.	NOUN
admet-1078	70	6	tuberculosis	tuberculosis	NOUN
admet-1078	70	7	,	,	PUNCT
admet-1078	70	8	the	the	DET
admet-1078	70	9	microorganism	microorganism	NOUN
admet-1078	70	10	forms	form	VERB
admet-1078	70	11	resistance	resistance	NOUN
admet-1078	70	12	due	due	ADP
admet-1078	70	13	to	to	ADP
admet-1078	70	14	the	the	DET
admet-1078	70	15	hydrophobic	hydrophobic	NOUN
admet-1078	70	16	cell	cell	NOUN
admet-1078	70	17	wall	wall	NOUN
admet-1078	70	18	,	,	PUNCT
admet-1078	70	19	β	β	NOUN
admet-1078	70	20	-	-	NOUN
admet-1078	70	21	lactamases	lactamase	NOUN
admet-1078	70	22	,	,	PUNCT
admet-1078	70	23	and	and	CCONJ
admet-1078	70	24	mutations	mutation	NOUN
admet-1078	70	25	in	in	ADP
admet-1078	70	26	the	the	DET
admet-1078	70	27	bacterial	bacterial	ADJ
admet-1078	70	28	genes	gene	NOUN
admet-1078	70	29	[	[	X
admet-1078	70	30	7	7	NUM
admet-1078	70	31	]	]	PUNCT
admet-1078	70	32	.	.	PUNCT
admet-1078	71	1	the	the	DET
admet-1078	71	2	immune	immune	ADJ
admet-1078	71	3	system	system	NOUN
admet-1078	71	4	ensures	ensure	VERB
admet-1078	71	5	the	the	DET
admet-1078	71	6	elimination	elimination	NOUN
admet-1078	71	7	of	of	ADP
admet-1078	71	8	the	the	DET
admet-1078	71	9	pathogen	pathogen	NOUN
admet-1078	71	10	primarily	primarily	ADV
admet-1078	71	11	due	due	ADP
admet-1078	71	12	to	to	ADP
admet-1078	71	13	the	the	DET
admet-1078	71	14	strength	strength	NOUN
admet-1078	71	15	of	of	ADP
admet-1078	71	16	the	the	DET
admet-1078	71	17	cellular	cellular	ADJ
admet-1078	71	18	immunity	immunity	NOUN
admet-1078	71	19	by	by	ADP
admet-1078	71	20	activating	activate	VERB
admet-1078	71	21	the	the	DET
admet-1078	71	22	phagocytosis	phagocytosis	NOUN
admet-1078	71	23	.	.	PUNCT
admet-1078	72	1	it	it	PRON
admet-1078	72	2	was	be	AUX
admet-1078	72	3	shown	show	VERB
admet-1078	72	4	that	that	SCONJ
admet-1078	72	5	ifn	ifn	PROPN
admet-1078	72	6	-	-	PUNCT
admet-1078	72	7	γ	γ	NOUN
admet-1078	72	8	could	could	AUX
admet-1078	72	9	affect	affect	VERB
admet-1078	72	10	each	each	PRON
admet-1078	72	11	of	of	ADP
admet-1078	72	12	the	the	DET
admet-1078	72	13	main	main	ADJ
admet-1078	72	14	aspects	aspect	NOUN
admet-1078	72	15	of	of	ADP
admet-1078	72	16	the	the	DET
admet-1078	72	17	phagocytes	phagocytes	ADJ
admet-1078	72	18	activation	activation	NOUN
admet-1078	72	19	,	,	PUNCT
admet-1078	72	20	thereby	thereby	ADV
admet-1078	72	21	playing	play	VERB
admet-1078	72	22	an	an	DET
admet-1078	72	23	important	important	ADJ
admet-1078	72	24	role	role	NOUN
admet-1078	72	25	in	in	ADP
admet-1078	72	26	the	the	DET
admet-1078	72	27	immune	immune	ADJ
admet-1078	72	28	response	response	NOUN
admet-1078	73	1	[	[	X
admet-1078	73	2	32	32	NUM
admet-1078	73	3	-	-	SYM
admet-1078	73	4	34	34	NUM
admet-1078	73	5	]	]	PUNCT
admet-1078	73	6	:	:	PUNCT
admet-1078	73	7			NOUN
admet-1078	73	8	activates	activate	VERB
admet-1078	73	9	macrophages	macrophage	NOUN
admet-1078	73	10	,	,	PUNCT
admet-1078	73	11	attracts	attract	VERB
admet-1078	73	12	them	they	PRON
admet-1078	73	13	to	to	ADP
admet-1078	73	14	the	the	DET
admet-1078	73	15	site	site	NOUN
admet-1078	73	16	of	of	ADP
admet-1078	73	17	infection	infection	NOUN
admet-1078	73	18	;	;	PUNCT
admet-1078	73	19			PRON
admet-1078	73	20	induces	induce	VERB
admet-1078	73	21	the	the	DET
admet-1078	73	22	release	release	NOUN
admet-1078	73	23	of	of	ADP
admet-1078	73	24	nitric	nitric	ADJ
admet-1078	73	25	oxide	oxide	NOUN
admet-1078	73	26	;	;	PUNCT
admet-1078	73	27			PRON
admet-1078	73	28	serves	serve	VERB
admet-1078	73	29	as	as	ADP
admet-1078	73	30	the	the	DET
admet-1078	73	31	only	only	ADJ
admet-1078	73	32	inducer	inducer	NOUN
admet-1078	73	33	in	in	ADP
admet-1078	73	34	the	the	DET
admet-1078	73	35	cell	cell	NOUN
admet-1078	73	36	of	of	ADP
admet-1078	73	37	the	the	DET
admet-1078	73	38	synthesis	synthesis	NOUN
admet-1078	73	39	of	of	ADP
admet-1078	73	40	proteins	protein	NOUN
admet-1078	73	41	of	of	ADP
admet-1078	73	42	the	the	DET
admet-1078	73	43	second	second	ADJ
admet-1078	73	44	class	class	NOUN
admet-1078	73	45	histocompatibility	histocompatibility	NOUN
admet-1078	73	46	complex	complex	NOUN
admet-1078	73	47	(	(	PUNCT
admet-1078	73	48	mhc	mhc	PROPN
admet-1078	73	49	class	class	PROPN
admet-1078	73	50	ii	ii	PROPN
admet-1078	73	51	)	)	PUNCT
admet-1078	73	52	an	an	DET
admet-1078	73	53	antigen	antigen	NOUN
admet-1078	73	54	-	-	PUNCT
admet-1078	73	55	presenting	present	VERB
admet-1078	73	56	complex	complex	NOUN
admet-1078	73	57	for	for	ADP
admet-1078	73	58	extracellular	extracellular	ADJ
admet-1078	73	59	pathogens	pathogen	NOUN
admet-1078	73	60	.	.	PUNCT
admet-1078	74	1	the	the	DET
admet-1078	74	2	primary	primary	ADJ
admet-1078	74	3	feature	feature	NOUN
admet-1078	74	4	of	of	ADP
admet-1078	74	5	the	the	DET
admet-1078	74	6	functioning	functioning	NOUN
admet-1078	74	7	of	of	ADP
admet-1078	74	8	phagocytes	phagocyte	NOUN
admet-1078	74	9	,	,	PUNCT
admet-1078	74	10	which	which	PRON
admet-1078	74	11	ensures	ensure	VERB
admet-1078	74	12	the	the	DET
admet-1078	74	13	relationship	relationship	NOUN
admet-1078	74	14	of	of	ADP
admet-1078	74	15	nonspecific	nonspecific	ADJ
admet-1078	74	16	and	and	CCONJ
admet-1078	74	17	specific	specific	ADJ
admet-1078	74	18	immunity	immunity	NOUN
admet-1078	74	19	,	,	PUNCT
admet-1078	74	20	is	be	AUX
admet-1078	74	21	the	the	DET
admet-1078	74	22	performance	performance	NOUN
admet-1078	74	23	of	of	ADP
admet-1078	74	24	the	the	DET
admet-1078	74	25	role	role	NOUN
admet-1078	74	26	of	of	ADP
admet-1078	74	27	antigen	antigen	NOUN
admet-1078	74	28	-	-	PUNCT
admet-1078	74	29	presenting	present	VERB
admet-1078	74	30	cells	cell	NOUN
admet-1078	74	31	.	.	PUNCT
admet-1078	75	1	antigen	antigen	NOUN
admet-1078	75	2	-	-	PUNCT
admet-1078	75	3	presenting	present	VERB
admet-1078	75	4	cells	cell	NOUN
admet-1078	75	5	are	be	AUX
admet-1078	75	6	located	locate	VERB
admet-1078	75	7	on	on	ADP
admet-1078	75	8	the	the	DET
admet-1078	75	9	main	main	ADJ
admet-1078	75	10	routes	route	NOUN
admet-1078	75	11	of	of	ADP
admet-1078	75	12	entry	entry	NOUN
admet-1078	75	13	of	of	ADP
admet-1078	75	14	antigens	antigen	NOUN
admet-1078	75	15	into	into	ADP
admet-1078	75	16	the	the	DET
admet-1078	75	17	body	body	NOUN
admet-1078	75	18	(	(	PUNCT
admet-1078	75	19	in	in	ADP
admet-1078	75	20	the	the	DET
admet-1078	75	21	skin	skin	NOUN
admet-1078	75	22	and	and	CCONJ
admet-1078	75	23	the	the	DET
admet-1078	75	24	mucous	mucous	ADJ
admet-1078	75	25	membranes	membrane	NOUN
admet-1078	75	26	)	)	PUNCT
admet-1078	75	27	,	,	PUNCT
admet-1078	75	28	from	from	ADP
admet-1078	75	29	where	where	SCONJ
admet-1078	75	30	,	,	PUNCT
admet-1078	75	31	after	after	ADP
admet-1078	75	32	capturing	capture	VERB
admet-1078	75	33	antigens	antigen	NOUN
admet-1078	75	34	,	,	PUNCT
admet-1078	75	35	they	they	PRON
admet-1078	75	36	migrate	migrate	VERB
admet-1078	75	37	to	to	ADP
admet-1078	75	38	the	the	DET
admet-1078	75	39	peripheral	peripheral	ADJ
admet-1078	75	40	organs	organ	NOUN
admet-1078	75	41	of	of	ADP
admet-1078	75	42	the	the	DET
admet-1078	75	43	immune	immune	ADJ
admet-1078	75	44	system	system	NOUN
admet-1078	75	45	,	,	PUNCT
admet-1078	75	46	where	where	SCONJ
admet-1078	75	47	they	they	PRON
admet-1078	75	48	present	present	VERB
admet-1078	75	49	antigens	antigen	NOUN
admet-1078	75	50	to	to	ADP
admet-1078	75	51	lymphocytes	lymphocyte	NOUN
admet-1078	75	52	.	.	PUNCT
admet-1078	76	1	phagocytes	phagocyte	NOUN
admet-1078	76	2	are	be	AUX
admet-1078	76	3	the	the	DET
admet-1078	76	4	cells	cell	NOUN
admet-1078	76	5	that	that	PRON
admet-1078	76	6	directly	directly	ADV
admet-1078	76	7	kill	kill	VERB
admet-1078	76	8	bacteria	bacteria	NOUN
admet-1078	76	9	through	through	ADP
admet-1078	76	10	phagocytosis	phagocytosis	NOUN
admet-1078	76	11	(	(	PUNCT
admet-1078	76	12	"	"	PUNCT
admet-1078	76	13	eating	eat	VERB
admet-1078	76	14	"	"	PUNCT
admet-1078	76	15	them	they	PRON
admet-1078	76	16	)	)	PUNCT
admet-1078	76	17	and	and	CCONJ
admet-1078	76	18	play	play	VERB
admet-1078	76	19	one	one	NUM
admet-1078	76	20	of	of	ADP
admet-1078	76	21	the	the	DET
admet-1078	76	22	leading	lead	VERB
admet-1078	76	23	roles	role	NOUN
admet-1078	76	24	in	in	ADP
admet-1078	76	25	the	the	DET
admet-1078	76	26	body	body	NOUN
admet-1078	76	27	's	's	PART
admet-1078	76	28	first	first	ADJ
admet-1078	76	29	immune	immune	ADJ
admet-1078	76	30	response	response	NOUN
admet-1078	76	31	to	to	ADP
admet-1078	76	32	bacterial	bacterial	ADJ
admet-1078	76	33	infection	infection	NOUN
admet-1078	76	34	.	.	PUNCT
admet-1078	77	1	hereditary	hereditary	ADJ
admet-1078	77	2	and	and	CCONJ
admet-1078	77	3	acquired	acquire	VERB
admet-1078	77	4	disorders	disorder	NOUN
admet-1078	77	5	of	of	ADP
admet-1078	77	6	phagocytosis	phagocytosis	NOUN
admet-1078	77	7	can	can	AUX
admet-1078	77	8	lead	lead	VERB
admet-1078	77	9	to	to	ADP
admet-1078	77	10	severe	severe	ADJ
admet-1078	77	11	pathologies	pathology	NOUN
admet-1078	77	12	of	of	ADP
admet-1078	77	13	the	the	DET
admet-1078	77	14	functioning	functioning	NOUN
admet-1078	77	15	of	of	ADP
admet-1078	77	16	the	the	DET
admet-1078	77	17	immune	immune	ADJ
admet-1078	77	18	system	system	NOUN
admet-1078	77	19	[	[	X
admet-1078	77	20	35	35	NUM
admet-1078	77	21	]	]	PUNCT
admet-1078	77	22	.	.	PUNCT
admet-1078	78	1	mechanisms	mechanism	NOUN
admet-1078	78	2	of	of	ADP
admet-1078	78	3	action	action	NOUN
admet-1078	78	4	of	of	ADP
admet-1078	78	5	phagocytes	phagocyte	NOUN
admet-1078	78	6	:	:	PUNCT
admet-1078	78	7			PRON
admet-1078	78	8	a	a	DET
admet-1078	78	9	phagocyte	phagocyte	NOUN
admet-1078	78	10	cell	cell	NOUN
admet-1078	78	11	carries	carry	VERB
admet-1078	78	12	receptors	receptor	NOUN
admet-1078	78	13	on	on	ADP
admet-1078	78	14	its	its	PRON
admet-1078	78	15	surface	surface	NOUN
admet-1078	78	16	that	that	PRON
admet-1078	78	17	recognize	recognize	VERB
admet-1078	78	18	an	an	DET
admet-1078	78	19	infectious	infectious	ADJ
admet-1078	78	20	agent	agent	NOUN
admet-1078	78	21	(	(	PUNCT
admet-1078	78	22	for	for	ADP
admet-1078	78	23	example	example	NOUN
admet-1078	78	24	,	,	PUNCT
admet-1078	78	25	the	the	DET
admet-1078	78	26	cell	cell	NOUN
admet-1078	78	27	wall	wall	NOUN
admet-1078	78	28	of	of	ADP
admet-1078	78	29	a	a	DET
admet-1078	78	30	bacterium	bacterium	NOUN
admet-1078	78	31	)	)	PUNCT
admet-1078	78	32	.	.	PUNCT
admet-1078	79	1	when	when	SCONJ
admet-1078	79	2	a	a	DET
admet-1078	79	3	phagocyte	phagocyte	NOUN
admet-1078	79	4	comes	come	VERB
admet-1078	79	5	into	into	ADP
admet-1078	79	6	contact	contact	NOUN
admet-1078	79	7	with	with	ADP
admet-1078	79	8	a	a	DET
admet-1078	79	9	bacterium	bacterium	NOUN
admet-1078	79	10	,	,	PUNCT
admet-1078	79	11	receptors	receptor	NOUN
admet-1078	79	12	on	on	ADP
admet-1078	79	13	its	its	PRON
admet-1078	79	14	surface	surface	NOUN
admet-1078	79	15	bind	bind	NOUN
admet-1078	79	16	to	to	ADP
admet-1078	79	17	it	it	PRON
admet-1078	79	18	,	,	PUNCT
admet-1078	79	19	leading	lead	VERB
admet-1078	79	20	to	to	ADP
admet-1078	79	21	the	the	DET
admet-1078	79	22	bacterium	bacterium	NOUN
admet-1078	79	23	's	's	PART
admet-1078	79	24	absorption	absorption	NOUN
admet-1078	79	25	by	by	ADP
admet-1078	79	26	the	the	DET
admet-1078	79	27	phagocyte	phagocyte	NOUN
admet-1078	79	28	.	.	PUNCT
admet-1078	80	1			PRON
admet-1078	80	2	release	release	NOUN
admet-1078	80	3	of	of	ADP
admet-1078	80	4	reactive	reactive	ADJ
admet-1078	80	5	oxygen	oxygen	NOUN
admet-1078	80	6	species	specie	NOUN
admet-1078	80	7	and	and	CCONJ
admet-1078	80	8	nitric	nitric	ADJ
admet-1078	80	9	oxide	oxide	NOUN
admet-1078	80	10	by	by	ADP
admet-1078	80	11	phagocytes	phagocyte	NOUN
admet-1078	80	12	cause	cause	VERB
admet-1078	80	13	oxidative	oxidative	ADJ
admet-1078	80	14	stress	stress	NOUN
admet-1078	80	15	that	that	PRON
admet-1078	80	16	destroys	destroy	VERB
admet-1078	80	17	bacteria	bacteria	NOUN
admet-1078	80	18	;	;	PUNCT
admet-1078	80	19			NOUN
admet-1078	80	20	stimulation	stimulation	NOUN
admet-1078	80	21	of	of	ADP
admet-1078	80	22	other	other	ADJ
admet-1078	80	23	cells	cell	NOUN
admet-1078	80	24	of	of	ADP
admet-1078	80	25	the	the	DET
admet-1078	80	26	immune	immune	ADJ
admet-1078	80	27	system	system	NOUN
admet-1078	80	28	through	through	ADP
admet-1078	80	29	"	"	PUNCT
admet-1078	80	30	antigen	antigen	ADJ
admet-1078	80	31	presentation	presentation	NOUN
admet-1078	80	32	"	"	PUNCT
admet-1078	80	33	is	be	AUX
admet-1078	80	34	a	a	DET
admet-1078	80	35	process	process	NOUN
admet-1078	80	36	in	in	ADP
admet-1078	80	37	which	which	PRON
admet-1078	80	38	phagocytes	phagocyte	VERB
admet-1078	80	39	place	place	NOUN
admet-1078	80	40	fragments	fragment	NOUN
admet-1078	80	41	of	of	ADP
admet-1078	80	42	pathogen	pathogen	NOUN
admet-1078	80	43	proteins	protein	NOUN
admet-1078	80	44	on	on	ADP
admet-1078	80	45	the	the	DET
admet-1078	80	46	surface	surface	NOUN
admet-1078	80	47	of	of	ADP
admet-1078	80	48	their	their	PRON
admet-1078	80	49	cells	cell	NOUN
admet-1078	80	50	,	,	PUNCT
admet-1078	80	51	thereby	thereby	ADV
admet-1078	80	52	presenting	present	VERB
admet-1078	80	53	these	these	DET
admet-1078	80	54	fragments	fragment	NOUN
admet-1078	80	55	to	to	ADP
admet-1078	80	56	other	other	ADJ
admet-1078	80	57	cells	cell	NOUN
admet-1078	80	58	of	of	ADP
admet-1078	80	59	the	the	DET
admet-1078	80	60	immune	immune	ADJ
admet-1078	80	61	system	system	NOUN
admet-1078	80	62	,	,	PUNCT
admet-1078	80	63	developing	develop	VERB
admet-1078	80	64	an	an	DET
admet-1078	80	65	antigen	antigen	NOUN
admet-1078	80	66	-	-	PUNCT
admet-1078	80	67	specific	specific	ADJ
admet-1078	80	68	immune	immune	ADJ
admet-1078	80	69	response	response	NOUN
admet-1078	80	70	[	[	X
admet-1078	80	71	8,35	8,35	NUM
admet-1078	80	72	-	-	SYM
admet-1078	80	73	37	37	NUM
admet-1078	80	74	]	]	PUNCT
admet-1078	80	75	.	.	PUNCT
admet-1078	81	1	it	it	PRON
admet-1078	81	2	is	be	AUX
admet-1078	81	3	important	important	ADJ
admet-1078	81	4	to	to	PART
admet-1078	81	5	note	note	VERB
admet-1078	81	6	that	that	SCONJ
admet-1078	81	7	at	at	ADP
admet-1078	81	8	an	an	DET
admet-1078	81	9	early	early	ADJ
admet-1078	81	10	stage	stage	NOUN
admet-1078	81	11	of	of	ADP
admet-1078	81	12	infection	infection	NOUN
admet-1078	81	13	,	,	PUNCT
admet-1078	81	14	ifns	ifns	NOUN
admet-1078	81	15	of	of	ADP
admet-1078	81	16	types	type	NOUN
admet-1078	81	17	i	i	PRON
admet-1078	81	18	and	and	CCONJ
admet-1078	81	19	ii	ii	PROPN
admet-1078	81	20	are	be	AUX
admet-1078	81	21	produced	produce	VERB
admet-1078	81	22	in	in	ADP
admet-1078	81	23	equal	equal	ADJ
admet-1078	81	24	concentrations	concentration	NOUN
admet-1078	81	25	,	,	PUNCT
admet-1078	81	26	and	and	CCONJ
admet-1078	81	27	ifns	ifns	NOUN
admet-1078	81	28	of	of	ADP
admet-1078	81	29	type	type	NOUN
admet-1078	81	30	i	i	PRON
admet-1078	81	31	are	be	AUX
admet-1078	81	32	able	able	ADJ
admet-1078	81	33	to	to	PART
admet-1078	81	34	reduce	reduce	VERB
admet-1078	81	35	the	the	DET
admet-1078	81	36	expression	expression	NOUN
admet-1078	81	37	of	of	ADP
admet-1078	81	38	the	the	DET
admet-1078	81	39	major	major	ADJ
admet-1078	81	40	histocompatibility	histocompatibility	NOUN
admet-1078	81	41	admet	admet	NOUN
admet-1078	81	42	&	&	CCONJ
admet-1078	81	43	dmpk	dmpk	PROPN
admet-1078	81	44	10(1	10(1	NUM
admet-1078	81	45	)	)	PUNCT
admet-1078	81	46	(	(	PUNCT
admet-1078	81	47	2022	2022	NUM
admet-1078	81	48	)	)	PUNCT
admet-1078	81	49	63	63	NUM
admet-1078	81	50	-	-	SYM
admet-1078	81	51	73	73	NUM
admet-1078	81	52	therapeutic	therapeutic	ADJ
admet-1078	81	53	potential	potential	NOUN
admet-1078	81	54	of	of	ADP
admet-1078	81	55	interferon	interferon	ADJ
admet-1078	81	56	-	-	PUNCT
admet-1078	81	57	gamma	gamma	NOUN
admet-1078	81	58	in	in	ADP
admet-1078	81	59	tuberculosis	tuberculosis	NOUN
admet-1078	81	60	doi	doi	NOUN
admet-1078	81	61	:	:	PUNCT
admet-1078	81	62	http://dx.doi.org/10.5599/admet.1078	http://dx.doi.org/10.5599/admet.1078	PROPN
admet-1078	81	63	67	67	NUM
admet-1078	81	64	complex	complex	ADJ
admet-1078	81	65	(	(	PUNCT
admet-1078	81	66	mhc	mhc	NOUN
admet-1078	81	67	or	or	CCONJ
admet-1078	81	68	mhc	mhc	PROPN
admet-1078	81	69	)	)	PUNCT
admet-1078	81	70	of	of	ADP
admet-1078	81	71	class	class	PROPN
admet-1078	81	72	ii	ii	PROPN
admet-1078	81	73	on	on	ADP
admet-1078	81	74	antigen	antigen	NOUN
admet-1078	81	75	-	-	PUNCT
admet-1078	81	76	presenting	present	VERB
admet-1078	81	77	cells	cell	NOUN
admet-1078	81	78	,	,	PUNCT
admet-1078	81	79	induced	induce	VERB
admet-1078	81	80	by	by	ADP
admet-1078	81	81	ifn	ifn	NOUN
admet-1078	81	82	of	of	ADP
admet-1078	81	83	type	type	PROPN
admet-1078	81	84	ii	ii	PROPN
admet-1078	81	85	,	,	PUNCT
admet-1078	81	86	preventing	prevent	VERB
admet-1078	81	87	it	it	PRON
admet-1078	81	88	action	action	NOUN
admet-1078	82	1	[	[	X
admet-1078	82	2	38	38	NUM
admet-1078	82	3	]	]	PUNCT
admet-1078	82	4	.	.	PUNCT
admet-1078	83	1	thus	thus	ADV
admet-1078	83	2	,	,	PUNCT
admet-1078	83	3	during	during	ADP
admet-1078	83	4	the	the	DET
admet-1078	83	5	development	development	NOUN
admet-1078	83	6	of	of	ADP
admet-1078	83	7	a	a	DET
admet-1078	83	8	bacterial	bacterial	ADJ
admet-1078	83	9	infection	infection	NOUN
admet-1078	83	10	,	,	PUNCT
admet-1078	83	11	the	the	DET
admet-1078	83	12	effects	effect	NOUN
admet-1078	83	13	of	of	ADP
admet-1078	83	14	ifn	ifn	PROPN
admet-1078	83	15	-	-	PUNCT
admet-1078	83	16	γ	γ	NOUN
admet-1078	83	17	provide	provide	VERB
admet-1078	83	18	a	a	DET
admet-1078	83	19	relationship	relationship	NOUN
admet-1078	83	20	between	between	ADP
admet-1078	83	21	the	the	DET
admet-1078	83	22	two	two	NUM
admet-1078	83	23	most	most	ADV
admet-1078	83	24	important	important	ADJ
admet-1078	83	25	links	link	NOUN
admet-1078	83	26	of	of	ADP
admet-1078	83	27	the	the	DET
admet-1078	83	28	immune	immune	ADJ
admet-1078	83	29	response	response	NOUN
admet-1078	83	30	of	of	ADP
admet-1078	83	31	a	a	DET
admet-1078	83	32	macroorganism	macroorganism	NOUN
admet-1078	83	33	,	,	PUNCT
admet-1078	83	34	enhancing	enhance	VERB
admet-1078	83	35	the	the	DET
admet-1078	83	36	antigen	antigen	NOUN
admet-1078	83	37	-	-	PUNCT
admet-1078	83	38	dependent	dependent	ADJ
admet-1078	83	39	immune	immune	ADJ
admet-1078	83	40	response	response	NOUN
admet-1078	83	41	and	and	CCONJ
admet-1078	83	42	stimulating	stimulate	VERB
admet-1078	83	43	the	the	DET
admet-1078	83	44	work	work	NOUN
admet-1078	83	45	of	of	ADP
admet-1078	83	46	phagocytes	phagocyte	NOUN
admet-1078	83	47	.	.	PUNCT
admet-1078	84	1	an	an	DET
admet-1078	84	2	additional	additional	ADJ
admet-1078	84	3	factor	factor	NOUN
admet-1078	84	4	affecting	affect	VERB
admet-1078	84	5	the	the	DET
admet-1078	84	6	course	course	NOUN
admet-1078	84	7	of	of	ADP
admet-1078	84	8	a	a	DET
admet-1078	84	9	bacterial	bacterial	ADJ
admet-1078	84	10	infection	infection	NOUN
admet-1078	84	11	is	be	AUX
admet-1078	84	12	the	the	DET
admet-1078	84	13	ability	ability	NOUN
admet-1078	84	14	of	of	ADP
admet-1078	84	15	bacteria	bacteria	NOUN
admet-1078	84	16	to	to	PART
admet-1078	84	17	inhibit	inhibit	VERB
admet-1078	84	18	the	the	DET
admet-1078	84	19	synthesis	synthesis	NOUN
admet-1078	84	20	of	of	ADP
admet-1078	84	21	pro	pro	ADJ
admet-1078	84	22	-	-	ADJ
admet-1078	84	23	inflammatory	inflammatory	ADJ
admet-1078	84	24	cytokines	cytokine	NOUN
admet-1078	84	25	.	.	PUNCT
admet-1078	85	1	it	it	PRON
admet-1078	85	2	has	have	AUX
admet-1078	85	3	been	be	AUX
admet-1078	85	4	shown	show	VERB
admet-1078	85	5	that	that	SCONJ
admet-1078	85	6	some	some	DET
admet-1078	85	7	microorganisms	microorganism	NOUN
admet-1078	85	8	can	can	AUX
admet-1078	85	9	specifically	specifically	ADV
admet-1078	85	10	repress	repress	VERB
admet-1078	85	11	the	the	DET
admet-1078	85	12	synthesis	synthesis	NOUN
admet-1078	85	13	of	of	ADP
admet-1078	85	14	endogenous	endogenous	ADJ
admet-1078	85	15	ifn	ifn	NOUN
admet-1078	85	16	-	-	PUNCT
admet-1078	85	17	γ	γ	NOUN
admet-1078	85	18	[	[	X
admet-1078	85	19	39	39	NUM
admet-1078	85	20	]	]	PUNCT
admet-1078	85	21	.	.	PUNCT
admet-1078	86	1	in	in	ADP
admet-1078	86	2	a	a	DET
admet-1078	86	3	study	study	NOUN
admet-1078	86	4	by	by	ADP
admet-1078	86	5	fortes	fortis	NOUN
admet-1078	86	6	et	et	PROPN
admet-1078	86	7	al	al	PROPN
admet-1078	86	8	.	.	PROPN
admet-1078	86	9	,	,	PUNCT
admet-1078	86	10	it	it	PRON
admet-1078	86	11	was	be	AUX
admet-1078	86	12	demonstrated	demonstrate	VERB
admet-1078	86	13	that	that	SCONJ
admet-1078	86	14	patients	patient	NOUN
admet-1078	86	15	infected	infect	VERB
admet-1078	86	16	with	with	ADP
admet-1078	86	17	an	an	DET
admet-1078	86	18	antibiotic	antibiotic	ADJ
admet-1078	86	19	-	-	PUNCT
admet-1078	86	20	resistant	resistant	ADJ
admet-1078	86	21	strain	strain	NOUN
admet-1078	86	22	of	of	ADP
admet-1078	86	23	mycobacterium	mycobacterium	NOUN
admet-1078	86	24	tuberculosis	tuberculosis	NOUN
admet-1078	86	25	have	have	VERB
admet-1078	86	26	a	a	DET
admet-1078	86	27	reduced	reduced	ADJ
admet-1078	86	28	level	level	NOUN
admet-1078	86	29	of	of	ADP
admet-1078	86	30	endogenous	endogenous	ADJ
admet-1078	86	31	ifn	ifn	NOUN
admet-1078	86	32	-	-	PUNCT
admet-1078	86	33	γ	γ	NOUN
admet-1078	86	34	compared	compare	VERB
admet-1078	86	35	to	to	ADP
admet-1078	86	36	normal	normal	ADJ
admet-1078	86	37	patients	patient	NOUN
admet-1078	86	38	[	[	X
admet-1078	86	39	40	40	NUM
admet-1078	86	40	]	]	PUNCT
admet-1078	86	41	.	.	PUNCT
admet-1078	87	1	it	it	PRON
admet-1078	87	2	has	have	AUX
admet-1078	87	3	also	also	ADV
admet-1078	87	4	been	be	AUX
admet-1078	87	5	shown	show	VERB
admet-1078	87	6	that	that	SCONJ
admet-1078	87	7	the	the	DET
admet-1078	87	8	use	use	NOUN
admet-1078	87	9	of	of	ADP
admet-1078	87	10	beta	beta	NOUN
admet-1078	87	11	-	-	PUNCT
admet-1078	87	12	lactam	lactam	NOUN
admet-1078	87	13	antibiotics	antibiotic	NOUN
admet-1078	87	14	can	can	AUX
admet-1078	87	15	decrease	decrease	VERB
admet-1078	87	16	the	the	DET
admet-1078	87	17	level	level	NOUN
admet-1078	87	18	of	of	ADP
admet-1078	87	19	endogenous	endogenous	ADJ
admet-1078	87	20	ifn	ifn	NOUN
admet-1078	87	21	-	-	PUNCT
admet-1078	87	22	γ	γ	NOUN
admet-1078	87	23	[	[	X
admet-1078	87	24	41	41	NUM
admet-1078	87	25	]	]	PUNCT
admet-1078	87	26	.	.	PUNCT
admet-1078	88	1	thus	thus	ADV
admet-1078	88	2	,	,	PUNCT
admet-1078	88	3	the	the	DET
admet-1078	88	4	ifn	ifn	NOUN
admet-1078	88	5	system	system	NOUN
admet-1078	88	6	and	and	CCONJ
admet-1078	88	7	directly	directly	ADV
admet-1078	88	8	ifn	ifn	NOUN
admet-1078	88	9	-	-	PUNCT
admet-1078	88	10	γ	γ	NOUN
admet-1078	88	11	are	be	AUX
admet-1078	88	12	key	key	ADJ
admet-1078	88	13	regulators	regulator	NOUN
admet-1078	88	14	of	of	ADP
admet-1078	88	15	the	the	DET
admet-1078	88	16	body	body	NOUN
admet-1078	88	17	's	's	PART
admet-1078	88	18	immune	immune	ADJ
admet-1078	88	19	response	response	NOUN
admet-1078	88	20	to	to	ADP
admet-1078	88	21	the	the	DET
admet-1078	88	22	infection	infection	NOUN
admet-1078	88	23	caused	cause	VERB
admet-1078	88	24	by	by	ADP
admet-1078	88	25	tb	tb	PROPN
admet-1078	88	26	.	.	PUNCT
admet-1078	89	1	therefore	therefore	ADV
admet-1078	89	2	,	,	PUNCT
admet-1078	89	3	additional	additional	ADJ
admet-1078	89	4	exposure	exposure	NOUN
admet-1078	89	5	to	to	AUX
admet-1078	89	6	exogenous	exogenous	ADJ
admet-1078	89	7	ifn	ifn	NOUN
admet-1078	89	8	-	-	PUNCT
admet-1078	89	9	γ	γ	NOUN
admet-1078	89	10	can	can	AUX
admet-1078	89	11	play	play	VERB
admet-1078	89	12	the	the	DET
admet-1078	89	13	role	role	NOUN
admet-1078	89	14	of	of	ADP
admet-1078	89	15	an	an	DET
admet-1078	89	16	inducer	inducer	NOUN
admet-1078	89	17	of	of	ADP
admet-1078	89	18	the	the	DET
admet-1078	89	19	immune	immune	ADJ
admet-1078	89	20	system	system	NOUN
admet-1078	89	21	under	under	ADP
admet-1078	89	22	conditions	condition	NOUN
admet-1078	89	23	of	of	ADP
admet-1078	89	24	a	a	DET
admet-1078	89	25	reduced	reduced	ADJ
admet-1078	89	26	response	response	NOUN
admet-1078	89	27	to	to	ADP
admet-1078	89	28	antibiotics	antibiotic	NOUN
admet-1078	89	29	and	and	CCONJ
admet-1078	89	30	correct	correct	VERB
admet-1078	89	31	the	the	DET
admet-1078	89	32	endogenous	endogenous	ADJ
admet-1078	89	33	cytokine	cytokine	NOUN
admet-1078	89	34	deficiency	deficiency	NOUN
admet-1078	89	35	.	.	PUNCT
admet-1078	90	1	despite	despite	SCONJ
admet-1078	90	2	all	all	DET
admet-1078	90	3	the	the	DET
admet-1078	90	4	attractiveness	attractiveness	NOUN
admet-1078	90	5	of	of	ADP
admet-1078	90	6	the	the	DET
admet-1078	90	7	idea	idea	NOUN
admet-1078	90	8	,	,	PUNCT
admet-1078	90	9	unfortunately	unfortunately	ADV
admet-1078	90	10	,	,	PUNCT
admet-1078	90	11	interest	interest	NOUN
admet-1078	90	12	in	in	ADP
admet-1078	90	13	the	the	DET
admet-1078	90	14	development	development	NOUN
admet-1078	90	15	has	have	AUX
admet-1078	90	16	not	not	PART
admet-1078	90	17	yet	yet	ADV
admet-1078	90	18	been	be	AUX
admet-1078	90	19	represented	represent	VERB
admet-1078	90	20	by	by	ADP
admet-1078	90	21	widely	widely	ADV
admet-1078	90	22	deployed	deploy	VERB
admet-1078	90	23	large	large	ADJ
admet-1078	90	24	-	-	PUNCT
admet-1078	90	25	scale	scale	NOUN
admet-1078	90	26	clinical	clinical	ADJ
admet-1078	90	27	trials	trial	NOUN
admet-1078	90	28	(	(	PUNCT
admet-1078	90	29	except	except	SCONJ
admet-1078	90	30	for	for	ADP
admet-1078	90	31	diagnostics	diagnostic	NOUN
admet-1078	90	32	use	use	VERB
admet-1078	90	33	research	research	NOUN
admet-1078	90	34	)	)	PUNCT
admet-1078	90	35	.	.	PUNCT
admet-1078	91	1	this	this	PRON
admet-1078	91	2	is	be	AUX
admet-1078	91	3	probably	probably	ADV
admet-1078	91	4	due	due	ADJ
admet-1078	91	5	to	to	ADP
admet-1078	91	6	the	the	DET
admet-1078	91	7	limited	limited	ADJ
admet-1078	91	8	number	number	NOUN
admet-1078	91	9	of	of	ADP
admet-1078	91	10	medical	medical	ADJ
admet-1078	91	11	products	product	NOUN
admet-1078	91	12	based	base	VERB
admet-1078	91	13	on	on	ADP
admet-1078	91	14	interferon	interferon	ADJ
admet-1078	91	15	-	-	PUNCT
admet-1078	91	16	gamma	gamma	NOUN
admet-1078	91	17	presented	present	VERB
admet-1078	91	18	on	on	ADP
admet-1078	91	19	the	the	DET
admet-1078	91	20	world	world	NOUN
admet-1078	91	21	market	market	NOUN
admet-1078	91	22	.	.	PUNCT
admet-1078	92	1	nevertheless	nevertheless	ADV
admet-1078	92	2	,	,	PUNCT
admet-1078	92	3	in	in	ADP
admet-1078	92	4	our	our	PRON
admet-1078	92	5	view	view	NOUN
admet-1078	92	6	,	,	PUNCT
admet-1078	92	7	the	the	DET
admet-1078	92	8	diagnostic	diagnostic	ADJ
admet-1078	92	9	and	and	CCONJ
admet-1078	92	10	clinical	clinical	ADJ
admet-1078	92	11	value	value	NOUN
admet-1078	92	12	of	of	ADP
admet-1078	92	13	the	the	DET
admet-1078	92	14	molecule	molecule	NOUN
admet-1078	92	15	will	will	AUX
admet-1078	92	16	undoubtedly	undoubtedly	ADV
admet-1078	92	17	gain	gain	VERB
admet-1078	92	18	momentum	momentum	NOUN
admet-1078	92	19	in	in	ADP
admet-1078	92	20	the	the	DET
admet-1078	92	21	nearest	near	ADJ
admet-1078	92	22	future	future	NOUN
admet-1078	92	23	.	.	PUNCT
admet-1078	93	1	clinical	clinical	ADJ
admet-1078	93	2	efficacy	efficacy	NOUN
admet-1078	93	3	of	of	ADP
admet-1078	93	4	interferon	interferon	ADJ
admet-1078	93	5	-	-	PUNCT
admet-1078	93	6	gamma	gamma	NOUN
admet-1078	93	7	in	in	ADP
admet-1078	93	8	the	the	DET
admet-1078	93	9	treatment	treatment	NOUN
admet-1078	93	10	of	of	ADP
admet-1078	93	11	tuberculosis	tuberculosis	NOUN
admet-1078	93	12	on	on	ADP
admet-1078	93	13	the	the	DET
admet-1078	93	14	open	open	ADJ
admet-1078	93	15	resource	resource	NOUN
admet-1078	93	16	https://clinicaltrials.gov/	https://clinicaltrials.gov/	VERB
admet-1078	93	17	99	99	NUM
admet-1078	93	18	clinical	clinical	ADJ
admet-1078	93	19	trials	trial	NOUN
admet-1078	93	20	with	with	ADP
admet-1078	93	21	keywords	keyword	NOUN
admet-1078	93	22	“	"	PUNCT
admet-1078	93	23	interferon	interferon	ADJ
admet-1078	93	24	-	-	PUNCT
admet-1078	93	25	gamma	gamma	NOUN
admet-1078	93	26	”	"	PUNCT
admet-1078	93	27	and	and	CCONJ
admet-1078	93	28	“	"	PUNCT
admet-1078	93	29	tuberculosis	tuberculosis	NOUN
admet-1078	93	30	”	"	PUNCT
admet-1078	93	31	were	be	AUX
admet-1078	93	32	found	find	VERB
admet-1078	93	33	,	,	PUNCT
admet-1078	93	34	15	15	NUM
admet-1078	93	35	of	of	ADP
admet-1078	93	36	which	which	PRON
admet-1078	93	37	are	be	AUX
admet-1078	93	38	in	in	ADP
admet-1078	93	39	active	active	ADJ
admet-1078	93	40	status	status	NOUN
admet-1078	93	41	,	,	PUNCT
admet-1078	93	42	64	64	NUM
admet-1078	93	43	are	be	AUX
admet-1078	93	44	completed	complete	VERB
admet-1078	93	45	,	,	PUNCT
admet-1078	93	46	20	20	NUM
admet-1078	93	47	are	be	AUX
admet-1078	93	48	cancelled	cancel	VERB
admet-1078	93	49	or	or	CCONJ
admet-1078	93	50	have	have	VERB
admet-1078	93	51	an	an	DET
admet-1078	93	52	unknown	unknown	ADJ
admet-1078	93	53	status	status	NOUN
admet-1078	93	54	.	.	PUNCT
admet-1078	94	1	out	out	ADP
admet-1078	94	2	of	of	ADP
admet-1078	94	3	64	64	NUM
admet-1078	94	4	completed	complete	VERB
admet-1078	94	5	studies	study	NOUN
admet-1078	94	6	,	,	PUNCT
admet-1078	94	7	16	16	NUM
admet-1078	94	8	studies	study	NOUN
admet-1078	94	9	have	have	AUX
admet-1078	94	10	published	publish	VERB
admet-1078	94	11	results	result	NOUN
admet-1078	94	12	.	.	PUNCT
admet-1078	95	1	current	current	ADJ
admet-1078	95	2	research	research	NOUN
admet-1078	95	3	is	be	AUX
admet-1078	95	4	mainly	mainly	ADV
admet-1078	95	5	concerned	concern	VERB
admet-1078	95	6	with	with	ADP
admet-1078	95	7	the	the	DET
admet-1078	95	8	diagnostic	diagnostic	ADJ
admet-1078	95	9	use	use	NOUN
admet-1078	95	10	of	of	ADP
admet-1078	95	11	the	the	DET
admet-1078	95	12	interferon	interferon	ADJ
admet-1078	95	13	-	-	PUNCT
admet-1078	95	14	gamma	gamma	NOUN
admet-1078	95	15	secretion	secretion	NOUN
admet-1078	95	16	test	test	NOUN
admet-1078	95	17	to	to	PART
admet-1078	95	18	assess	assess	VERB
admet-1078	95	19	the	the	DET
admet-1078	95	20	immune	immune	ADJ
admet-1078	95	21	status	status	NOUN
admet-1078	95	22	of	of	ADP
admet-1078	95	23	the	the	DET
admet-1078	95	24	body	body	NOUN
admet-1078	95	25	[	[	X
admet-1078	95	26	42	42	NUM
admet-1078	95	27	]	]	PUNCT
admet-1078	95	28	.	.	PUNCT
admet-1078	96	1	the	the	DET
admet-1078	96	2	therapeutic	therapeutic	ADJ
admet-1078	96	3	activity	activity	NOUN
admet-1078	96	4	of	of	ADP
admet-1078	96	5	ifn	ifn	PROPN
admet-1078	96	6	-	-	PUNCT
admet-1078	96	7	γ	γ	NOUN
admet-1078	96	8	against	against	ADP
admet-1078	96	9	tb	tb	NOUN
admet-1078	96	10	and	and	CCONJ
admet-1078	96	11	mdr	mdr	PROPN
admet-1078	96	12	-	-	PROPN
admet-1078	96	13	tb	tb	PROPN
admet-1078	96	14	has	have	AUX
admet-1078	96	15	been	be	AUX
admet-1078	96	16	intensively	intensively	ADV
admet-1078	96	17	studied	study	VERB
admet-1078	96	18	since	since	SCONJ
admet-1078	96	19	the	the	DET
admet-1078	96	20	end	end	NOUN
admet-1078	96	21	of	of	ADP
admet-1078	96	22	the	the	DET
admet-1078	96	23	last	last	ADJ
admet-1078	96	24	century	century	NOUN
admet-1078	96	25	;	;	PUNCT
admet-1078	96	26	a	a	DET
admet-1078	96	27	number	number	NOUN
admet-1078	96	28	of	of	ADP
admet-1078	96	29	clinical	clinical	ADJ
admet-1078	96	30	studies	study	NOUN
admet-1078	96	31	have	have	AUX
admet-1078	96	32	demonstrated	demonstrate	VERB
admet-1078	96	33	the	the	DET
admet-1078	96	34	effectiveness	effectiveness	NOUN
admet-1078	96	35	of	of	ADP
admet-1078	96	36	ifn	ifn	PROPN
admet-1078	96	37	-	-	PUNCT
admet-1078	96	38	γ	γ	NOUN
admet-1078	96	39	against	against	ADP
admet-1078	96	40	tb	tb	NOUN
admet-1078	96	41	,	,	PUNCT
admet-1078	96	42	including	include	VERB
admet-1078	96	43	mdr	mdr	PROPN
admet-1078	96	44	-	-	NOUN
admet-1078	96	45	tb	tb	X
admet-1078	96	46	[	[	PUNCT
admet-1078	96	47	43	43	NUM
admet-1078	96	48	-	-	SYM
admet-1078	96	49	49	49	NUM
admet-1078	96	50	]	]	PUNCT
admet-1078	96	51	.	.	PUNCT
admet-1078	97	1	a	a	DET
admet-1078	97	2	meta	meta	ADJ
admet-1078	97	3	-	-	PUNCT
admet-1078	97	4	analysis	analysis	NOUN
admet-1078	97	5	that	that	PRON
admet-1078	97	6	pooled	pool	VERB
admet-1078	97	7	data	datum	NOUN
admet-1078	97	8	from	from	ADP
admet-1078	97	9	9	9	NUM
admet-1078	97	10	clinical	clinical	ADJ
admet-1078	97	11	trials	trial	NOUN
admet-1078	97	12	showed	show	VERB
admet-1078	97	13	a	a	DET
admet-1078	97	14	statistically	statistically	ADV
admet-1078	97	15	significant	significant	ADJ
admet-1078	97	16	effect	effect	NOUN
admet-1078	97	17	for	for	ADP
admet-1078	97	18	ifn	ifn	NOUN
admet-1078	97	19	-	-	PUNCT
admet-1078	97	20	γ	γ	NOUN
admet-1078	97	21	as	as	ADP
admet-1078	97	22	an	an	DET
admet-1078	97	23	adjunct	adjunct	ADJ
admet-1078	97	24	drug	drug	NOUN
admet-1078	97	25	for	for	ADP
admet-1078	97	26	tb	tb	NOUN
admet-1078	97	27	[	[	X
admet-1078	97	28	43	43	NUM
admet-1078	97	29	]	]	PUNCT
admet-1078	97	30	.	.	PUNCT
admet-1078	98	1	the	the	DET
admet-1078	98	2	studies	study	NOUN
admet-1078	98	3	of	of	ADP
admet-1078	98	4	nebulized	nebulized	ADJ
admet-1078	98	5	ifn	ifn	PROPN
admet-1078	98	6	-	-	PUNCT
admet-1078	98	7	γ	γ	NOUN
admet-1078	98	8	showed	show	VERB
admet-1078	98	9	statistically	statistically	ADV
admet-1078	98	10	significant	significant	ADJ
admet-1078	98	11	benefits	benefit	NOUN
admet-1078	98	12	as	as	ADP
admet-1078	98	13	a	a	DET
admet-1078	98	14	result	result	NOUN
admet-1078	98	15	of	of	ADP
admet-1078	98	16	negative	negative	ADJ
admet-1078	98	17	sputum	sputum	PROPN
admet-1078	98	18	conversion	conversion	NOUN
admet-1078	98	19	and	and	CCONJ
admet-1078	98	20	chest	chest	NOUN
admet-1078	98	21	radiographs	radiograph	NOUN
admet-1078	98	22	:	:	PUNCT
admet-1078	98	23	the	the	DET
admet-1078	98	24	pooled	pooled	ADJ
admet-1078	98	25	relative	relative	ADJ
admet-1078	98	26	risk	risk	NOUN
admet-1078	98	27	(	(	PUNCT
admet-1078	98	28	rr	rr	NOUN
admet-1078	98	29	)	)	PUNCT
admet-1078	98	30	for	for	ADP
admet-1078	98	31	conversion	conversion	NOUN
admet-1078	98	32	was	be	AUX
admet-1078	98	33	1.97	1.97	NUM
admet-1078	98	34	(	(	PUNCT
admet-1078	98	35	95	95	NUM
admet-1078	98	36	%	%	NOUN
admet-1078	98	37	confidence	confidence	NOUN
admet-1078	98	38	interval	interval	NOUN
admet-1078	98	39	(	(	PUNCT
admet-1078	98	40	ci	ci	NOUN
admet-1078	98	41	)	)	PUNCT
admet-1078	98	42	1.20	1.20	NUM
admet-1078	98	43	-	-	SYM
admet-1078	98	44	3.24	3.24	NUM
admet-1078	98	45	,	,	PUNCT
admet-1078	98	46	p	p	X
admet-1078	98	47	=	=	NOUN
admet-1078	98	48	0.008	0.008	NUM
admet-1078	98	49	)	)	PUNCT
admet-1078	98	50	after	after	ADP
admet-1078	98	51	1	1	NUM
admet-1078	98	52	month	month	NOUN
admet-1078	98	53	of	of	ADP
admet-1078	98	54	treatment	treatment	NOUN
admet-1078	98	55	,	,	PUNCT
admet-1078	98	56	1.74	1.74	NUM
admet-1078	98	57	(	(	PUNCT
admet-1078	98	58	95	95	NUM
admet-1078	98	59	%	%	NOUN
admet-1078	98	60	ci	ci	NOUN
admet-1078	98	61	1.302.34	1.302.34	PROPN
admet-1078	98	62	,	,	PUNCT
admet-1078	98	63	p	p	NOUN
admet-1078	98	64	=	=	NOUN
admet-1078	98	65	0.0002	0.0002	NUM
admet-1078	98	66	)	)	PUNCT
admet-1078	98	67	after	after	ADP
admet-1078	98	68	2	2	NUM
admet-1078	98	69	months	month	NOUN
admet-1078	98	70	of	of	ADP
admet-1078	98	71	treatment	treatment	NOUN
admet-1078	98	72	,	,	PUNCT
admet-1078	98	73	1.53	1.53	NUM
admet-1078	98	74	(	(	PUNCT
admet-1078	98	75	95	95	NUM
admet-1078	98	76	%	%	NOUN
admet-1078	98	77	ci	ci	NOUN
admet-1078	98	78	1.16	1.16	NUM
admet-1078	98	79	-	-	SYM
admet-1078	98	80	2.01	2.01	NUM
admet-1078	98	81	,	,	PUNCT
admet-1078	98	82	p	p	X
admet-1078	98	83	=	=	NOUN
admet-1078	98	84	0.003	0.003	NUM
admet-1078	98	85	)	)	PUNCT
admet-1078	98	86	after	after	ADP
admet-1078	98	87	3	3	NUM
admet-1078	98	88	months	month	NOUN
admet-1078	98	89	of	of	ADP
admet-1078	98	90	treatment	treatment	NOUN
admet-1078	98	91	,	,	PUNCT
admet-1078	98	92	1.57	1.57	NUM
admet-1078	98	93	(	(	PUNCT
admet-1078	98	94	95	95	NUM
admet-1078	98	95	%	%	NOUN
admet-1078	98	96	ci	ci	NOUN
admet-1078	98	97	1.20	1.20	NUM
admet-1078	98	98	-	-	SYM
admet-1078	98	99	2.06	2.06	NUM
admet-1078	98	100	,	,	PUNCT
admet-1078	98	101	p	p	NOUN
admet-1078	98	102	=	=	NOUN
admet-1078	98	103	0.001	0.001	NUM
admet-1078	98	104	)	)	PUNCT
admet-1078	98	105	after	after	ADP
admet-1078	98	106	6	6	NUM
admet-1078	98	107	months	month	NOUN
admet-1078	98	108	of	of	ADP
admet-1078	98	109	treatment	treatment	NOUN
admet-1078	98	110	,	,	PUNCT
admet-1078	98	111	and	and	CCONJ
admet-1078	98	112	1.55	1.55	NUM
admet-1078	98	113	(	(	PUNCT
admet-1078	98	114	95	95	NUM
admet-1078	98	115	%	%	NOUN
admet-1078	98	116	ci	ci	NOUN
admet-1078	98	117	1.17	1.17	NUM
admet-1078	98	118	-	-	SYM
admet-1078	98	119	2.05	2.05	NUM
admet-1078	98	120	,	,	PUNCT
admet-1078	98	121	p	p	X
admet-1078	98	122	=	=	NOUN
admet-1078	98	123	0.002	0.002	NUM
admet-1078	98	124	)	)	PUNCT
admet-1078	98	125	at	at	ADP
admet-1078	98	126	the	the	DET
admet-1078	98	127	end	end	NOUN
admet-1078	98	128	of	of	ADP
admet-1078	98	129	treatment	treatment	NOUN
admet-1078	98	130	;	;	PUNCT
admet-1078	98	131	the	the	DET
admet-1078	98	132	pooled	pool	VERB
admet-1078	98	133	rr	rr	PROPN
admet-1078	98	134	for	for	ADP
admet-1078	98	135	chest	chest	NOUN
admet-1078	98	136	radiographs	radiograph	NOUN
admet-1078	98	137	was	be	AUX
admet-1078	98	138	1.38	1.38	NUM
admet-1078	98	139	(	(	PUNCT
admet-1078	98	140	95	95	NUM
admet-1078	98	141	%	%	NOUN
admet-1078	98	142	ci	ci	NOUN
admet-1078	98	143	1.10–1.17	1.10–1.17	PROPN
admet-1078	98	144	,	,	PUNCT
admet-1078	98	145	p	p	X
admet-1078	98	146	=	=	NOUN
admet-1078	98	147	0.006	0.006	NUM
admet-1078	98	148	)	)	PUNCT
admet-1078	98	149	at	at	ADP
admet-1078	98	150	the	the	DET
admet-1078	98	151	end	end	NOUN
admet-1078	98	152	of	of	ADP
admet-1078	98	153	treatment	treatment	NOUN
admet-1078	98	154	[	[	X
admet-1078	98	155	44	44	NUM
admet-1078	98	156	]	]	PUNCT
admet-1078	98	157	.	.	PUNCT
admet-1078	99	1	a	a	DET
admet-1078	99	2	randomized	randomized	ADJ
admet-1078	99	3	controlled	control	VERB
admet-1078	99	4	trial	trial	NOUN
admet-1078	99	5	with	with	ADP
admet-1078	99	6	aerosol	aerosol	NOUN
admet-1078	99	7	and	and	CCONJ
admet-1078	99	8	subcutaneous	subcutaneous	ADJ
admet-1078	99	9	injected	inject	VERB
admet-1078	99	10	ifn	ifn	PROPN
admet-1078	99	11	-	-	PUNCT
admet-1078	99	12	γ	γ	NOUN
admet-1078	99	13	showed	show	VERB
admet-1078	99	14	a	a	DET
admet-1078	99	15	significant	significant	ADJ
admet-1078	99	16	reduction	reduction	NOUN
admet-1078	99	17	in	in	ADP
admet-1078	99	18	fever	fever	NOUN
admet-1078	99	19	symptoms	symptom	NOUN
admet-1078	99	20	,	,	PUNCT
admet-1078	99	21	wheezing	wheezing	NOUN
admet-1078	99	22	and	and	CCONJ
admet-1078	99	23	night	night	NOUN
admet-1078	99	24	sweats	sweat	NOUN
admet-1078	99	25	compared	compare	VERB
admet-1078	99	26	with	with	ADP
admet-1078	99	27	the	the	DET
admet-1078	99	28	control	control	NOUN
admet-1078	99	29	group	group	NOUN
admet-1078	99	30	after	after	ADP
admet-1078	99	31	one	one	NUM
admet-1078	99	32	month	month	NOUN
admet-1078	99	33	of	of	ADP
admet-1078	99	34	treatment	treatment	NOUN
admet-1078	99	35	[	[	X
admet-1078	99	36	46	46	NUM
admet-1078	99	37	]	]	PUNCT
admet-1078	99	38	.	.	PUNCT
admet-1078	100	1	for	for	ADP
admet-1078	100	2	intramuscularly	intramuscularly	ADV
admet-1078	100	3	administered	administer	VERB
admet-1078	100	4	ifn	ifn	PROPN
admet-1078	100	5	-	-	PUNCT
admet-1078	100	6	γ	γ	NOUN
admet-1078	100	7	,	,	PUNCT
admet-1078	100	8	the	the	DET
admet-1078	100	9	meta	meta	ADJ
admet-1078	100	10	-	-	PUNCT
admet-1078	100	11	analysis	analysis	NOUN
admet-1078	100	12	included	include	VERB
admet-1078	100	13	three	three	NUM
admet-1078	100	14	studies	study	NOUN
admet-1078	100	15	that	that	PRON
admet-1078	100	16	showed	show	VERB
admet-1078	100	17	significant	significant	ADJ
admet-1078	100	18	improvement	improvement	NOUN
admet-1078	100	19	in	in	ADP
admet-1078	100	20	negative	negative	ADJ
admet-1078	100	21	sputum	sputum	NOUN
admet-1078	100	22	conversion	conversion	NOUN
admet-1078	100	23	after	after	ADP
admet-1078	100	24	two	two	NUM
admet-1078	100	25	months	month	NOUN
admet-1078	100	26	of	of	ADP
admet-1078	100	27	treatment	treatment	NOUN
admet-1078	100	28	[	[	X
admet-1078	100	29	43	43	NUM
admet-1078	100	30	]	]	PUNCT
admet-1078	100	31	.	.	PUNCT
admet-1078	101	1	intramuscular	intramuscular	ADJ
admet-1078	101	2	injection	injection	NOUN
admet-1078	101	3	of	of	ADP
admet-1078	101	4	ifn	ifn	PROPN
admet-1078	101	5	-	-	PUNCT
admet-1078	101	6	γ	γ	NOUN
admet-1078	101	7	also	also	ADV
admet-1078	101	8	showed	show	VERB
admet-1078	101	9	a	a	DET
admet-1078	101	10	beneficial	beneficial	ADJ
admet-1078	101	11	effect	effect	NOUN
admet-1078	101	12	in	in	ADP
admet-1078	101	13	treating	treat	VERB
admet-1078	101	14	pulmonary	pulmonary	ADJ
admet-1078	101	15	mdr	mdr	NOUN
admet-1078	101	16	-	-	NOUN
admet-1078	101	17	tb	tb	X
admet-1078	102	1	[	[	X
admet-1078	102	2	45	45	NUM
admet-1078	102	3	]	]	PUNCT
admet-1078	102	4	.	.	PUNCT
admet-1078	103	1	the	the	DET
admet-1078	103	2	authors	author	NOUN
admet-1078	103	3	concluded	conclude	VERB
admet-1078	103	4	that	that	SCONJ
admet-1078	103	5	adjuvant	adjuvant	ADJ
admet-1078	103	6	therapy	therapy	NOUN
admet-1078	103	7	with	with	ADP
admet-1078	103	8	ifn	ifn	PROPN
admet-1078	103	9	-	-	PUNCT
admet-1078	103	10	γ	γ	NOUN
admet-1078	103	11	,	,	PUNCT
admet-1078	103	12	especially	especially	ADV
admet-1078	103	13	in	in	ADP
admet-1078	103	14	an	an	DET
admet-1078	103	15	aerosol	aerosol	NOUN
admet-1078	103	16	form	form	NOUN
admet-1078	103	17	,	,	PUNCT
admet-1078	103	18	may	may	AUX
admet-1078	103	19	be	be	AUX
admet-1078	103	20	beneficial	beneficial	ADJ
admet-1078	103	21	for	for	ADP
admet-1078	103	22	tb	tb	ADP
admet-1078	103	23	patients	patient	NOUN
admet-1078	103	24	.	.	PUNCT
admet-1078	104	1	http://dx.doi.org/10.5599/admet.1078	http://dx.doi.org/10.5599/admet.1078	PROPN
admet-1078	104	2	https://clinicaltrials.gov/	https://clinicaltrials.gov/	PROPN
admet-1078	104	3	svetlana	svetlana	PROPN
admet-1078	104	4	a.	a.	PROPN
admet-1078	104	5	berns	berns	PROPN
admet-1078	104	6	et	et	PROPN
admet-1078	104	7	al	al	PROPN
admet-1078	104	8	.	.	PROPN
admet-1078	104	9	admet	admet	PROPN
admet-1078	104	10	&	&	CCONJ
admet-1078	104	11	dmpk	dmpk	PROPN
admet-1078	104	12	10(1	10(1	NUM
admet-1078	104	13	)	)	PUNCT
admet-1078	104	14	(	(	PUNCT
admet-1078	104	15	2022	2022	NUM
admet-1078	104	16	)	)	PUNCT
admet-1078	104	17	63	63	NUM
admet-1078	104	18	-	-	SYM
admet-1078	104	19	73	73	NUM
admet-1078	104	20	68	68	NUM
admet-1078	104	21	the	the	DET
admet-1078	104	22	results	result	NOUN
admet-1078	104	23	of	of	ADP
admet-1078	104	24	another	another	DET
admet-1078	104	25	randomized	randomized	ADJ
admet-1078	104	26	clinical	clinical	ADJ
admet-1078	104	27	trial	trial	NOUN
admet-1078	104	28	published	publish	VERB
admet-1078	104	29	in	in	ADP
admet-1078	104	30	2016	2016	NUM
admet-1078	104	31	also	also	ADV
admet-1078	104	32	confirmed	confirm	VERB
admet-1078	104	33	the	the	DET
admet-1078	104	34	high	high	ADJ
admet-1078	104	35	clinical	clinical	ADJ
admet-1078	104	36	efficacy	efficacy	NOUN
admet-1078	104	37	of	of	ADP
admet-1078	104	38	ifn	ifn	PROPN
admet-1078	104	39	-	-	PUNCT
admet-1078	104	40	γ	γ	NOUN
admet-1078	104	41	as	as	ADP
admet-1078	104	42	part	part	NOUN
admet-1078	104	43	of	of	ADP
admet-1078	104	44	the	the	DET
admet-1078	104	45	complex	complex	ADJ
admet-1078	104	46	therapy	therapy	NOUN
admet-1078	104	47	for	for	ADP
admet-1078	104	48	tb	tb	NOUN
admet-1078	104	49	.	.	PUNCT
admet-1078	105	1	this	this	DET
admet-1078	105	2	study	study	NOUN
admet-1078	105	3	evaluated	evaluate	VERB
admet-1078	105	4	the	the	DET
admet-1078	105	5	clinical	clinical	ADJ
admet-1078	105	6	efficacy	efficacy	NOUN
admet-1078	105	7	of	of	ADP
admet-1078	105	8	ifn	ifn	PROPN
admet-1078	105	9	-	-	PUNCT
admet-1078	105	10	γ	γ	NOUN
admet-1078	105	11	in	in	ADP
admet-1078	105	12	the	the	DET
admet-1078	105	13	intensive	intensive	ADJ
admet-1078	105	14	phase	phase	NOUN
admet-1078	105	15	of	of	ADP
admet-1078	105	16	complex	complex	ADJ
admet-1078	105	17	treatment	treatment	NOUN
admet-1078	105	18	of	of	ADP
admet-1078	105	19	newly	newly	ADV
admet-1078	105	20	diagnosed	diagnose	VERB
admet-1078	105	21	patients	patient	NOUN
admet-1078	105	22	with	with	ADP
admet-1078	105	23	destructive	destructive	ADJ
admet-1078	105	24	pulmonary	pulmonary	NOUN
admet-1078	105	25	tb	tb	NOUN
admet-1078	105	26	with	with	ADP
admet-1078	105	27	bacterial	bacterial	ADJ
admet-1078	105	28	excretion	excretion	NOUN
admet-1078	105	29	.	.	PUNCT
admet-1078	106	1	the	the	DET
admet-1078	106	2	dynamics	dynamic	NOUN
admet-1078	106	3	of	of	ADP
admet-1078	106	4	laboratory	laboratory	NOUN
admet-1078	106	5	and	and	CCONJ
admet-1078	106	6	immunological	immunological	ADJ
admet-1078	106	7	parameters	parameter	NOUN
admet-1078	106	8	were	be	AUX
admet-1078	106	9	also	also	ADV
admet-1078	106	10	assessed	assess	VERB
admet-1078	106	11	.	.	PUNCT
admet-1078	107	1	the	the	DET
admet-1078	107	2	study	study	NOUN
admet-1078	107	3	included	include	VERB
admet-1078	107	4	60	60	NUM
admet-1078	107	5	patients	patient	NOUN
admet-1078	107	6	(	(	PUNCT
admet-1078	107	7	the	the	DET
admet-1078	107	8	study	study	NOUN
admet-1078	107	9	group	group	NOUN
admet-1078	107	10	included	include	VERB
admet-1078	107	11	30	30	NUM
admet-1078	107	12	newly	newly	ADV
admet-1078	107	13	diagnosed	diagnose	VERB
admet-1078	107	14	patients	patient	NOUN
admet-1078	107	15	who	who	PRON
admet-1078	107	16	received	receive	VERB
admet-1078	107	17	500,000	500,000	NUM
admet-1078	107	18	iu	iu	NOUN
admet-1078	107	19	of	of	ADP
admet-1078	107	20	ifn	ifn	NOUN
admet-1078	107	21	-	-	PUNCT
admet-1078	107	22	γ	γ	NOUN
admet-1078	107	23	intramuscularly	intramuscularly	ADV
admet-1078	107	24	every	every	DET
admet-1078	107	25	other	other	ADJ
admet-1078	107	26	day	day	NOUN
admet-1078	107	27	,	,	PUNCT
admet-1078	107	28	for	for	ADP
admet-1078	107	29	a	a	DET
admet-1078	107	30	month	month	NOUN
admet-1078	107	31	in	in	ADP
admet-1078	107	32	addition	addition	NOUN
admet-1078	107	33	to	to	ADP
admet-1078	107	34	standard	standard	ADJ
admet-1078	107	35	therapy	therapy	NOUN
admet-1078	107	36	;	;	PUNCT
admet-1078	107	37	control	control	NOUN
admet-1078	107	38	group	group	NOUN
admet-1078	107	39	30	30	NUM
admet-1078	107	40	patients	patient	NOUN
admet-1078	107	41	who	who	PRON
admet-1078	107	42	received	receive	VERB
admet-1078	107	43	only	only	ADV
admet-1078	107	44	standard	standard	ADJ
admet-1078	107	45	therapy	therapy	NOUN
admet-1078	107	46	)	)	PUNCT
admet-1078	107	47	.	.	PUNCT
admet-1078	108	1	the	the	DET
admet-1078	108	2	predominant	predominant	ADJ
admet-1078	108	3	clinical	clinical	ADJ
admet-1078	108	4	form	form	NOUN
admet-1078	108	5	was	be	AUX
admet-1078	108	6	infiltrative	infiltrative	ADJ
admet-1078	108	7	,	,	PUNCT
admet-1078	108	8	diagnosed	diagnose	VERB
admet-1078	108	9	in	in	ADP
admet-1078	108	10	80	80	NUM
admet-1078	108	11	%	%	NOUN
admet-1078	108	12	of	of	ADP
admet-1078	108	13	patients	patient	NOUN
admet-1078	108	14	in	in	ADP
admet-1078	108	15	both	both	DET
admet-1078	108	16	groups	group	NOUN
admet-1078	108	17	(	(	PUNCT
admet-1078	108	18	p	p	X
admet-1078	108	19	>	>	X
admet-1078	108	20	0.05	0.05	NUM
admet-1078	108	21	)	)	PUNCT
admet-1078	108	22	.	.	PUNCT
admet-1078	109	1	clinical	clinical	ADJ
admet-1078	109	2	efficacy	efficacy	NOUN
admet-1078	109	3	was	be	AUX
admet-1078	109	4	assessed	assess	VERB
admet-1078	109	5	in	in	ADP
admet-1078	109	6	patients	patient	NOUN
admet-1078	109	7	who	who	PRON
admet-1078	109	8	received	receive	VERB
admet-1078	109	9	ifn	ifn	PROPN
admet-1078	109	10	-	-	PUNCT
admet-1078	109	11	γ	γ	NOUN
admet-1078	109	12	after	after	ADP
admet-1078	109	13	two	two	NUM
admet-1078	109	14	months	month	NOUN
admet-1078	109	15	of	of	ADP
admet-1078	109	16	the	the	DET
admet-1078	109	17	intensive	intensive	ADJ
admet-1078	109	18	phase	phase	NOUN
admet-1078	109	19	of	of	ADP
admet-1078	109	20	treatment	treatment	NOUN
admet-1078	109	21	.	.	PUNCT
admet-1078	110	1	according	accord	VERB
admet-1078	110	2	to	to	ADP
admet-1078	110	3	the	the	DET
admet-1078	110	4	results	result	NOUN
admet-1078	110	5	of	of	ADP
admet-1078	110	6	a	a	DET
admet-1078	110	7	control	control	NOUN
admet-1078	110	8	x	x	NOUN
admet-1078	110	9	-	-	NOUN
admet-1078	110	10	ray	ray	NOUN
admet-1078	110	11	examination	examination	NOUN
admet-1078	110	12	,	,	PUNCT
admet-1078	110	13	cavities	cavity	NOUN
admet-1078	110	14	in	in	ADP
admet-1078	110	15	the	the	DET
admet-1078	110	16	lungs	lung	NOUN
admet-1078	110	17	closed	close	VERB
admet-1078	110	18	in	in	ADP
admet-1078	110	19	23	23	NUM
admet-1078	110	20	%	%	NOUN
admet-1078	110	21	of	of	ADP
admet-1078	110	22	cases	case	NOUN
admet-1078	110	23	,	,	PUNCT
admet-1078	110	24	and	and	CCONJ
admet-1078	110	25	by	by	ADP
admet-1078	110	26	four	four	NUM
admet-1078	110	27	months	month	NOUN
admet-1078	110	28	,	,	PUNCT
admet-1078	110	29	this	this	DET
admet-1078	110	30	indicator	indicator	NOUN
admet-1078	110	31	was	be	AUX
admet-1078	110	32	50	50	NUM
admet-1078	110	33	%	%	NOUN
admet-1078	110	34	.	.	PUNCT
admet-1078	111	1	while	while	SCONJ
admet-1078	111	2	in	in	ADP
admet-1078	111	3	patients	patient	NOUN
admet-1078	111	4	in	in	ADP
admet-1078	111	5	the	the	DET
admet-1078	111	6	control	control	NOUN
admet-1078	111	7	group	group	NOUN
admet-1078	111	8	,	,	PUNCT
admet-1078	111	9	the	the	DET
admet-1078	111	10	closure	closure	NOUN
admet-1078	111	11	of	of	ADP
admet-1078	111	12	cavities	cavity	NOUN
admet-1078	111	13	in	in	ADP
admet-1078	111	14	the	the	DET
admet-1078	111	15	lungs	lung	NOUN
admet-1078	111	16	was	be	AUX
admet-1078	111	17	10	10	NUM
admet-1078	111	18	%	%	NOUN
admet-1078	111	19	,	,	PUNCT
admet-1078	111	20	in	in	ADP
admet-1078	111	21	the	the	DET
admet-1078	111	22	study	study	NOUN
admet-1078	111	23	group	group	NOUN
admet-1078	111	24	,	,	PUNCT
admet-1078	111	25	this	this	DET
admet-1078	111	26	indicator	indicator	NOUN
admet-1078	111	27	was	be	AUX
admet-1078	111	28	three	three	NUM
admet-1078	111	29	times	time	NOUN
admet-1078	111	30	higher	high	ADJ
admet-1078	111	31	(	(	PUNCT
admet-1078	111	32	37	37	NUM
admet-1078	111	33	%	%	NOUN
admet-1078	111	34	)	)	PUNCT
admet-1078	111	35	(	(	PUNCT
admet-1078	111	36	p	p	X
admet-1078	111	37	<	<	X
admet-1078	111	38	0.05	0.05	NUM
admet-1078	111	39	)	)	PUNCT
admet-1078	111	40	.	.	PUNCT
admet-1078	112	1	abacillation	abacillation	NOUN
admet-1078	112	2	occurred	occur	VERB
admet-1078	112	3	in	in	ADP
admet-1078	112	4	90	90	NUM
admet-1078	112	5	%	%	NOUN
admet-1078	112	6	of	of	ADP
admet-1078	112	7	patients	patient	NOUN
admet-1078	112	8	receiving	receive	VERB
admet-1078	112	9	ifn	ifn	PROPN
admet-1078	112	10	-	-	PUNCT
admet-1078	112	11	γ	γ	NOUN
admet-1078	112	12	.	.	PROPN
admet-1078	112	13	a	a	DET
admet-1078	112	14	month	month	NOUN
admet-1078	112	15	later	later	ADV
admet-1078	112	16	,	,	PUNCT
admet-1078	112	17	the	the	DET
admet-1078	112	18	normalization	normalization	NOUN
admet-1078	112	19	of	of	ADP
admet-1078	112	20	indicators	indicator	NOUN
admet-1078	112	21	of	of	ADP
admet-1078	112	22	the	the	DET
admet-1078	112	23	clinical	clinical	ADJ
admet-1078	112	24	analysis	analysis	NOUN
admet-1078	112	25	of	of	ADP
admet-1078	112	26	blood	blood	NOUN
admet-1078	112	27	occurred	occur	VERB
admet-1078	112	28	in	in	ADP
admet-1078	112	29	70	70	NUM
admet-1078	112	30	%	%	NOUN
admet-1078	112	31	of	of	ADP
admet-1078	112	32	patients	patient	NOUN
admet-1078	112	33	.	.	PUNCT
admet-1078	113	1	in	in	ADP
admet-1078	113	2	the	the	DET
admet-1078	113	3	group	group	NOUN
admet-1078	113	4	of	of	ADP
admet-1078	113	5	patients	patient	NOUN
admet-1078	113	6	who	who	PRON
admet-1078	113	7	additionally	additionally	ADV
admet-1078	113	8	received	receive	VERB
admet-1078	113	9	ifn	ifn	PROPN
admet-1078	113	10	-	-	PUNCT
admet-1078	113	11	γ	γ	NOUN
admet-1078	113	12	,	,	PUNCT
admet-1078	113	13	the	the	DET
admet-1078	113	14	number	number	NOUN
admet-1078	113	15	of	of	ADP
admet-1078	113	16	cd4	cd4	PROPN
admet-1078	113	17	+	+	PROPN
admet-1078	113	18	lymphocytes	lymphocyte	NOUN
admet-1078	113	19	increased	increase	VERB
admet-1078	113	20	to	to	ADP
admet-1078	113	21	41	41	NUM
admet-1078	113	22	%	%	NOUN
admet-1078	113	23	,	,	PUNCT
admet-1078	113	24	exceeding	exceed	VERB
admet-1078	113	25	the	the	DET
admet-1078	113	26	initial	initial	ADJ
admet-1078	113	27	level	level	NOUN
admet-1078	113	28	by	by	ADP
admet-1078	113	29	1.7	1.7	NUM
admet-1078	113	30	times	time	NOUN
admet-1078	113	31	(	(	PUNCT
admet-1078	113	32	p	p	X
admet-1078	113	33	<	<	X
admet-1078	113	34	0.001	0.001	NUM
admet-1078	113	35	)	)	PUNCT
admet-1078	113	36	.	.	PUNCT
admet-1078	114	1	the	the	DET
admet-1078	114	2	authors	author	NOUN
admet-1078	114	3	of	of	ADP
admet-1078	114	4	the	the	DET
admet-1078	114	5	study	study	NOUN
admet-1078	114	6	concluded	conclude	VERB
admet-1078	114	7	that	that	SCONJ
admet-1078	114	8	the	the	DET
admet-1078	114	9	addition	addition	NOUN
admet-1078	114	10	of	of	ADP
admet-1078	114	11	immunomodulatory	immunomodulatory	ADJ
admet-1078	114	12	therapy	therapy	NOUN
admet-1078	114	13	is	be	AUX
admet-1078	114	14	a	a	DET
admet-1078	114	15	significant	significant	ADJ
admet-1078	114	16	addition	addition	NOUN
admet-1078	114	17	to	to	ADP
admet-1078	114	18	anti	anti	ADJ
admet-1078	114	19	-	-	ADJ
admet-1078	114	20	tb	tb	ADJ
admet-1078	114	21	drugs	drug	NOUN
admet-1078	114	22	in	in	ADP
admet-1078	114	23	terms	term	NOUN
admet-1078	114	24	of	of	ADP
admet-1078	114	25	pathogenesis	pathogenesis	NOUN
admet-1078	114	26	.	.	PUNCT
admet-1078	115	1	the	the	DET
admet-1078	115	2	use	use	NOUN
admet-1078	115	3	of	of	ADP
admet-1078	115	4	ifn	ifn	PROPN
admet-1078	115	5	-	-	PUNCT
admet-1078	115	6	γ	γ	NOUN
admet-1078	115	7	in	in	ADP
admet-1078	115	8	the	the	DET
admet-1078	115	9	complex	complex	ADJ
admet-1078	115	10	treatment	treatment	NOUN
admet-1078	115	11	of	of	ADP
admet-1078	115	12	patients	patient	NOUN
admet-1078	115	13	with	with	ADP
admet-1078	115	14	destructive	destructive	ADJ
admet-1078	115	15	pulmonary	pulmonary	NOUN
admet-1078	115	16	tb	tb	NOUN
admet-1078	115	17	with	with	ADP
admet-1078	115	18	bacterial	bacterial	ADJ
admet-1078	115	19	excretion	excretion	NOUN
admet-1078	115	20	has	have	AUX
admet-1078	115	21	shown	show	VERB
admet-1078	115	22	its	its	PRON
admet-1078	115	23	high	high	ADJ
admet-1078	115	24	efficiency	efficiency	NOUN
admet-1078	115	25	in	in	ADP
admet-1078	115	26	the	the	DET
admet-1078	115	27	intensive	intensive	ADJ
admet-1078	115	28	phase	phase	NOUN
admet-1078	115	29	of	of	ADP
admet-1078	115	30	chemotherapy	chemotherapy	NOUN
admet-1078	115	31	,	,	PUNCT
admet-1078	115	32	accompanied	accompany	VERB
admet-1078	115	33	by	by	ADP
admet-1078	115	34	an	an	DET
admet-1078	115	35	increase	increase	NOUN
admet-1078	115	36	in	in	ADP
admet-1078	115	37	patients	patient	NOUN
admet-1078	115	38	'	'	PART
admet-1078	115	39	quality	quality	NOUN
admet-1078	115	40	of	of	ADP
admet-1078	115	41	life	life	NOUN
admet-1078	115	42	.	.	PUNCT
admet-1078	116	1	the	the	DET
admet-1078	116	2	results	result	NOUN
admet-1078	116	3	of	of	ADP
admet-1078	116	4	the	the	DET
admet-1078	116	5	study	study	NOUN
admet-1078	116	6	indicate	indicate	VERB
admet-1078	116	7	a	a	DET
admet-1078	116	8	significant	significant	ADJ
admet-1078	116	9	improvement	improvement	NOUN
admet-1078	116	10	in	in	ADP
admet-1078	116	11	the	the	DET
admet-1078	116	12	quality	quality	NOUN
admet-1078	116	13	of	of	ADP
admet-1078	116	14	life	life	NOUN
admet-1078	116	15	based	base	VERB
admet-1078	116	16	on	on	ADP
admet-1078	116	17	the	the	DET
admet-1078	116	18	assessment	assessment	NOUN
admet-1078	116	19	according	accord	VERB
admet-1078	116	20	to	to	ADP
admet-1078	116	21	the	the	DET
admet-1078	116	22	methodology	methodology	NOUN
admet-1078	116	23	recommended	recommend	VERB
admet-1078	116	24	by	by	ADP
admet-1078	116	25	the	the	DET
admet-1078	116	26	who	who	PRON
admet-1078	116	27	.	.	PUNCT
admet-1078	117	1	after	after	ADP
admet-1078	117	2	complex	complex	ADJ
admet-1078	117	3	treatment	treatment	NOUN
admet-1078	117	4	,	,	PUNCT
admet-1078	117	5	when	when	SCONJ
admet-1078	117	6	studying	study	VERB
admet-1078	117	7	the	the	DET
admet-1078	117	8	quality	quality	NOUN
admet-1078	117	9	of	of	ADP
admet-1078	117	10	life	life	NOUN
admet-1078	117	11	of	of	ADP
admet-1078	117	12	patients	patient	NOUN
admet-1078	117	13	in	in	ADP
admet-1078	117	14	the	the	DET
admet-1078	117	15	main	main	ADJ
admet-1078	117	16	group	group	NOUN
admet-1078	117	17	,	,	PUNCT
admet-1078	117	18	there	there	PRON
admet-1078	117	19	was	be	VERB
admet-1078	117	20	a	a	DET
admet-1078	117	21	positive	positive	ADJ
admet-1078	117	22	trend	trend	NOUN
admet-1078	117	23	in	in	ADP
admet-1078	117	24	aspects	aspect	NOUN
admet-1078	117	25	characterizing	characterize	VERB
admet-1078	117	26	social	social	ADJ
admet-1078	117	27	relationships	relationship	NOUN
admet-1078	117	28	and	and	CCONJ
admet-1078	117	29	the	the	DET
admet-1078	117	30	psychological	psychological	ADJ
admet-1078	117	31	sphere	sphere	NOUN
admet-1078	117	32	,	,	PUNCT
admet-1078	117	33	as	as	ADV
admet-1078	117	34	well	well	ADV
admet-1078	117	35	as	as	ADP
admet-1078	117	36	reflecting	reflect	VERB
admet-1078	117	37	the	the	DET
admet-1078	117	38	physical	physical	ADJ
admet-1078	117	39	and	and	CCONJ
admet-1078	117	40	mental	mental	ADJ
admet-1078	117	41	health	health	NOUN
admet-1078	117	42	of	of	ADP
admet-1078	117	43	the	the	DET
admet-1078	117	44	patient	patient	NOUN
admet-1078	117	45	.	.	PUNCT
admet-1078	118	1	it	it	PRON
admet-1078	118	2	should	should	AUX
admet-1078	118	3	be	be	AUX
admet-1078	118	4	noted	note	VERB
admet-1078	118	5	that	that	SCONJ
admet-1078	118	6	the	the	DET
admet-1078	118	7	addition	addition	NOUN
admet-1078	118	8	of	of	ADP
admet-1078	118	9	ifn	ifn	PROPN
admet-1078	118	10	-	-	PUNCT
admet-1078	118	11	γ	γ	NOUN
admet-1078	118	12	to	to	ADP
admet-1078	118	13	anti	anti	ADJ
admet-1078	118	14	-	-	ADJ
admet-1078	118	15	tuberculosis	tuberculosis	ADJ
admet-1078	118	16	therapy	therapy	NOUN
admet-1078	118	17	was	be	AUX
admet-1078	118	18	not	not	PART
admet-1078	118	19	accompanied	accompany	VERB
admet-1078	118	20	by	by	ADP
admet-1078	118	21	a	a	DET
admet-1078	118	22	significant	significant	ADJ
admet-1078	118	23	increase	increase	NOUN
admet-1078	118	24	in	in	ADP
admet-1078	118	25	the	the	DET
admet-1078	118	26	number	number	NOUN
admet-1078	118	27	of	of	ADP
admet-1078	118	28	adverse	adverse	ADJ
admet-1078	118	29	reactions	reaction	NOUN
admet-1078	118	30	(	(	PUNCT
admet-1078	118	31	20	20	NUM
admet-1078	118	32	%	%	NOUN
admet-1078	118	33	vs.	vs.	ADP
admet-1078	118	34	17	17	NUM
admet-1078	118	35	%	%	NOUN
admet-1078	118	36	in	in	ADP
admet-1078	118	37	the	the	DET
admet-1078	118	38	control	control	NOUN
admet-1078	118	39	group	group	NOUN
admet-1078	118	40	)	)	PUNCT
admet-1078	118	41	(	(	PUNCT
admet-1078	118	42	p	p	X
admet-1078	118	43	>	>	X
admet-1078	118	44	0.05	0.05	NUM
admet-1078	118	45	)	)	PUNCT
admet-1078	118	46	.	.	PUNCT
admet-1078	119	1	all	all	DET
admet-1078	119	2	adverse	adverse	ADJ
admet-1078	119	3	reactions	reaction	NOUN
admet-1078	119	4	were	be	AUX
admet-1078	119	5	removable	removable	ADJ
admet-1078	119	6	and	and	CCONJ
admet-1078	119	7	stopped	stop	VERB
admet-1078	119	8	by	by	ADP
admet-1078	119	9	pathogenetic	pathogenetic	ADJ
admet-1078	119	10	methods	method	NOUN
admet-1078	119	11	of	of	ADP
admet-1078	119	12	concomitant	concomitant	ADJ
admet-1078	119	13	treatment	treatment	NOUN
admet-1078	119	14	[	[	X
admet-1078	119	15	48	48	NUM
admet-1078	119	16	]	]	PUNCT
admet-1078	119	17	.	.	PUNCT
admet-1078	120	1	one	one	NUM
admet-1078	120	2	more	more	ADV
admet-1078	120	3	clinical	clinical	ADJ
admet-1078	120	4	example	example	NOUN
admet-1078	120	5	was	be	AUX
admet-1078	120	6	published	publish	VERB
admet-1078	120	7	in	in	ADP
admet-1078	120	8	the	the	DET
admet-1078	120	9	scientific	scientific	ADJ
admet-1078	120	10	literature	literature	NOUN
admet-1078	120	11	about	about	ADP
admet-1078	120	12	the	the	DET
admet-1078	120	13	experience	experience	NOUN
admet-1078	120	14	of	of	ADP
admet-1078	120	15	ifn	ifn	PROPN
admet-1078	120	16	-	-	PUNCT
admet-1078	120	17	γ	γ	NOUN
admet-1078	120	18	medical	medical	ADJ
admet-1078	120	19	use	use	NOUN
admet-1078	120	20	in	in	ADP
admet-1078	120	21	mdr	mdr	PROPN
admet-1078	120	22	-	-	PROPN
admet-1078	120	23	tb	tb	PROPN
admet-1078	120	24	.	.	PUNCT
admet-1078	121	1	the	the	DET
admet-1078	121	2	treatment	treatment	NOUN
admet-1078	121	3	of	of	ADP
admet-1078	121	4	mdr	mdr	PROPN
admet-1078	121	5	-	-	PROPN
admet-1078	121	6	tb	tb	ADP
admet-1078	121	7	of	of	ADP
admet-1078	121	8	the	the	DET
admet-1078	121	9	brain	brain	NOUN
admet-1078	121	10	in	in	ADP
admet-1078	121	11	a	a	DET
admet-1078	121	12	patient	patient	NOUN
admet-1078	121	13	with	with	ADP
admet-1078	121	14	acute	acute	ADJ
admet-1078	121	15	lymphocytic	lymphocytic	ADJ
admet-1078	121	16	leukemia	leukemia	NOUN
admet-1078	121	17	,	,	PUNCT
admet-1078	121	18	after	after	ADP
admet-1078	121	19	five	five	NUM
admet-1078	121	20	months	month	NOUN
admet-1078	121	21	of	of	ADP
admet-1078	121	22	adjuvant	adjuvant	ADJ
admet-1078	121	23	therapy	therapy	NOUN
admet-1078	121	24	using	use	VERB
admet-1078	121	25	subcutaneously	subcutaneously	ADV
admet-1078	121	26	injected	inject	VERB
admet-1078	121	27	ifn	ifn	PROPN
admet-1078	121	28	-	-	PUNCT
admet-1078	121	29	γ	γ	NOUN
admet-1078	121	30	,	,	PUNCT
admet-1078	121	31	showed	show	VERB
admet-1078	121	32	a	a	DET
admet-1078	121	33	positive	positive	ADJ
admet-1078	121	34	trend	trend	NOUN
admet-1078	121	35	with	with	ADP
admet-1078	121	36	the	the	DET
admet-1078	121	37	achievement	achievement	NOUN
admet-1078	121	38	of	of	ADP
admet-1078	121	39	complete	complete	ADJ
admet-1078	121	40	remission	remission	NOUN
admet-1078	121	41	after	after	ADP
admet-1078	121	42	12	12	NUM
admet-1078	121	43	months	month	NOUN
admet-1078	121	44	of	of	ADP
admet-1078	121	45	therapy	therapy	NOUN
admet-1078	121	46	[	[	X
admet-1078	121	47	47	47	NUM
admet-1078	121	48	]	]	PUNCT
admet-1078	121	49	.	.	PUNCT
admet-1078	122	1	in	in	ADP
admet-1078	122	2	another	another	DET
admet-1078	122	3	study	study	NOUN
admet-1078	122	4	evaluating	evaluate	VERB
admet-1078	122	5	the	the	DET
admet-1078	122	6	effects	effect	NOUN
admet-1078	122	7	of	of	ADP
admet-1078	122	8	ifn	ifn	NOUN
admet-1078	122	9	-	-	PUNCT
admet-1078	122	10	γ	γ	NOUN
admet-1078	122	11	in	in	ADP
admet-1078	122	12	mdr	mdr	PROPN
admet-1078	122	13	-	-	PROPN
admet-1078	122	14	tb	tb	PROPN
admet-1078	122	15	,	,	PUNCT
admet-1078	122	16	it	it	PRON
admet-1078	122	17	was	be	AUX
admet-1078	122	18	found	find	VERB
admet-1078	122	19	for	for	ADP
admet-1078	122	20	resistant	resistant	ADJ
admet-1078	122	21	forms	form	NOUN
admet-1078	122	22	of	of	ADP
admet-1078	122	23	tb	tb	ADP
admet-1078	122	24	that	that	SCONJ
admet-1078	122	25	there	there	PRON
admet-1078	122	26	is	be	VERB
admet-1078	122	27	an	an	DET
admet-1078	122	28	increase	increase	NOUN
admet-1078	122	29	in	in	ADP
admet-1078	122	30	the	the	DET
admet-1078	122	31	basal	basal	NOUN
admet-1078	122	32	and	and	CCONJ
admet-1078	122	33	il12	il12	PROPN
admet-1078	122	34	/	/	SYM
admet-1078	122	35	il27	il27	PROPN
admet-1078	122	36	-	-	PUNCT
admet-1078	122	37	induced	induce	VERB
admet-1078	122	38	secretion	secretion	NOUN
admet-1078	122	39	of	of	ADP
admet-1078	122	40	ifn	ifn	PROPN
admet-1078	122	41	-	-	PUNCT
admet-1078	122	42	γ	γ	NOUN
admet-1078	122	43	by	by	ADP
admet-1078	122	44	blood	blood	NOUN
admet-1078	122	45	lymphocytes	lymphocyte	VERB
admet-1078	122	46	in	in	ADP
admet-1078	122	47	vitro	vitro	NOUN
admet-1078	122	48	,	,	PUNCT
admet-1078	122	49	with	with	ADP
admet-1078	122	50	the	the	DET
admet-1078	122	51	maximum	maximum	ADJ
admet-1078	122	52	severity	severity	NOUN
admet-1078	122	53	of	of	ADP
admet-1078	122	54	changes	change	NOUN
admet-1078	122	55	in	in	ADP
admet-1078	122	56	the	the	DET
admet-1078	122	57	disseminated	disseminate	VERB
admet-1078	122	58	form	form	NOUN
admet-1078	122	59	of	of	ADP
admet-1078	122	60	the	the	DET
admet-1078	122	61	disease	disease	NOUN
admet-1078	122	62	.	.	PUNCT
admet-1078	123	1	hypersecretion	hypersecretion	NOUN
admet-1078	123	2	of	of	ADP
admet-1078	123	3	ifn	ifn	PROPN
admet-1078	123	4	-	-	PUNCT
admet-1078	123	5	γ	γ	NOUN
admet-1078	123	6	in	in	ADP
admet-1078	123	7	vitro	vitro	X
admet-1078	123	8	is	be	AUX
admet-1078	123	9	associated	associate	VERB
admet-1078	123	10	with	with	ADP
admet-1078	123	11	a	a	DET
admet-1078	123	12	low	low	ADJ
admet-1078	123	13	content	content	NOUN
admet-1078	123	14	of	of	ADP
admet-1078	123	15	cd3	cd3	PROPN
admet-1078	123	16	-	-	PUNCT
admet-1078	123	17	ifn	ifn	PROPN
admet-1078	123	18	-	-	PUNCT
admet-1078	123	19	γ+	γ+	NOUN
admet-1078	123	20	lymphocytes	lymphocyte	NOUN
admet-1078	123	21	and	and	CCONJ
admet-1078	123	22	an	an	DET
admet-1078	123	23	increase	increase	NOUN
admet-1078	123	24	in	in	ADP
admet-1078	123	25	the	the	DET
admet-1078	123	26	proportion	proportion	NOUN
admet-1078	123	27	of	of	ADP
admet-1078	123	28	cd3ifn	cd3ifn	PROPN
admet-1078	123	29	-	-	PUNCT
admet-1078	123	30	γ+	γ+	X
admet-1078	123	31	against	against	ADP
admet-1078	123	32	the	the	DET
admet-1078	123	33	background	background	NOUN
admet-1078	123	34	of	of	ADP
admet-1078	123	35	general	general	PROPN
admet-1078	123	36	t	t	PROPN
admet-1078	123	37	-	-	PUNCT
admet-1078	123	38	lymphocytopenia	lymphocytopenia	NOUN
admet-1078	124	1	[	[	X
admet-1078	124	2	50	50	NUM
admet-1078	124	3	]	]	PUNCT
admet-1078	124	4	.	.	PUNCT
admet-1078	125	1	a	a	DET
admet-1078	125	2	recent	recent	ADJ
admet-1078	125	3	study	study	NOUN
admet-1078	125	4	to	to	PART
admet-1078	125	5	assess	assess	VERB
admet-1078	125	6	the	the	DET
admet-1078	125	7	effects	effect	NOUN
admet-1078	125	8	of	of	ADP
admet-1078	125	9	ifn	ifn	PROPN
admet-1078	125	10	-	-	PUNCT
admet-1078	125	11	γ	γ	NOUN
admet-1078	125	12	on	on	ADP
admet-1078	125	13	macrophage	macrophage	ADJ
admet-1078	125	14	activity	activity	NOUN
admet-1078	125	15	in	in	ADP
admet-1078	125	16	overcoming	overcome	VERB
admet-1078	125	17	mdr	mdr	PROPN
admet-1078	125	18	-	-	ADJ
admet-1078	125	19	tb	tb	ADP
admet-1078	125	20	drug	drug	NOUN
admet-1078	125	21	resistance	resistance	NOUN
admet-1078	125	22	demonstrated	demonstrate	VERB
admet-1078	125	23	the	the	DET
admet-1078	125	24	high	high	ADJ
admet-1078	125	25	efficacy	efficacy	NOUN
admet-1078	125	26	of	of	ADP
admet-1078	125	27	ifn	ifn	PROPN
admet-1078	125	28	-	-	PUNCT
admet-1078	125	29	γ	γ	NOUN
admet-1078	125	30	as	as	ADP
admet-1078	125	31	an	an	DET
admet-1078	125	32	adjuvant	adjuvant	ADJ
admet-1078	125	33	therapy	therapy	NOUN
admet-1078	125	34	for	for	ADP
admet-1078	125	35	mdr	mdr	PROPN
admet-1078	125	36	-	-	PROPN
admet-1078	125	37	tb	tb	PROPN
admet-1078	125	38	.	.	PUNCT
admet-1078	126	1	the	the	DET
admet-1078	126	2	authors	author	NOUN
admet-1078	126	3	of	of	ADP
admet-1078	126	4	the	the	DET
admet-1078	126	5	study	study	NOUN
admet-1078	126	6	draw	draw	VERB
admet-1078	126	7	encouraging	encourage	VERB
admet-1078	126	8	conclusions	conclusion	NOUN
admet-1078	126	9	about	about	ADP
admet-1078	126	10	the	the	DET
admet-1078	126	11	prospect	prospect	NOUN
admet-1078	126	12	of	of	ADP
admet-1078	126	13	using	use	VERB
admet-1078	126	14	ifn	ifn	PROPN
admet-1078	126	15	-	-	PUNCT
admet-1078	126	16	γ	γ	NOUN
admet-1078	126	17	as	as	ADP
admet-1078	126	18	a	a	DET
admet-1078	126	19	part	part	NOUN
admet-1078	126	20	of	of	ADP
admet-1078	126	21	adjuvant	adjuvant	ADJ
admet-1078	126	22	therapy	therapy	NOUN
admet-1078	126	23	for	for	ADP
admet-1078	126	24	mdr	mdr	PROPN
admet-1078	126	25	-	-	PROPN
admet-1078	126	26	tb	tb	PROPN
admet-1078	126	27	.	.	PUNCT
admet-1078	127	1	it	it	PRON
admet-1078	127	2	increases	increase	VERB
admet-1078	127	3	the	the	DET
admet-1078	127	4	activity	activity	NOUN
admet-1078	127	5	of	of	ADP
admet-1078	127	6	macrophages	macrophage	NOUN
admet-1078	127	7	against	against	ADP
admet-1078	127	8	mycobacterium	mycobacterium	NOUN
admet-1078	127	9	tuberculosis	tuberculosis	NOUN
admet-1078	127	10	and	and	CCONJ
admet-1078	127	11	improves	improve	VERB
admet-1078	127	12	the	the	DET
admet-1078	127	13	activity	activity	NOUN
admet-1078	127	14	of	of	ADP
admet-1078	127	15	macrophages	macrophage	NOUN
admet-1078	127	16	treatment	treatment	NOUN
admet-1078	127	17	outcomes	outcome	NOUN
admet-1078	127	18	in	in	ADP
admet-1078	127	19	patients	patient	NOUN
admet-1078	127	20	with	with	ADP
admet-1078	127	21	poor	poor	ADJ
admet-1078	127	22	response	response	NOUN
admet-1078	127	23	to	to	ADP
admet-1078	127	24	therapy	therapy	NOUN
admet-1078	127	25	[	[	X
admet-1078	127	26	7	7	NUM
admet-1078	127	27	]	]	PUNCT
admet-1078	127	28	.	.	PUNCT
admet-1078	128	1	the	the	DET
admet-1078	128	2	use	use	NOUN
admet-1078	128	3	of	of	ADP
admet-1078	128	4	exogenous	exogenous	ADJ
admet-1078	128	5	ifn	ifn	NOUN
admet-1078	128	6	-	-	PUNCT
admet-1078	128	7	γ	γ	NOUN
admet-1078	128	8	in	in	ADP
admet-1078	128	9	adjuvant	adjuvant	ADJ
admet-1078	128	10	therapy	therapy	NOUN
admet-1078	128	11	,	,	PUNCT
admet-1078	128	12	especially	especially	ADV
admet-1078	128	13	in	in	ADP
admet-1078	128	14	the	the	DET
admet-1078	128	15	case	case	NOUN
admet-1078	128	16	of	of	ADP
admet-1078	128	17	diseases	disease	NOUN
admet-1078	128	18	caused	cause	VERB
admet-1078	128	19	by	by	ADP
admet-1078	128	20	microorganisms	microorganism	NOUN
admet-1078	128	21	resistant	resistant	ADJ
admet-1078	128	22	to	to	ADP
admet-1078	128	23	antibiotics	antibiotic	NOUN
admet-1078	128	24	,	,	PUNCT
admet-1078	128	25	can	can	AUX
admet-1078	128	26	have	have	VERB
admet-1078	128	27	a	a	DET
admet-1078	128	28	significant	significant	ADJ
admet-1078	128	29	effect	effect	NOUN
admet-1078	128	30	on	on	ADP
admet-1078	128	31	the	the	DET
admet-1078	128	32	course	course	NOUN
admet-1078	128	33	of	of	ADP
admet-1078	128	34	the	the	DET
admet-1078	128	35	disease	disease	NOUN
admet-1078	128	36	and	and	CCONJ
admet-1078	128	37	accelerate	accelerate	VERB
admet-1078	128	38	the	the	DET
admet-1078	128	39	patient	patient	NOUN
admet-1078	128	40	's	's	PART
admet-1078	128	41	recovery	recovery	NOUN
admet-1078	128	42	,	,	PUNCT
admet-1078	128	43	contributing	contribute	VERB
admet-1078	128	44	to	to	ADP
admet-1078	128	45	earlier	early	ADJ
admet-1078	128	46	abacillation	abacillation	NOUN
admet-1078	128	47	of	of	ADP
admet-1078	128	48	sputum	sputum	NOUN
admet-1078	128	49	.	.	PUNCT
admet-1078	129	1	admet	admet	PROPN
admet-1078	129	2	&	&	CCONJ
admet-1078	129	3	dmpk	dmpk	PROPN
admet-1078	129	4	10(1	10(1	NUM
admet-1078	129	5	)	)	PUNCT
admet-1078	129	6	(	(	PUNCT
admet-1078	129	7	2022	2022	NUM
admet-1078	129	8	)	)	PUNCT
admet-1078	129	9	63	63	NUM
admet-1078	129	10	-	-	SYM
admet-1078	129	11	73	73	NUM
admet-1078	129	12	therapeutic	therapeutic	ADJ
admet-1078	129	13	potential	potential	NOUN
admet-1078	129	14	of	of	ADP
admet-1078	129	15	interferon	interferon	ADJ
admet-1078	129	16	-	-	PUNCT
admet-1078	129	17	gamma	gamma	NOUN
admet-1078	129	18	in	in	ADP
admet-1078	129	19	tuberculosis	tuberculosis	NOUN
admet-1078	129	20	doi	doi	NOUN
admet-1078	129	21	:	:	PUNCT
admet-1078	129	22	http://dx.doi.org/10.5599/admet.1078	http://dx.doi.org/10.5599/admet.1078	PROPN
admet-1078	129	23	69	69	NUM
admet-1078	129	24	assessment	assessment	NOUN
admet-1078	129	25	of	of	ADP
admet-1078	129	26	the	the	DET
admet-1078	129	27	economic	economic	ADJ
admet-1078	129	28	feasibility	feasibility	NOUN
admet-1078	129	29	of	of	ADP
admet-1078	129	30	using	use	VERB
admet-1078	129	31	interferon	interferon	ADJ
admet-1078	129	32	-	-	PUNCT
admet-1078	129	33	gamma	gamma	NOUN
admet-1078	129	34	in	in	ADP
admet-1078	129	35	the	the	DET
admet-1078	129	36	treatment	treatment	NOUN
admet-1078	129	37	of	of	ADP
admet-1078	129	38	tuberculosis	tuberculosis	NOUN
admet-1078	129	39	(	(	PUNCT
admet-1078	129	40	experience	experience	NOUN
admet-1078	129	41	of	of	ADP
admet-1078	129	42	the	the	DET
admet-1078	129	43	russian	russian	PROPN
admet-1078	129	44	federation	federation	PROPN
admet-1078	129	45	)	)	PUNCT
admet-1078	129	46	as	as	ADP
admet-1078	129	47	a	a	DET
admet-1078	129	48	socially	socially	ADV
admet-1078	129	49	significant	significant	ADJ
admet-1078	129	50	disease	disease	NOUN
admet-1078	129	51	,	,	PUNCT
admet-1078	129	52	tb	tb	X
admet-1078	129	53	poses	pose	VERB
admet-1078	129	54	a	a	DET
admet-1078	129	55	significant	significant	ADJ
admet-1078	129	56	social	social	ADJ
admet-1078	129	57	and	and	CCONJ
admet-1078	129	58	economic	economic	ADJ
admet-1078	129	59	burden	burden	NOUN
admet-1078	129	60	on	on	ADP
admet-1078	129	61	the	the	DET
admet-1078	129	62	healthcare	healthcare	NOUN
admet-1078	129	63	system	system	NOUN
admet-1078	129	64	around	around	ADP
admet-1078	129	65	the	the	DET
admet-1078	129	66	world	world	NOUN
admet-1078	129	67	[	[	X
admet-1078	129	68	51	51	NUM
admet-1078	129	69	]	]	PUNCT
admet-1078	129	70	.	.	PUNCT
admet-1078	130	1	the	the	DET
admet-1078	130	2	economic	economic	ADJ
admet-1078	130	3	burden	burden	NOUN
admet-1078	130	4	of	of	ADP
admet-1078	130	5	tb	tb	NOUN
admet-1078	130	6	is	be	AUX
admet-1078	130	7	conditioned	condition	VERB
admet-1078	130	8	by	by	ADP
admet-1078	130	9	several	several	ADJ
admet-1078	130	10	components	component	NOUN
admet-1078	130	11	:	:	PUNCT
admet-1078	130	12	direct	direct	ADJ
admet-1078	130	13	economic	economic	ADJ
admet-1078	130	14	losses	loss	NOUN
admet-1078	130	15	associated	associate	VERB
admet-1078	130	16	with	with	ADP
admet-1078	130	17	medical	medical	ADJ
admet-1078	130	18	costs	cost	NOUN
admet-1078	130	19	and	and	CCONJ
admet-1078	130	20	indirect	indirect	ADJ
admet-1078	130	21	economic	economic	ADJ
admet-1078	130	22	losses	loss	NOUN
admet-1078	130	23	of	of	ADP
admet-1078	130	24	the	the	DET
admet-1078	130	25	country	country	NOUN
admet-1078	130	26	's	's	PART
admet-1078	130	27	gross	gross	ADJ
admet-1078	130	28	domestic	domestic	ADJ
admet-1078	130	29	product	product	NOUN
admet-1078	130	30	due	due	ADP
admet-1078	130	31	to	to	ADP
admet-1078	130	32	the	the	DET
admet-1078	130	33	loss	loss	NOUN
admet-1078	130	34	of	of	ADP
admet-1078	130	35	“	"	PUNCT
admet-1078	130	36	human	human	ADJ
admet-1078	130	37	capital	capital	NOUN
admet-1078	130	38	”	"	PUNCT
admet-1078	130	39	.	.	PUNCT
admet-1078	131	1	the	the	DET
admet-1078	131	2	costs	cost	NOUN
admet-1078	131	3	of	of	ADP
admet-1078	131	4	drug	drug	NOUN
admet-1078	131	5	therapy	therapy	NOUN
admet-1078	131	6	account	account	VERB
admet-1078	131	7	for	for	ADP
admet-1078	131	8	more	more	ADJ
admet-1078	131	9	than	than	ADP
admet-1078	131	10	half	half	NOUN
admet-1078	131	11	of	of	ADP
admet-1078	131	12	the	the	DET
admet-1078	131	13	direct	direct	ADJ
admet-1078	131	14	medical	medical	ADJ
admet-1078	131	15	costs	cost	NOUN
admet-1078	131	16	of	of	ADP
admet-1078	131	17	tb	tb	ADP
admet-1078	131	18	treatment	treatment	NOUN
admet-1078	131	19	[	[	X
admet-1078	131	20	52	52	NUM
admet-1078	131	21	]	]	PUNCT
admet-1078	131	22	.	.	PUNCT
admet-1078	132	1	in	in	ADP
admet-1078	132	2	this	this	DET
admet-1078	132	3	regard	regard	NOUN
admet-1078	132	4	,	,	PUNCT
admet-1078	132	5	when	when	SCONJ
admet-1078	132	6	adding	add	VERB
admet-1078	132	7	new	new	ADJ
admet-1078	132	8	drugs	drug	NOUN
admet-1078	132	9	to	to	PART
admet-1078	132	10	tb	tb	ADP
admet-1078	132	11	treatment	treatment	NOUN
admet-1078	132	12	regimens	regimen	NOUN
admet-1078	132	13	,	,	PUNCT
admet-1078	132	14	not	not	PART
admet-1078	132	15	only	only	ADV
admet-1078	132	16	clinical	clinical	ADJ
admet-1078	132	17	indicators	indicator	NOUN
admet-1078	132	18	of	of	ADP
admet-1078	132	19	the	the	DET
admet-1078	132	20	effectiveness	effectiveness	NOUN
admet-1078	132	21	of	of	ADP
admet-1078	132	22	therapy	therapy	NOUN
admet-1078	132	23	should	should	AUX
admet-1078	132	24	be	be	AUX
admet-1078	132	25	taken	take	VERB
admet-1078	132	26	into	into	ADP
admet-1078	132	27	account	account	NOUN
admet-1078	132	28	,	,	PUNCT
admet-1078	132	29	but	but	CCONJ
admet-1078	132	30	also	also	ADV
admet-1078	132	31	their	their	PRON
admet-1078	132	32	impact	impact	NOUN
admet-1078	132	33	on	on	ADP
admet-1078	132	34	the	the	DET
admet-1078	132	35	health	health	NOUN
admet-1078	132	36	economics	economic	NOUN
admet-1078	132	37	.	.	PUNCT
admet-1078	133	1	assessment	assessment	NOUN
admet-1078	133	2	of	of	ADP
admet-1078	133	3	health	health	NOUN
admet-1078	133	4	technologies	technology	NOUN
admet-1078	133	5	when	when	SCONJ
admet-1078	133	6	deciding	decide	VERB
admet-1078	133	7	on	on	ADP
admet-1078	133	8	the	the	DET
admet-1078	133	9	inclusion	inclusion	NOUN
admet-1078	133	10	of	of	ADP
admet-1078	133	11	medicines	medicine	NOUN
admet-1078	133	12	in	in	ADP
admet-1078	133	13	the	the	DET
admet-1078	133	14	drug	drug	NOUN
admet-1078	133	15	supply	supply	NOUN
admet-1078	133	16	system	system	NOUN
admet-1078	133	17	is	be	AUX
admet-1078	133	18	a	a	DET
admet-1078	133	19	mandatory	mandatory	ADJ
admet-1078	133	20	component	component	NOUN
admet-1078	133	21	of	of	ADP
admet-1078	133	22	health	health	NOUN
admet-1078	133	23	systems	system	NOUN
admet-1078	133	24	in	in	ADP
admet-1078	133	25	all	all	DET
admet-1078	133	26	countries	country	NOUN
admet-1078	133	27	of	of	ADP
admet-1078	133	28	the	the	DET
admet-1078	133	29	world	world	NOUN
admet-1078	133	30	,	,	PUNCT
admet-1078	133	31	regardless	regardless	ADV
admet-1078	133	32	of	of	ADP
admet-1078	133	33	economic	economic	ADJ
admet-1078	133	34	development	development	NOUN
admet-1078	133	35	,	,	PUNCT
admet-1078	133	36	morbidity	morbidity	NOUN
admet-1078	133	37	and	and	CCONJ
admet-1078	133	38	mortality	mortality	NOUN
admet-1078	133	39	.	.	PUNCT
admet-1078	134	1	in	in	ADP
admet-1078	134	2	the	the	DET
admet-1078	134	3	russian	russian	ADJ
admet-1078	134	4	study	study	NOUN
admet-1078	134	5	published	publish	VERB
admet-1078	134	6	in	in	ADP
admet-1078	134	7	2018	2018	NUM
admet-1078	134	8	[	[	X
admet-1078	134	9	53	53	NUM
admet-1078	134	10	]	]	PUNCT
admet-1078	134	11	on	on	ADP
admet-1078	134	12	the	the	DET
admet-1078	134	13	assessment	assessment	NOUN
admet-1078	134	14	of	of	ADP
admet-1078	134	15	the	the	DET
admet-1078	134	16	cost	cost	NOUN
admet-1078	134	17	-	-	PUNCT
admet-1078	134	18	effectiveness	effectiveness	NOUN
admet-1078	134	19	for	for	ADP
admet-1078	134	20	ifn	ifn	NOUN
admet-1078	134	21	-	-	PUNCT
admet-1078	134	22	γ	γ	NOUN
admet-1078	134	23	,	,	PUNCT
admet-1078	134	24	a	a	DET
admet-1078	134	25	positive	positive	ADJ
admet-1078	134	26	impact	impact	NOUN
admet-1078	134	27	on	on	ADP
admet-1078	134	28	the	the	DET
admet-1078	134	29	budget	budget	NOUN
admet-1078	134	30	from	from	ADP
admet-1078	134	31	the	the	DET
admet-1078	134	32	use	use	NOUN
admet-1078	134	33	of	of	ADP
admet-1078	134	34	ifn	ifn	PROPN
admet-1078	134	35	-	-	PUNCT
admet-1078	134	36	γ	γ	NOUN
admet-1078	134	37	as	as	ADP
admet-1078	134	38	a	a	DET
admet-1078	134	39	part	part	NOUN
admet-1078	134	40	of	of	ADP
admet-1078	134	41	complex	complex	ADJ
admet-1078	134	42	tb	tb	ADP
admet-1078	134	43	therapy	therapy	NOUN
admet-1078	134	44	was	be	AUX
admet-1078	134	45	demonstrated	demonstrate	VERB
admet-1078	134	46	due	due	ADJ
admet-1078	134	47	to	to	ADP
admet-1078	134	48	reducing	reduce	VERB
admet-1078	134	49	the	the	DET
admet-1078	134	50	duration	duration	NOUN
admet-1078	134	51	of	of	ADP
admet-1078	134	52	hospitalization	hospitalization	NOUN
admet-1078	134	53	.	.	PUNCT
admet-1078	135	1	as	as	ADP
admet-1078	135	2	a	a	DET
admet-1078	135	3	result	result	NOUN
admet-1078	135	4	of	of	ADP
admet-1078	135	5	the	the	DET
admet-1078	135	6	behavioural	behavioural	ADJ
admet-1078	135	7	pharmacoeconomic	pharmacoeconomic	ADJ
admet-1078	135	8	analysis	analysis	NOUN
admet-1078	135	9	,	,	PUNCT
admet-1078	135	10	it	it	PRON
admet-1078	135	11	was	be	AUX
admet-1078	135	12	shown	show	VERB
admet-1078	135	13	that	that	SCONJ
admet-1078	135	14	ifn	ifn	PROPN
admet-1078	135	15	-	-	PUNCT
admet-1078	135	16	γ	γ	NOUN
admet-1078	135	17	contributed	contribute	VERB
admet-1078	135	18	to	to	ADP
admet-1078	135	19	an	an	DET
admet-1078	135	20	increase	increase	NOUN
admet-1078	135	21	of	of	ADP
admet-1078	135	22	the	the	DET
admet-1078	135	23	duration	duration	NOUN
admet-1078	135	24	of	of	ADP
admet-1078	135	25	quality	quality	NOUN
admet-1078	135	26	life	life	NOUN
admet-1078	135	27	by	by	ADP
admet-1078	135	28	2.1	2.1	NUM
admet-1078	135	29	qaly	qaly	NOUN
admet-1078	135	30	,	,	PUNCT
admet-1078	135	31	and	and	CCONJ
admet-1078	135	32	its	its	PRON
admet-1078	135	33	use	use	NOUN
admet-1078	135	34	will	will	AUX
admet-1078	135	35	be	be	AUX
admet-1078	135	36	accompanied	accompany	VERB
admet-1078	135	37	by	by	ADP
admet-1078	135	38	savings	saving	NOUN
admet-1078	135	39	in	in	ADP
admet-1078	135	40	the	the	DET
admet-1078	135	41	budget	budget	NOUN
admet-1078	135	42	of	of	ADP
admet-1078	135	43	the	the	DET
admet-1078	135	44	russian	russian	PROPN
admet-1078	135	45	federation	federation	PROPN
admet-1078	135	46	in	in	ADP
admet-1078	135	47	the	the	DET
admet-1078	135	48	amount	amount	NOUN
admet-1078	135	49	of	of	ADP
admet-1078	135	50	up	up	ADP
admet-1078	135	51	to	to	PART
admet-1078	135	52	27	27	NUM
admet-1078	135	53	%	%	NOUN
admet-1078	135	54	of	of	ADP
admet-1078	135	55	funds	fund	NOUN
admet-1078	135	56	for	for	ADP
admet-1078	135	57	the	the	DET
admet-1078	135	58	treatment	treatment	NOUN
admet-1078	135	59	of	of	ADP
admet-1078	135	60	this	this	DET
admet-1078	135	61	group	group	NOUN
admet-1078	135	62	of	of	ADP
admet-1078	135	63	patients	patient	NOUN
admet-1078	135	64	[	[	X
admet-1078	135	65	53	53	NUM
admet-1078	135	66	]	]	PUNCT
admet-1078	135	67	.	.	PUNCT
admet-1078	136	1	results	result	NOUN
admet-1078	136	2	and	and	CCONJ
admet-1078	136	3	discussion	discussion	NOUN
admet-1078	136	4	analysis	analysis	NOUN
admet-1078	136	5	of	of	ADP
admet-1078	136	6	data	datum	NOUN
admet-1078	136	7	from	from	ADP
admet-1078	136	8	preclinical	preclinical	ADJ
admet-1078	136	9	and	and	CCONJ
admet-1078	136	10	clinical	clinical	ADJ
admet-1078	136	11	studies	study	NOUN
admet-1078	136	12	shows	show	VERB
admet-1078	136	13	that	that	SCONJ
admet-1078	136	14	the	the	DET
admet-1078	136	15	inflammatory	inflammatory	ADJ
admet-1078	136	16	cytokine	cytokine	VERB
admet-1078	136	17	ifn	ifn	NOUN
admet-1078	136	18	-	-	PUNCT
admet-1078	136	19	γ	γ	NOUN
admet-1078	136	20	occupies	occupy	VERB
admet-1078	136	21	an	an	DET
admet-1078	136	22	important	important	ADJ
admet-1078	136	23	place	place	NOUN
admet-1078	136	24	in	in	ADP
admet-1078	136	25	the	the	DET
admet-1078	136	26	pathogenesis	pathogenesis	NOUN
admet-1078	136	27	of	of	ADP
admet-1078	136	28	bacterial	bacterial	ADJ
admet-1078	136	29	infections	infection	NOUN
admet-1078	136	30	,	,	PUNCT
admet-1078	136	31	including	include	VERB
admet-1078	136	32	tb	tb	NOUN
admet-1078	136	33	.	.	PUNCT
admet-1078	137	1	the	the	DET
admet-1078	137	2	significance	significance	NOUN
admet-1078	137	3	and	and	CCONJ
admet-1078	137	4	potential	potential	NOUN
admet-1078	137	5	of	of	ADP
admet-1078	137	6	the	the	DET
admet-1078	137	7	use	use	NOUN
admet-1078	137	8	of	of	ADP
admet-1078	137	9	interferons	interferon	NOUN
admet-1078	137	10	are	be	AUX
admet-1078	137	11	discussed	discuss	VERB
admet-1078	137	12	in	in	ADP
admet-1078	137	13	all	all	DET
admet-1078	137	14	areas	area	NOUN
admet-1078	137	15	of	of	ADP
admet-1078	137	16	phthisiology	phthisiology	NOUN
admet-1078	137	17	:	:	PUNCT
admet-1078	137	18	diagnosis	diagnosis	NOUN
admet-1078	137	19	,	,	PUNCT
admet-1078	137	20	therapy	therapy	NOUN
admet-1078	137	21	,	,	PUNCT
admet-1078	137	22	and	and	CCONJ
admet-1078	137	23	prevention	prevention	NOUN
admet-1078	137	24	of	of	ADP
admet-1078	137	25	tb	tb	ADP
admet-1078	137	26	[	[	X
admet-1078	137	27	54	54	NUM
admet-1078	137	28	]	]	PUNCT
admet-1078	137	29	.	.	PUNCT
admet-1078	138	1	for	for	ADP
admet-1078	138	2	instance	instance	NOUN
admet-1078	138	3	,	,	PUNCT
admet-1078	138	4	the	the	DET
admet-1078	138	5	main	main	ADJ
admet-1078	138	6	alternative	alternative	NOUN
admet-1078	138	7	to	to	ADP
admet-1078	138	8	tuberculin	tuberculin	ADJ
admet-1078	138	9	skin	skin	NOUN
admet-1078	138	10	test	test	NOUN
admet-1078	138	11	widely	widely	ADV
admet-1078	138	12	used	use	VERB
admet-1078	138	13	for	for	ADP
admet-1078	138	14	diagnostic	diagnostic	ADJ
admet-1078	138	15	purposes	purpose	NOUN
admet-1078	138	16	is	be	AUX
admet-1078	138	17	ifn	ifn	NOUN
admet-1078	138	18	-	-	PUNCT
admet-1078	138	19	γ	γ	NOUN
admet-1078	138	20	release	release	NOUN
admet-1078	138	21	assays	assay	NOUN
admet-1078	138	22	(	(	PUNCT
admet-1078	138	23	igra	igra	PROPN
admet-1078	138	24	)	)	PUNCT
admet-1078	138	25	test	test	NOUN
admet-1078	138	26	.	.	PUNCT
admet-1078	139	1	it	it	PRON
admet-1078	139	2	measures	measure	VERB
admet-1078	139	3	the	the	DET
admet-1078	139	4	ex	ex	ADJ
admet-1078	139	5	vivo	vivo	NOUN
admet-1078	139	6	production	production	NOUN
admet-1078	139	7	of	of	ADP
admet-1078	139	8	ifn	ifn	PROPN
admet-1078	139	9	-	-	PUNCT
admet-1078	139	10	γ	γ	NOUN
admet-1078	139	11	from	from	ADP
admet-1078	139	12	t	t	PROPN
admet-1078	139	13	-	-	PUNCT
admet-1078	139	14	cells	cell	NOUN
admet-1078	139	15	stimulated	stimulate	VERB
admet-1078	139	16	with	with	ADP
admet-1078	139	17	the	the	DET
admet-1078	139	18	tb	tb	NOUN
admet-1078	139	19	-	-	PUNCT
admet-1078	139	20	specific	specific	ADJ
admet-1078	139	21	antigens	antigen	NOUN
admet-1078	139	22	.	.	PUNCT
admet-1078	140	1	the	the	DET
admet-1078	140	2	test	test	NOUN
admet-1078	140	3	does	do	AUX
admet-1078	140	4	n’t	not	PART
admet-1078	140	5	have	have	VERB
admet-1078	140	6	cross	cross	ADJ
admet-1078	140	7	-	-	NOUN
admet-1078	140	8	reactivity	reactivity	NOUN
admet-1078	140	9	to	to	ADP
admet-1078	140	10	bcg	bcg	PROPN
admet-1078	140	11	and	and	CCONJ
admet-1078	140	12	nontuberculous	nontuberculous	ADJ
admet-1078	140	13	mycobacteria	mycobacterium	NOUN
admet-1078	140	14	showing	show	VERB
admet-1078	140	15	higher	high	ADJ
admet-1078	140	16	specificity	specificity	NOUN
admet-1078	140	17	keeping	keep	VERB
admet-1078	140	18	the	the	DET
admet-1078	140	19	same	same	ADJ
admet-1078	140	20	level	level	NOUN
admet-1078	140	21	of	of	ADP
admet-1078	140	22	sensitivity	sensitivity	NOUN
admet-1078	140	23	[	[	X
admet-1078	140	24	55	55	NUM
admet-1078	140	25	-	-	SYM
admet-1078	140	26	57	57	NUM
admet-1078	140	27	]	]	PUNCT
admet-1078	140	28	.	.	PUNCT
admet-1078	141	1	preclinical	preclinical	ADJ
admet-1078	141	2	data	datum	NOUN
admet-1078	141	3	confirm	confirm	VERB
admet-1078	141	4	the	the	DET
admet-1078	141	5	enhancement	enhancement	NOUN
admet-1078	141	6	of	of	ADP
admet-1078	141	7	the	the	DET
admet-1078	141	8	cellular	cellular	ADJ
admet-1078	141	9	component	component	NOUN
admet-1078	141	10	of	of	ADP
admet-1078	141	11	immunity	immunity	NOUN
admet-1078	141	12	when	when	SCONJ
admet-1078	141	13	using	use	VERB
admet-1078	141	14	ifn	ifn	NOUN
admet-1078	141	15	-	-	PUNCT
admet-1078	141	16	γ	γ	NOUN
admet-1078	141	17	in	in	ADP
admet-1078	141	18	combination	combination	NOUN
admet-1078	141	19	with	with	ADP
admet-1078	141	20	the	the	DET
admet-1078	141	21	recombinant	recombinant	ADJ
admet-1078	141	22	bcg	bcg	NOUN
admet-1078	141	23	vaccine	vaccine	NOUN
admet-1078	141	24	(	(	PUNCT
admet-1078	141	25	bacillus	bacillus	NOUN
admet-1078	141	26	calmette	calmette	NOUN
admet-1078	141	27	guérin	guérin	PROPN
admet-1078	141	28	(	(	PUNCT
admet-1078	141	29	bcg	bcg	PROPN
admet-1078	141	30	)	)	PUNCT
admet-1078	141	31	)	)	PUNCT
admet-1078	142	1	[	[	X
admet-1078	142	2	58	58	NUM
admet-1078	142	3	]	]	PUNCT
admet-1078	142	4	.	.	PUNCT
admet-1078	143	1	the	the	DET
admet-1078	143	2	use	use	NOUN
admet-1078	143	3	of	of	ADP
admet-1078	143	4	ifn	ifn	PROPN
admet-1078	143	5	-	-	PUNCT
admet-1078	143	6	γ	γ	NOUN
admet-1078	143	7	as	as	ADP
admet-1078	143	8	a	a	DET
admet-1078	143	9	means	means	NOUN
admet-1078	143	10	of	of	ADP
admet-1078	143	11	preventing	prevent	VERB
admet-1078	143	12	infection	infection	NOUN
admet-1078	143	13	,	,	PUNCT
admet-1078	143	14	as	as	ADV
admet-1078	143	15	well	well	ADV
admet-1078	143	16	as	as	ADP
admet-1078	143	17	the	the	DET
admet-1078	143	18	transition	transition	NOUN
admet-1078	143	19	of	of	ADP
admet-1078	143	20	the	the	DET
admet-1078	143	21	latent	latent	NOUN
admet-1078	143	22	phase	phase	NOUN
admet-1078	143	23	of	of	ADP
admet-1078	143	24	tb	tb	NOUN
admet-1078	143	25	to	to	ADP
admet-1078	143	26	the	the	DET
admet-1078	143	27	active	active	ADJ
admet-1078	143	28	form	form	NOUN
admet-1078	143	29	,	,	PUNCT
admet-1078	143	30	requires	require	VERB
admet-1078	143	31	the	the	DET
admet-1078	143	32	study	study	NOUN
admet-1078	143	33	of	of	ADP
admet-1078	143	34	this	this	DET
admet-1078	143	35	agent	agent	NOUN
admet-1078	143	36	in	in	ADP
admet-1078	143	37	clinical	clinical	ADJ
admet-1078	143	38	trials	trial	NOUN
admet-1078	143	39	of	of	ADP
admet-1078	143	40	vaccines	vaccine	NOUN
admet-1078	143	41	and	and	CCONJ
admet-1078	143	42	other	other	ADJ
admet-1078	143	43	therapeutic	therapeutic	ADJ
admet-1078	143	44	drugs	drug	NOUN
admet-1078	143	45	[	[	X
admet-1078	143	46	20	20	NUM
admet-1078	143	47	]	]	PUNCT
admet-1078	143	48	.	.	PUNCT
admet-1078	144	1	the	the	DET
admet-1078	144	2	greatest	great	ADJ
admet-1078	144	3	amount	amount	NOUN
admet-1078	144	4	of	of	ADP
admet-1078	144	5	evidence	evidence	NOUN
admet-1078	144	6	and	and	CCONJ
admet-1078	144	7	data	datum	NOUN
admet-1078	144	8	today	today	NOUN
admet-1078	144	9	is	be	AUX
admet-1078	144	10	obtained	obtain	VERB
admet-1078	144	11	in	in	ADP
admet-1078	144	12	the	the	DET
admet-1078	144	13	direction	direction	NOUN
admet-1078	144	14	of	of	ADP
admet-1078	144	15	the	the	DET
admet-1078	144	16	use	use	NOUN
admet-1078	144	17	of	of	ADP
admet-1078	144	18	ifn	ifn	PROPN
admet-1078	144	19	-	-	PUNCT
admet-1078	144	20	γ	γ	NOUN
admet-1078	144	21	as	as	ADP
admet-1078	144	22	a	a	DET
admet-1078	144	23	therapeutic	therapeutic	ADJ
admet-1078	144	24	option	option	NOUN
admet-1078	144	25	in	in	ADP
admet-1078	144	26	the	the	DET
admet-1078	144	27	complex	complex	ADJ
admet-1078	144	28	therapy	therapy	NOUN
admet-1078	144	29	of	of	ADP
admet-1078	144	30	pulmonary	pulmonary	ADJ
admet-1078	144	31	tb	tb	NOUN
admet-1078	144	32	.	.	PUNCT
admet-1078	145	1	it	it	PRON
admet-1078	145	2	has	have	AUX
admet-1078	145	3	been	be	AUX
admet-1078	145	4	shown	show	VERB
admet-1078	145	5	that	that	SCONJ
admet-1078	145	6	ifn	ifn	PROPN
admet-1078	145	7	-	-	PUNCT
admet-1078	145	8	γ	γ	NOUN
admet-1078	145	9	plays	play	VERB
admet-1078	145	10	a	a	DET
admet-1078	145	11	significant	significant	ADJ
admet-1078	145	12	role	role	NOUN
admet-1078	145	13	in	in	ADP
admet-1078	145	14	the	the	DET
admet-1078	145	15	pathogenesis	pathogenesis	NOUN
admet-1078	145	16	of	of	ADP
admet-1078	145	17	tb	tb	X
admet-1078	145	18	[	[	X
admet-1078	145	19	15,59	15,59	NUM
admet-1078	145	20	]	]	PUNCT
admet-1078	145	21	,	,	PUNCT
admet-1078	145	22	is	be	AUX
admet-1078	145	23	a	a	DET
admet-1078	145	24	marker	marker	NOUN
admet-1078	145	25	of	of	ADP
admet-1078	145	26	type	type	NOUN
admet-1078	145	27	1	1	NUM
admet-1078	145	28	th	th	VERB
admet-1078	145	29	-	-	PUNCT
admet-1078	145	30	helper	helper	NOUN
admet-1078	145	31	lymphocytes	lymphocyte	VERB
admet-1078	145	32	[	[	X
admet-1078	145	33	55	55	NUM
admet-1078	145	34	]	]	PUNCT
admet-1078	145	35	,	,	PUNCT
admet-1078	145	36	and	and	CCONJ
admet-1078	145	37	is	be	AUX
admet-1078	145	38	considered	consider	VERB
admet-1078	145	39	a	a	DET
admet-1078	145	40	key	key	ADJ
admet-1078	145	41	immunomodulatory	immunomodulatory	ADJ
admet-1078	145	42	agent	agent	NOUN
admet-1078	145	43	for	for	ADP
admet-1078	145	44	the	the	DET
admet-1078	145	45	maintenance	maintenance	NOUN
admet-1078	145	46	adjuvant	adjuvant	NOUN
admet-1078	145	47	therapy	therapy	NOUN
admet-1078	145	48	of	of	ADP
admet-1078	145	49	tb	tb	ADP
admet-1078	145	50	patients	patient	NOUN
admet-1078	145	51	.	.	PUNCT
admet-1078	146	1	many	many	ADJ
admet-1078	146	2	factors	factor	NOUN
admet-1078	146	3	play	play	VERB
admet-1078	146	4	a	a	DET
admet-1078	146	5	role	role	NOUN
admet-1078	146	6	in	in	ADP
admet-1078	146	7	the	the	DET
admet-1078	146	8	infectious	infectious	ADJ
admet-1078	146	9	process	process	NOUN
admet-1078	146	10	and	and	CCONJ
admet-1078	146	11	outcomes	outcome	NOUN
admet-1078	146	12	of	of	ADP
admet-1078	146	13	tb	tb	NOUN
admet-1078	146	14	,	,	PUNCT
admet-1078	146	15	but	but	CCONJ
admet-1078	146	16	the	the	DET
admet-1078	146	17	most	most	ADV
admet-1078	146	18	important	important	ADJ
admet-1078	146	19	of	of	ADP
admet-1078	146	20	them	they	PRON
admet-1078	146	21	is	be	AUX
admet-1078	146	22	the	the	DET
admet-1078	146	23	activity	activity	NOUN
admet-1078	146	24	of	of	ADP
admet-1078	146	25	the	the	DET
admet-1078	146	26	body	body	NOUN
admet-1078	146	27	's	's	PART
admet-1078	146	28	immune	immune	ADJ
admet-1078	146	29	system	system	NOUN
admet-1078	146	30	and	and	CCONJ
admet-1078	146	31	its	its	PRON
admet-1078	146	32	ability	ability	NOUN
admet-1078	146	33	to	to	PART
admet-1078	146	34	resist	resist	VERB
admet-1078	146	35	infection	infection	NOUN
admet-1078	146	36	.	.	PUNCT
admet-1078	147	1	the	the	DET
admet-1078	147	2	human	human	ADJ
admet-1078	147	3	immune	immune	ADJ
admet-1078	147	4	system	system	NOUN
admet-1078	147	5	is	be	AUX
admet-1078	147	6	able	able	ADJ
admet-1078	147	7	to	to	PART
admet-1078	147	8	control	control	VERB
admet-1078	147	9	it	it	PRON
admet-1078	147	10	.	.	PUNCT
admet-1078	148	1	weakness	weakness	NOUN
admet-1078	148	2	of	of	ADP
admet-1078	148	3	the	the	DET
admet-1078	148	4	immune	immune	ADJ
admet-1078	148	5	response	response	NOUN
admet-1078	148	6	is	be	AUX
admet-1078	148	7	the	the	DET
admet-1078	148	8	main	main	ADJ
admet-1078	148	9	condition	condition	NOUN
admet-1078	148	10	for	for	ADP
admet-1078	148	11	the	the	DET
admet-1078	148	12	development	development	NOUN
admet-1078	148	13	of	of	ADP
admet-1078	148	14	the	the	DET
admet-1078	148	15	disease	disease	NOUN
admet-1078	148	16	and	and	CCONJ
admet-1078	148	17	subsequently	subsequently	ADV
admet-1078	148	18	for	for	ADP
admet-1078	148	19	the	the	DET
admet-1078	148	20	prolonged	prolonged	ADJ
admet-1078	148	21	course	course	NOUN
admet-1078	148	22	of	of	ADP
admet-1078	148	23	the	the	DET
admet-1078	148	24	infectious	infectious	ADJ
admet-1078	148	25	process	process	NOUN
admet-1078	148	26	against	against	ADP
admet-1078	148	27	the	the	DET
admet-1078	148	28	background	background	NOUN
admet-1078	148	29	of	of	ADP
admet-1078	148	30	antibiotic	antibiotic	ADJ
admet-1078	148	31	therapy	therapy	NOUN
admet-1078	148	32	.	.	PUNCT
admet-1078	149	1	in	in	ADP
admet-1078	149	2	patients	patient	NOUN
admet-1078	149	3	with	with	ADP
admet-1078	149	4	immunodeficiency	immunodeficiency	NOUN
admet-1078	149	5	,	,	PUNCT
admet-1078	149	6	the	the	DET
admet-1078	149	7	treatment	treatment	NOUN
admet-1078	149	8	of	of	ADP
admet-1078	149	9	the	the	DET
admet-1078	149	10	disease	disease	NOUN
admet-1078	149	11	is	be	AUX
admet-1078	149	12	always	always	ADV
admet-1078	149	13	difficult	difficult	ADJ
admet-1078	149	14	,	,	PUNCT
admet-1078	149	15	even	even	ADV
admet-1078	149	16	with	with	ADP
admet-1078	149	17	maximum	maximum	ADJ
admet-1078	149	18	doses	dose	NOUN
admet-1078	149	19	of	of	ADP
admet-1078	149	20	drugs	drug	NOUN
admet-1078	149	21	as	as	ADP
admet-1078	149	22	part	part	NOUN
admet-1078	149	23	of	of	ADP
admet-1078	149	24	complex	complex	ADJ
admet-1078	149	25	antibiotic	antibiotic	ADJ
admet-1078	149	26	therapy	therapy	NOUN
admet-1078	149	27	[	[	X
admet-1078	149	28	6	6	NUM
admet-1078	149	29	]	]	PUNCT
admet-1078	149	30	.	.	PUNCT
admet-1078	150	1	in	in	ADP
admet-1078	150	2	conditions	condition	NOUN
admet-1078	150	3	of	of	ADP
admet-1078	150	4	bacterial	bacterial	ADJ
admet-1078	150	5	resistance	resistance	NOUN
admet-1078	150	6	to	to	ADP
admet-1078	150	7	antibiotics	antibiotic	NOUN
admet-1078	150	8	,	,	PUNCT
admet-1078	150	9	the	the	DET
admet-1078	150	10	role	role	NOUN
admet-1078	150	11	of	of	ADP
admet-1078	150	12	the	the	DET
admet-1078	150	13	immune	immune	ADJ
admet-1078	150	14	response	response	NOUN
admet-1078	150	15	in	in	ADP
admet-1078	150	16	the	the	DET
admet-1078	150	17	fight	fight	NOUN
admet-1078	150	18	against	against	ADP
admet-1078	150	19	infection	infection	NOUN
admet-1078	150	20	and	and	CCONJ
admet-1078	150	21	the	the	DET
admet-1078	150	22	stress	stress	NOUN
admet-1078	150	23	on	on	ADP
admet-1078	150	24	the	the	DET
admet-1078	150	25	immune	immune	ADJ
admet-1078	150	26	system	system	NOUN
admet-1078	150	27	increases	increase	VERB
admet-1078	150	28	dramatically	dramatically	ADV
admet-1078	150	29	.	.	PUNCT
admet-1078	151	1	s.h	s.h	PROPN
admet-1078	151	2	.	.	PROPN
admet-1078	151	3	kaufman	kaufman	PROPN
admet-1078	151	4	et	et	PROPN
admet-1078	151	5	al	al	PROPN
admet-1078	151	6	.	.	PROPN
admet-1078	151	7	,	,	PUNCT
admet-1078	151	8	in	in	ADP
admet-1078	151	9	their	their	PRON
admet-1078	151	10	review	review	NOUN
admet-1078	151	11	published	publish	VERB
admet-1078	151	12	in	in	ADP
admet-1078	151	13	2014	2014	NUM
admet-1078	151	14	in	in	ADP
admet-1078	151	15	the	the	DET
admet-1078	151	16	lancet	lancet	NOUN
admet-1078	151	17	[	[	X
admet-1078	151	18	60	60	NUM
admet-1078	151	19	]	]	PUNCT
admet-1078	151	20	,	,	PUNCT
admet-1078	151	21	focused	focus	VERB
admet-1078	151	22	on	on	ADP
admet-1078	151	23	host	host	NOUN
admet-1078	151	24	-	-	PUNCT
admet-1078	151	25	directed	direct	VERB
admet-1078	151	26	therapies	therapy	NOUN
admet-1078	151	27	defining	define	VERB
admet-1078	151	28	such	such	ADJ
admet-1078	151	29	strategy	strategy	NOUN
admet-1078	151	30	“	"	PUNCT
admet-1078	151	31	especially	especially	ADV
admet-1078	151	32	beneficial	beneficial	ADJ
admet-1078	151	33	for	for	ADP
admet-1078	151	34	patients	patient	NOUN
admet-1078	151	35	with	with	ADP
admet-1078	151	36	multidrughttp://dx.doi.org/10.5599/admet.1078	multidrughttp://dx.doi.org/10.5599/admet.1078	PRON
admet-1078	151	37	svetlana	svetlana	PROPN
admet-1078	151	38	a.	a.	PROPN
admet-1078	151	39	berns	berns	PROPN
admet-1078	151	40	et	et	PROPN
admet-1078	151	41	al	al	PROPN
admet-1078	151	42	.	.	PROPN
admet-1078	151	43	admet	admet	PROPN
admet-1078	151	44	&	&	CCONJ
admet-1078	151	45	dmpk	dmpk	PROPN
admet-1078	151	46	10(1	10(1	NUM
admet-1078	151	47	)	)	PUNCT
admet-1078	151	48	(	(	PUNCT
admet-1078	151	49	2022	2022	NUM
admet-1078	151	50	)	)	PUNCT
admet-1078	151	51	63	63	NUM
admet-1078	151	52	-	-	SYM
admet-1078	151	53	73	73	NUM
admet-1078	151	54	70	70	NUM
admet-1078	151	55	resistant	resistant	ADJ
admet-1078	151	56	tuberculosis	tuberculosis	NOUN
admet-1078	151	57	”	"	PUNCT
admet-1078	151	58	.	.	PUNCT
admet-1078	152	1	the	the	DET
admet-1078	152	2	use	use	NOUN
admet-1078	152	3	of	of	ADP
admet-1078	152	4	traditional	traditional	ADJ
admet-1078	152	5	anti	anti	ADJ
admet-1078	152	6	-	-	ADJ
admet-1078	152	7	tuberculosis	tuberculosis	ADJ
admet-1078	152	8	drugs	drug	NOUN
admet-1078	152	9	only	only	ADV
admet-1078	152	10	is	be	AUX
admet-1078	152	11	no	no	PRON
admet-1078	152	12	more	more	ADV
admet-1078	152	13	a	a	DET
admet-1078	152	14	sufficient	sufficient	ADJ
admet-1078	152	15	tactic	tactic	NOUN
admet-1078	152	16	to	to	PART
admet-1078	152	17	achieve	achieve	VERB
admet-1078	152	18	the	the	DET
admet-1078	152	19	target	target	NOUN
admet-1078	152	20	[	[	X
admet-1078	152	21	60	60	NUM
admet-1078	152	22	]	]	PUNCT
admet-1078	152	23	.	.	PUNCT
admet-1078	153	1	conclusions	conclusion	NOUN
admet-1078	153	2	understanding	understand	VERB
admet-1078	153	3	the	the	DET
admet-1078	153	4	pathogenesis	pathogenesis	NOUN
admet-1078	153	5	of	of	ADP
admet-1078	153	6	the	the	DET
admet-1078	153	7	development	development	NOUN
admet-1078	153	8	of	of	ADP
admet-1078	153	9	the	the	DET
admet-1078	153	10	infectious	infectious	ADJ
admet-1078	153	11	process	process	NOUN
admet-1078	153	12	and	and	CCONJ
admet-1078	153	13	the	the	DET
admet-1078	153	14	role	role	NOUN
admet-1078	153	15	of	of	ADP
admet-1078	153	16	ifn	ifn	PROPN
admet-1078	153	17	-	-	PUNCT
admet-1078	153	18	γ	γ	NOUN
admet-1078	153	19	in	in	ADP
admet-1078	153	20	the	the	DET
admet-1078	153	21	activation	activation	NOUN
admet-1078	153	22	of	of	ADP
admet-1078	153	23	the	the	DET
admet-1078	153	24	immune	immune	ADJ
admet-1078	153	25	system	system	NOUN
admet-1078	153	26	in	in	ADP
admet-1078	153	27	tb	tb	NOUN
admet-1078	153	28	,	,	PUNCT
admet-1078	153	29	made	make	VERB
admet-1078	153	30	it	it	PRON
admet-1078	153	31	possible	possible	ADJ
admet-1078	153	32	to	to	PART
admet-1078	153	33	identify	identify	VERB
admet-1078	153	34	ifn	ifn	PROPN
admet-1078	153	35	-	-	PUNCT
admet-1078	153	36	γ	γ	NOUN
admet-1078	153	37	as	as	ADP
admet-1078	153	38	a	a	DET
admet-1078	153	39	promising	promising	ADJ
admet-1078	153	40	therapeutic	therapeutic	ADJ
admet-1078	153	41	option	option	NOUN
admet-1078	153	42	for	for	ADP
admet-1078	153	43	improving	improve	VERB
admet-1078	153	44	treatment	treatment	NOUN
admet-1078	153	45	results	result	NOUN
admet-1078	153	46	and	and	CCONJ
admet-1078	153	47	overcoming	overcome	VERB
admet-1078	153	48	the	the	DET
admet-1078	153	49	development	development	NOUN
admet-1078	153	50	of	of	ADP
admet-1078	153	51	bacterial	bacterial	ADJ
admet-1078	153	52	resistance	resistance	NOUN
admet-1078	153	53	.	.	PUNCT
admet-1078	154	1	the	the	DET
admet-1078	154	2	clinical	clinical	ADJ
admet-1078	154	3	efficacy	efficacy	NOUN
admet-1078	154	4	of	of	ADP
admet-1078	154	5	ifn	ifn	PROPN
admet-1078	154	6	-	-	PUNCT
admet-1078	154	7	γ	γ	NOUN
admet-1078	154	8	against	against	ADP
admet-1078	154	9	tb	tb	NOUN
admet-1078	154	10	has	have	AUX
admet-1078	154	11	been	be	AUX
admet-1078	154	12	studied	study	VERB
admet-1078	154	13	in	in	ADP
admet-1078	154	14	clinical	clinical	ADJ
admet-1078	154	15	trials	trial	NOUN
admet-1078	154	16	for	for	ADP
admet-1078	154	17	over	over	ADP
admet-1078	154	18	20	20	NUM
admet-1078	154	19	years	year	NOUN
admet-1078	154	20	.	.	PUNCT
admet-1078	155	1	the	the	DET
admet-1078	155	2	clinical	clinical	ADJ
admet-1078	155	3	experience	experience	NOUN
admet-1078	155	4	and	and	CCONJ
admet-1078	155	5	medical	medical	ADJ
admet-1078	155	6	application	application	NOUN
admet-1078	155	7	of	of	ADP
admet-1078	155	8	ifn	ifn	PROPN
admet-1078	155	9	-	-	PUNCT
admet-1078	155	10	γ	γ	NOUN
admet-1078	155	11	accumulated	accumulate	VERB
admet-1078	155	12	in	in	ADP
admet-1078	155	13	the	the	DET
admet-1078	155	14	course	course	NOUN
admet-1078	155	15	of	of	ADP
admet-1078	155	16	long	long	ADJ
admet-1078	155	17	research	research	NOUN
admet-1078	155	18	allow	allow	VERB
admet-1078	155	19	us	we	PRON
admet-1078	155	20	to	to	PART
admet-1078	155	21	recommend	recommend	VERB
admet-1078	155	22	it	it	PRON
admet-1078	155	23	as	as	ADP
admet-1078	155	24	a	a	DET
admet-1078	155	25	safe	safe	ADJ
admet-1078	155	26	and	and	CCONJ
admet-1078	155	27	effective	effective	ADJ
admet-1078	155	28	therapeutic	therapeutic	ADJ
admet-1078	155	29	agent	agent	NOUN
admet-1078	155	30	in	in	ADP
admet-1078	155	31	a	a	DET
admet-1078	155	32	complex	complex	ADJ
admet-1078	155	33	,	,	PUNCT
admet-1078	155	34	comprehensive	comprehensive	ADJ
admet-1078	155	35	tb	tb	ADP
admet-1078	155	36	treatment	treatment	NOUN
admet-1078	155	37	,	,	PUNCT
admet-1078	155	38	not	not	PART
admet-1078	155	39	only	only	ADV
admet-1078	155	40	from	from	ADP
admet-1078	155	41	the	the	DET
admet-1078	155	42	standpoint	standpoint	NOUN
admet-1078	155	43	of	of	ADP
admet-1078	155	44	evidence	evidence	NOUN
admet-1078	155	45	-	-	PUNCT
admet-1078	155	46	based	base	VERB
admet-1078	155	47	medicine	medicine	NOUN
admet-1078	155	48	but	but	CCONJ
admet-1078	155	49	also	also	ADV
admet-1078	155	50	from	from	ADP
admet-1078	155	51	the	the	DET
admet-1078	155	52	point	point	NOUN
admet-1078	155	53	of	of	ADP
admet-1078	155	54	view	view	NOUN
admet-1078	155	55	of	of	ADP
admet-1078	155	56	health	health	NOUN
admet-1078	155	57	economics	economic	NOUN
admet-1078	155	58	.	.	PUNCT
admet-1078	156	1	for	for	ADP
admet-1078	156	2	the	the	DET
admet-1078	156	3	full	full	ADJ
admet-1078	156	4	disclosure	disclosure	NOUN
admet-1078	156	5	of	of	ADP
admet-1078	156	6	the	the	DET
admet-1078	156	7	therapeutic	therapeutic	ADJ
admet-1078	156	8	potential	potential	NOUN
admet-1078	156	9	of	of	ADP
admet-1078	156	10	ifn	ifn	PROPN
admet-1078	156	11	-	-	PUNCT
admet-1078	156	12	γ	γ	NOUN
admet-1078	156	13	in	in	ADP
admet-1078	156	14	overcoming	overcome	VERB
admet-1078	156	15	multidrug	multidrug	NOUN
admet-1078	156	16	resistance	resistance	NOUN
admet-1078	156	17	of	of	ADP
admet-1078	156	18	tb	tb	NOUN
admet-1078	156	19	,	,	PUNCT
admet-1078	156	20	further	further	ADJ
admet-1078	156	21	study	study	NOUN
admet-1078	156	22	of	of	ADP
admet-1078	156	23	its	its	PRON
admet-1078	156	24	effectiveness	effectiveness	NOUN
admet-1078	156	25	in	in	ADP
admet-1078	156	26	controlled	control	VERB
admet-1078	156	27	clinical	clinical	ADJ
admet-1078	156	28	trials	trial	NOUN
admet-1078	156	29	is	be	AUX
admet-1078	156	30	necessary	necessary	ADJ
admet-1078	156	31	.	.	PUNCT
admet-1078	157	1	conflict	conflict	NOUN
admet-1078	157	2	of	of	ADP
admet-1078	157	3	interest	interest	NOUN
admet-1078	157	4	:	:	PUNCT
admet-1078	157	5	the	the	DET
admet-1078	157	6	authors	author	NOUN
admet-1078	157	7	declare	declare	VERB
admet-1078	157	8	that	that	SCONJ
admet-1078	157	9	they	they	PRON
admet-1078	157	10	have	have	VERB
admet-1078	157	11	no	no	DET
admet-1078	157	12	competing	compete	VERB
admet-1078	157	13	interests	interest	NOUN
admet-1078	157	14	.	.	PUNCT
admet-1078	158	1	references	reference	NOUN
admet-1078	158	2	[	[	X
admet-1078	158	3	1	1	NUM
admet-1078	158	4	]	]	PUNCT
admet-1078	158	5	world	world	NOUN
admet-1078	158	6	health	health	NOUN
admet-1078	158	7	organization	organization	PROPN
admet-1078	158	8	.	.	PUNCT
admet-1078	159	1	who	who	PRON
admet-1078	159	2	global	global	ADJ
admet-1078	159	3	strategy	strategy	NOUN
admet-1078	159	4	for	for	ADP
admet-1078	159	5	containment	containment	NOUN
admet-1078	159	6	of	of	ADP
admet-1078	159	7	antimicrobial	antimicrobial	ADJ
admet-1078	159	8	resistance	resistance	NOUN
admet-1078	159	9	.	.	PUNCT
admet-1078	160	1	geneva	geneva	PROPN
admet-1078	160	2	,	,	PUNCT
admet-1078	160	3	2001	2001	NUM
admet-1078	160	4	.	.	PUNCT
admet-1078	161	1	who	who	PRON
admet-1078	161	2	/	/	SYM
admet-1078	161	3	cds	cds	PROPN
admet-1078	161	4	/	/	SYM
admet-1078	161	5	csr	csr	NOUN
admet-1078	161	6	/	/	SYM
admet-1078	161	7	drs/2001.2	drs/2001.2	PROPN
admet-1078	161	8	.	.	PUNCT
admet-1078	161	9	https://www.who.int/drugresistance/who%20global%20strategy%20-%20executive%20summary%20-%20english%20version.pdf?ua=1	https://www.who.int/drugresistance/who%20global%20strategy%20-%20executive%20summary%20-%20english%20version.pdf?ua=1	NOUN
admet-1078	161	10	.	.	PUNCT
admet-1078	162	1	[	[	X
admet-1078	162	2	2	2	NUM
admet-1078	162	3	]	]	X
admet-1078	162	4	j.p	j.p	PROPN
admet-1078	162	5	.	.	PROPN
admet-1078	162	6	cegielski	cegielski	PROPN
admet-1078	162	7	,	,	PUNCT
admet-1078	162	8	t.	t.	PROPN
admet-1078	162	9	dalton	dalton	PROPN
admet-1078	162	10	,	,	PUNCT
admet-1078	162	11	m.	m.	NOUN
admet-1078	162	12	yagui	yagui	PROPN
admet-1078	162	13	m	m	PROPN
admet-1078	162	14	,	,	PUNCT
admet-1078	162	15	et	et	PROPN
admet-1078	162	16	al	al	PROPN
admet-1078	162	17	.	.	PROPN
admet-1078	162	18	extensive	extensive	ADJ
admet-1078	162	19	drug	drug	NOUN
admet-1078	162	20	resistance	resistance	NOUN
admet-1078	162	21	acquired	acquire	VERB
admet-1078	162	22	during	during	ADP
admet-1078	162	23	treatment	treatment	NOUN
admet-1078	162	24	of	of	ADP
admet-1078	162	25	multidrug	multidrug	NOUN
admet-1078	162	26	-	-	PUNCT
admet-1078	162	27	resistant	resistant	ADJ
admet-1078	162	28	tuberculosis	tuberculosis	NOUN
admet-1078	162	29	.	.	PUNCT
admet-1078	163	1	clinical	clinical	ADJ
admet-1078	163	2	infectious	infectious	ADJ
admet-1078	163	3	diseases	disease	NOUN
admet-1078	163	4	59(8	59(8	NUM
admet-1078	163	5	)	)	PUNCT
admet-1078	163	6	(	(	PUNCT
admet-1078	163	7	2014	2014	NUM
admet-1078	163	8	)	)	PUNCT
admet-1078	163	9	1049	1049	NUM
admet-1078	163	10	-	-	SYM
admet-1078	163	11	1063	1063	NUM
admet-1078	163	12	.	.	PUNCT
admet-1078	164	1	https://doi.org/10.1093/cid/ciu572	https://doi.org/10.1093/cid/ciu572	NOUN
admet-1078	164	2	.	.	PUNCT
admet-1078	165	1	[	[	X
admet-1078	165	2	3	3	X
admet-1078	165	3	]	]	X
admet-1078	165	4	a.v	a.v	PROPN
admet-1078	165	5	.	.	PROPN
admet-1078	165	6	dehnich	dehnich	PROPN
admet-1078	165	7	.	.	PUNCT
admet-1078	166	1	antibiotic	antibiotic	ADJ
admet-1078	166	2	resistance	resistance	NOUN
admet-1078	166	3	:	:	PUNCT
admet-1078	166	4	problems	problem	NOUN
admet-1078	166	5	and	and	CCONJ
admet-1078	166	6	solutions	solution	NOUN
admet-1078	166	7	.	.	PUNCT
admet-1078	167	1	materials	material	NOUN
admet-1078	167	2	of	of	ADP
admet-1078	167	3	the	the	DET
admet-1078	167	4	ix	ix	PROPN
admet-1078	167	5	national	national	PROPN
admet-1078	167	6	congress	congress	PROPN
admet-1078	167	7	on	on	ADP
admet-1078	167	8	cystic	cystic	ADJ
admet-1078	167	9	fibrosis	fibrosis	NOUN
admet-1078	167	10	"	"	PUNCT
admet-1078	167	11	cystic	cystic	ADJ
admet-1078	167	12	fibrosis	fibrosis	NOUN
admet-1078	167	13	in	in	ADP
admet-1078	167	14	children	child	NOUN
admet-1078	167	15	and	and	CCONJ
admet-1078	167	16	adults	adult	NOUN
admet-1078	167	17	2009	2009	NUM
admet-1078	167	18	»	»	NOUN
admet-1078	167	19	,	,	PUNCT
admet-1078	167	20	cjsc	cjsc	NOUN
admet-1078	167	21	«	«	PUNCT
admet-1078	167	22	reklamno	reklamno	VERB
admet-1078	167	23	-	-	PUNCT
admet-1078	167	24	izdatel'skaja	izdatel'skaja	NOUN
admet-1078	167	25	gruppa	gruppa	NOUN
admet-1078	167	26	megapro	megapro	ADJ
admet-1078	167	27	»	»	NOUN
admet-1078	167	28	,	,	PUNCT
admet-1078	167	29	2009	2009	NUM
admet-1078	167	30	,	,	PUNCT
admet-1078	167	31	стр	стр	NOUN
admet-1078	167	32	.	.	PUNCT
admet-1078	168	1	34	34	NUM
admet-1078	168	2	-	-	SYM
admet-1078	168	3	35	35	NUM
admet-1078	168	4	.	.	PUNCT
admet-1078	169	1	[	[	X
admet-1078	169	2	4	4	NUM
admet-1078	169	3	]	]	X
admet-1078	169	4	johns	johns	PROPN
admet-1078	169	5	hopkins	hopkins	PROPN
admet-1078	169	6	university	university	PROPN
admet-1078	169	7	.	.	PUNCT
admet-1078	170	1	corona	corona	PROPN
admet-1078	170	2	virus	virus	PROPN
admet-1078	170	3	resource	resource	NOUN
admet-1078	170	4	center	center	NOUN
admet-1078	170	5	.	.	PUNCT
admet-1078	171	1	2020	2020	NUM
admet-1078	171	2	.	.	PUNCT
admet-1078	172	1	available	available	ADJ
admet-1078	172	2	from	from	ADP
admet-1078	172	3	:	:	PUNCT
admet-1078	172	4	https://coronavirus.jhu.edu/map.html	https://coronavirus.jhu.edu/map.html	PROPN
admet-1078	172	5	.	.	PUNCT
admet-1078	173	1	[	[	X
admet-1078	173	2	5	5	X
admet-1078	173	3	]	]	PUNCT
admet-1078	173	4	who	who	PRON
admet-1078	173	5	,	,	PUNCT
admet-1078	173	6	global	global	ADJ
admet-1078	173	7	tuberculosis	tuberculosis	NOUN
admet-1078	173	8	report	report	NOUN
admet-1078	173	9	,	,	PUNCT
admet-1078	173	10	2020	2020	NUM
admet-1078	173	11	,	,	PUNCT
admet-1078	173	12	https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf	https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf	PROPN
admet-1078	173	13	.	.	PUNCT
admet-1078	174	1	[	[	X
admet-1078	174	2	6	6	NUM
admet-1078	174	3	]	]	X
admet-1078	174	4	a.k	a.k	PROPN
admet-1078	174	5	.	.	PROPN
admet-1078	174	6	azad	azad	PROPN
admet-1078	174	7	,	,	PUNCT
admet-1078	174	8	w.	w.	PROPN
admet-1078	174	9	sadee	sadee	PROPN
admet-1078	174	10	,	,	PUNCT
admet-1078	174	11	and	and	CCONJ
admet-1078	174	12	l.	l.	PROPN
admet-1078	174	13	s.	s.	PROPN
admet-1078	174	14	schlesinger	schlesinger	PROPN
admet-1078	174	15	.	.	PUNCT
admet-1078	175	1	innate	innate	ADJ
admet-1078	175	2	immune	immune	ADJ
admet-1078	175	3	gene	gene	NOUN
admet-1078	175	4	polymorphisms	polymorphism	NOUN
admet-1078	175	5	in	in	ADP
admet-1078	175	6	tuberculosis	tuberculosis	NOUN
admet-1078	175	7	.	.	PUNCT
admet-1078	176	1	infection	infection	NOUN
admet-1078	176	2	and	and	CCONJ
admet-1078	176	3	immunity	immunity	NOUN
admet-1078	176	4	80(10	80(10	NUM
admet-1078	176	5	)	)	PUNCT
admet-1078	176	6	(	(	PUNCT
admet-1078	176	7	2012	2012	NUM
admet-1078	176	8	)	)	PUNCT
admet-1078	176	9	3343–3359	3343–3359	NUM
admet-1078	176	10	.	.	PUNCT
admet-1078	177	1	https://doi.org/10.1128/iai.00443-12	https://doi.org/10.1128/iai.00443-12	NOUN
admet-1078	177	2	.	.	PUNCT
admet-1078	178	1	[	[	X
admet-1078	178	2	7	7	X
admet-1078	178	3	]	]	X
admet-1078	178	4	t.a	t.a	PROPN
admet-1078	178	5	.	.	PROPN
admet-1078	178	6	khan	khan	PROPN
admet-1078	178	7	,	,	PUNCT
admet-1078	178	8	h.	h.	PROPN
admet-1078	178	9	mazhar	mazhar	PROPN
admet-1078	178	10	,	,	PUNCT
admet-1078	178	11	sh	sh	PROPN
admet-1078	178	12	.	.	PROPN
admet-1078	178	13	saleha	saleha	PROPN
admet-1078	178	14	,	,	PUNCT
admet-1078	178	15	h.n	h.n	PROPN
admet-1078	178	16	.	.	PROPN
admet-1078	178	17	tipu	tipu	PROPN
admet-1078	178	18	,	,	PUNCT
admet-1078	178	19	n.	n.	PROPN
admet-1078	178	20	muhammad	muhammad	PROPN
admet-1078	178	21	,	,	PUNCT
admet-1078	178	22	m.n	m.n	PROPN
admet-1078	178	23	.	.	PROPN
admet-1078	178	24	abbas	abbas	PROPN
admet-1078	178	25	.	.	PUNCT
admet-1078	179	1	interferon	interferon	ADJ
admet-1078	179	2	-	-	PUNCT
admet-1078	179	3	gamma	gamma	NOUN
admet-1078	179	4	improves	improve	VERB
admet-1078	179	5	macrophages	macrophage	NOUN
admet-1078	179	6	function	function	NOUN
admet-1078	179	7	against	against	ADP
admet-1078	179	8	m.	m.	NOUN
admet-1078	179	9	tuberculosis	tuberculosis	NOUN
admet-1078	179	10	in	in	ADP
admet-1078	179	11	multidrug	multidrug	NOUN
admet-1078	179	12	-	-	PUNCT
admet-1078	179	13	resistant	resistant	ADJ
admet-1078	179	14	tuberculosis	tuberculosis	NOUN
admet-1078	179	15	patients	patient	NOUN
admet-1078	179	16	.	.	PUNCT
admet-1078	180	1	chemotherapy	chemotherapy	NOUN
admet-1078	180	2	research	research	NOUN
admet-1078	180	3	and	and	CCONJ
admet-1078	180	4	practice	practice	NOUN
admet-1078	180	5	(	(	PUNCT
admet-1078	180	6	2016	2016	NUM
admet-1078	180	7	)	)	PUNCT
admet-1078	180	8	7295390	7295390	NUM
admet-1078	180	9	.	.	PUNCT
admet-1078	181	1	https://doi.org/10.1155/2016/7295390	https://doi.org/10.1155/2016/7295390	PROPN
admet-1078	181	2	.	.	PUNCT
admet-1078	182	1	[	[	X
admet-1078	182	2	8	8	NUM
admet-1078	182	3	]	]	X
admet-1078	182	4	c.a	c.a	PROPN
admet-1078	182	5	.	.	PROPN
admet-1078	182	6	jr	jr	PROPN
admet-1078	182	7	.	.	PROPN
admet-1078	182	8	janeway	janeway	PROPN
admet-1078	182	9	,	,	PUNCT
admet-1078	182	10	p.	p.	NOUN
admet-1078	182	11	travers	travers	PROPN
admet-1078	182	12	,	,	PUNCT
admet-1078	182	13	m.	m.	NOUN
admet-1078	182	14	walport	walport	NOUN
admet-1078	182	15	,	,	PUNCT
admet-1078	182	16	et	et	PROPN
admet-1078	182	17	al	al	PROPN
admet-1078	182	18	.	.	PROPN
admet-1078	182	19	immunobiology	immunobiology	PROPN
admet-1078	182	20	:	:	PUNCT
admet-1078	182	21	the	the	DET
admet-1078	182	22	immune	immune	ADJ
admet-1078	182	23	system	system	NOUN
admet-1078	182	24	in	in	ADP
admet-1078	182	25	health	health	NOUN
admet-1078	182	26	and	and	CCONJ
admet-1078	182	27	disease	disease	NOUN
admet-1078	182	28	.	.	PUNCT
admet-1078	183	1	5th	5th	ADJ
admet-1078	183	2	edition	edition	NOUN
admet-1078	183	3	.	.	PUNCT
admet-1078	184	1	new	new	PROPN
admet-1078	184	2	york	york	PROPN
admet-1078	184	3	:	:	PUNCT
admet-1078	184	4	garland	garland	PROPN
admet-1078	184	5	science	science	PROPN
admet-1078	184	6	(	(	PUNCT
admet-1078	184	7	2001	2001	NUM
admet-1078	184	8	)	)	PUNCT
admet-1078	184	9	.	.	PUNCT
admet-1078	185	1	[	[	X
admet-1078	185	2	9	9	NUM
admet-1078	185	3	]	]	X
admet-1078	185	4	r.j	r.j	PROPN
admet-1078	185	5	.	.	PROPN
admet-1078	185	6	meshkova	meshkova	PROPN
admet-1078	185	7	.	.	PUNCT
admet-1078	186	1	immunization	immunization	NOUN
admet-1078	186	2	guidelines	guideline	NOUN
admet-1078	186	3	for	for	ADP
admet-1078	186	4	physicians	physician	NOUN
admet-1078	186	5	.	.	PUNCT
admet-1078	187	1	smolensk	smolensk	ADV
admet-1078	187	2	state	state	PROPN
admet-1078	187	3	medical	medical	PROPN
admet-1078	187	4	academy	academy	NOUN
admet-1078	187	5	(	(	PUNCT
admet-1078	187	6	1998	1998	NUM
admet-1078	187	7	)	)	PUNCT
admet-1078	187	8	.	.	PUNCT
admet-1078	188	1	[	[	X
admet-1078	188	2	10	10	NUM
admet-1078	188	3	]	]	PUNCT
admet-1078	188	4	s.	s.	PROPN
admet-1078	188	5	sharma	sharma	PROPN
admet-1078	188	6	,	,	PUNCT
admet-1078	188	7	m.	m.	NOUN
admet-1078	188	8	bose	bose	PROPN
admet-1078	188	9	.	.	PUNCT
admet-1078	189	1	role	role	NOUN
admet-1078	189	2	of	of	ADP
admet-1078	189	3	cytokines	cytokine	NOUN
admet-1078	189	4	in	in	ADP
admet-1078	189	5	immune	immune	ADJ
admet-1078	189	6	response	response	NOUN
admet-1078	189	7	to	to	ADP
admet-1078	189	8	pulmonary	pulmonary	ADJ
admet-1078	189	9	tuberculosis	tuberculosis	NOUN
admet-1078	189	10	.	.	PUNCT
admet-1078	190	1	asian	asian	PROPN
admet-1078	190	2	pac	pac	PROPN
admet-1078	190	3	j	j	PROPN
admet-1078	190	4	allergy	allergy	PROPN
admet-1078	190	5	immunol	immunol	PROPN
admet-1078	190	6	.	.	PUNCT
admet-1078	191	1	19(3	19(3	NUM
admet-1078	191	2	)	)	PUNCT
admet-1078	191	3	(	(	PUNCT
admet-1078	191	4	2001	2001	NUM
admet-1078	191	5	)	)	PUNCT
admet-1078	191	6	213	213	NUM
admet-1078	191	7	-	-	SYM
admet-1078	191	8	219	219	NUM
admet-1078	191	9	.	.	PUNCT
admet-1078	192	1	[	[	X
admet-1078	192	2	11	11	NUM
admet-1078	192	3	]	]	PUNCT
admet-1078	192	4	j.	j.	PROPN
admet-1078	192	5	parkin	parkin	PROPN
admet-1078	192	6	,	,	PUNCT
admet-1078	192	7	b.	b.	PROPN
admet-1078	192	8	cohen	cohen	PROPN
admet-1078	192	9	.	.	PUNCT
admet-1078	193	1	an	an	DET
admet-1078	193	2	overview	overview	NOUN
admet-1078	193	3	of	of	ADP
admet-1078	193	4	the	the	DET
admet-1078	193	5	immune	immune	ADJ
admet-1078	193	6	system	system	NOUN
admet-1078	193	7	.	.	PUNCT
admet-1078	194	1	lancet	lancet	NOUN
admet-1078	194	2	357(9270	357(9270	NUM
admet-1078	194	3	)	)	PUNCT
admet-1078	194	4	(	(	PUNCT
admet-1078	194	5	2001	2001	NUM
admet-1078	194	6	)	)	PUNCT
admet-1078	194	7	1777–1789	1777–1789	NUM
admet-1078	194	8	.	.	PUNCT
admet-1078	195	1	https://doi.org/10.1016/s0140-6736(00)04904-7	https://doi.org/10.1016/s0140-6736(00)04904-7	NOUN
admet-1078	195	2	.	.	PUNCT
admet-1078	196	1	[	[	X
admet-1078	196	2	12	12	NUM
admet-1078	196	3	]	]	PUNCT
admet-1078	196	4	j.	j.	PROPN
admet-1078	196	5	piehler	piehler	PROPN
admet-1078	196	6	,	,	PUNCT
admet-1078	196	7	c.	c.	PROPN
admet-1078	196	8	thomas	thomas	PROPN
admet-1078	196	9	,	,	PUNCT
admet-1078	196	10	k.c	k.c	PROPN
admet-1078	196	11	.	.	PROPN
admet-1078	196	12	garcia	garcia	PROPN
admet-1078	196	13	,	,	PUNCT
admet-1078	196	14	g.	g.	PROPN
admet-1078	196	15	schreiber	schreiber	PROPN
admet-1078	196	16	.	.	PUNCT
admet-1078	197	1	structural	structural	ADJ
admet-1078	197	2	and	and	CCONJ
admet-1078	197	3	dynamic	dynamic	ADJ
admet-1078	197	4	determinants	determinant	NOUN
admet-1078	197	5	of	of	ADP
admet-1078	197	6	type	type	NOUN
admet-1078	197	7	i	i	PRON
admet-1078	197	8	interferon	interferon	ADJ
admet-1078	197	9	receptor	receptor	NOUN
admet-1078	197	10	assembly	assembly	NOUN
admet-1078	197	11	and	and	CCONJ
admet-1078	197	12	their	their	PRON
admet-1078	197	13	functional	functional	ADJ
admet-1078	197	14	interpretation	interpretation	NOUN
admet-1078	197	15	.	.	PUNCT
admet-1078	198	1	immunological	immunological	ADJ
admet-1078	198	2	reviews	review	NOUN
admet-1078	198	3	250	250	NUM
admet-1078	198	4	(	(	PUNCT
admet-1078	198	5	2012	2012	NUM
admet-1078	198	6	)	)	PUNCT
admet-1078	198	7	317–334	317–334	NUM
admet-1078	198	8	.	.	PUNCT
admet-1078	199	1	https://doi.org/10.1111/imr.12001	https://doi.org/10.1111/imr.12001	NOUN
admet-1078	199	2	.	.	PUNCT
admet-1078	200	1	[	[	X
admet-1078	200	2	13	13	NUM
admet-1078	200	3	]	]	X
admet-1078	200	4	j.	j.	PROPN
admet-1078	200	5	ye	ye	PROPN
admet-1078	200	6	,	,	PUNCT
admet-1078	200	7	j.r	j.r	PROPN
admet-1078	200	8	.	.	PROPN
admet-1078	200	9	ortaldo	ortaldo	PROPN
admet-1078	200	10	,	,	PUNCT
admet-1078	200	11	k.	k.	PROPN
admet-1078	200	12	conlon	conlon	PROPN
admet-1078	200	13	,	,	PUNCT
admet-1078	200	14	r.	r.	PROPN
admet-1078	200	15	winkler	winkler	PROPN
admet-1078	200	16	-	-	PUNCT
admet-1078	200	17	pickett	pickett	PROPN
admet-1078	200	18	,	,	PUNCT
admet-1078	200	19	h.a	h.a	PROPN
admet-1078	200	20	.	.	PROPN
admet-1078	200	21	young	young	PROPN
admet-1078	200	22	.	.	PUNCT
admet-1078	201	1	cellular	cellular	ADJ
admet-1078	201	2	and	and	CCONJ
admet-1078	201	3	molecular	molecular	ADJ
admet-1078	201	4	mechanisms	mechanism	NOUN
admet-1078	201	5	of	of	ADP
admet-1078	201	6	ifn	ifn	PROPN
admet-1078	201	7	-	-	PUNCT
admet-1078	201	8	gamma	gamma	NOUN
admet-1078	201	9	production	production	NOUN
admet-1078	201	10	induced	induce	VERB
admet-1078	201	11	by	by	ADP
admet-1078	201	12	il-2	il-2	NOUN
admet-1078	201	13	and	and	CCONJ
admet-1078	201	14	il-12	il-12	NOUN
admet-1078	201	15	in	in	ADP
admet-1078	201	16	a	a	DET
admet-1078	201	17	human	human	ADJ
admet-1078	201	18	nk	nk	PROPN
admet-1078	201	19	cell	cell	NOUN
admet-1078	201	20	line	line	NOUN
admet-1078	201	21	.	.	PUNCT
admet-1078	202	1	journal	journal	NOUN
admet-1078	202	2	of	of	ADP
admet-1078	202	3	leukocyte	leukocyte	NOUN
admet-1078	202	4	biology	biology	NOUN
admet-1078	202	5	58(2	58(2	NUM
admet-1078	202	6	)	)	PUNCT
admet-1078	202	7	(	(	PUNCT
admet-1078	202	8	1995	1995	NUM
admet-1078	202	9	)	)	PUNCT
admet-1078	202	10	225–233	225–233	NUM
admet-1078	202	11	.	.	PUNCT
admet-1078	203	1	https://doi.org/10.1002/jlb.58.2.225	https://doi.org/10.1002/jlb.58.2.225	NOUN
admet-1078	203	2	.	.	PUNCT
admet-1078	204	1	https://www.who.int/drugresistance/who%20global%20strategy%20-%20executive%20summary%20-%20english%20version.pdf?ua=1	https://www.who.int/drugresistance/who%20global%20strategy%20-%20executive%20summary%20-%20english%20version.pdf?ua=1	NOUN
admet-1078	204	2	https://www.who.int/drugresistance/who%20global%20strategy%20-%20executive%20summary%20-%20english%20version.pdf?ua=1	https://www.who.int/drugresistance/who%20global%20strategy%20-%20executive%20summary%20-%20english%20version.pdf?ua=1	VERB
admet-1078	204	3	https://doi.org/10.1093/cid/ciu572	https://doi.org/10.1093/cid/ciu572	PROPN
admet-1078	204	4	https://doi.org/10.1093/cid/ciu572	https://doi.org/10.1093/cid/ciu572	NOUN
admet-1078	204	5	https://coronavirus.jhu.edu/map.html	https://coronavirus.jhu.edu/map.html	PROPN
admet-1078	205	1	https://coronavirus.jhu.edu/map.html	https://coronavirus.jhu.edu/map.html	PROPN
admet-1078	206	1	https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf	https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf	PROPN
admet-1078	206	2	https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf	https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf	PROPN
admet-1078	206	3	https://doi.org/10.1128/iai.00443-12	https://doi.org/10.1128/iai.00443-12	NOUN
admet-1078	206	4	https://doi.org/10.1155/2016/7295390	https://doi.org/10.1155/2016/7295390	NOUN
admet-1078	206	5	https://www.ncbi.nlm.nih.gov/pubmed/?term=sharma%20s%5bauthor%5d&cauthor=true&cauthor_uid=11826917	https://www.ncbi.nlm.nih.gov/pubmed/?term=sharma%20s%5bauthor%5d&cauthor=true&cauthor_uid=11826917	X
admet-1078	206	6	https://www.ncbi.nlm.nih.gov/pubmed/?term=bose%20m%5bauthor%5d&cauthor=true&cauthor_uid=11826917	https://www.ncbi.nlm.nih.gov/pubmed/?term=bose%20m%5bauthor%5d&cauthor=true&cauthor_uid=11826917	NOUN
admet-1078	206	7	https://www.ncbi.nlm.nih.gov/pubmed/11826917	https://www.ncbi.nlm.nih.gov/pubmed/11826917	NOUN
admet-1078	206	8	https://www.ncbi.nlm.nih.gov/pubmed/11826917	https://www.ncbi.nlm.nih.gov/pubmed/11826917	NUM
admet-1078	206	9	https://doi.org/10.1016/s0140-6736(00)04904-7	https://doi.org/10.1016/s0140-6736(00)04904-7	PROPN
admet-1078	206	10	https://doi.org/10.1111/imr.12001	https://doi.org/10.1111/imr.12001	PROPN
admet-1078	206	11	https://doi.org/10.1002/jlb.58.2.225	https://doi.org/10.1002/jlb.58.2.225	PROPN
admet-1078	206	12	admet	admet	PROPN
admet-1078	206	13	&	&	CCONJ
admet-1078	206	14	dmpk	dmpk	PROPN
admet-1078	206	15	10(1	10(1	NUM
admet-1078	206	16	)	)	PUNCT
admet-1078	206	17	(	(	PUNCT
admet-1078	206	18	2022	2022	NUM
admet-1078	206	19	)	)	PUNCT
admet-1078	206	20	63	63	NUM
admet-1078	206	21	-	-	SYM
admet-1078	206	22	73	73	NUM
admet-1078	206	23	therapeutic	therapeutic	ADJ
admet-1078	206	24	potential	potential	NOUN
admet-1078	206	25	of	of	ADP
admet-1078	206	26	interferon	interferon	ADJ
admet-1078	206	27	-	-	PUNCT
admet-1078	206	28	gamma	gamma	NOUN
admet-1078	206	29	in	in	ADP
admet-1078	206	30	tuberculosis	tuberculosis	NOUN
admet-1078	206	31	doi	doi	NOUN
admet-1078	206	32	:	:	PUNCT
admet-1078	206	33	http://dx.doi.org/10.5599/admet.1078	http://dx.doi.org/10.5599/admet.1078	PROPN
admet-1078	206	34	71	71	NUM
admet-1078	206	35	[	[	X
admet-1078	206	36	14	14	NUM
admet-1078	206	37	]	]	X
admet-1078	206	38	h.	h.	PROPN
admet-1078	206	39	bierne	bierne	PROPN
admet-1078	206	40	,	,	PUNCT
admet-1078	206	41	l.	l.	PROPN
admet-1078	206	42	travier	travier	PROPN
admet-1078	206	43	,	,	PUNCT
admet-1078	206	44	t.	t.	NOUN
admet-1078	206	45	mahlakõiv	mahlakõiv	PROPN
admet-1078	206	46	,	,	PUNCT
admet-1078	206	47	et	et	PROPN
admet-1078	206	48	al	al	PROPN
admet-1078	206	49	.	.	PUNCT
admet-1078	206	50	activation	activation	NOUN
admet-1078	206	51	of	of	ADP
admet-1078	206	52	type	type	NOUN
admet-1078	206	53	iii	iii	NUM
admet-1078	206	54	interferon	interferon	ADJ
admet-1078	206	55	genes	gene	NOUN
admet-1078	206	56	by	by	ADP
admet-1078	206	57	pathogenic	pathogenic	ADJ
admet-1078	206	58	bacteria	bacteria	NOUN
admet-1078	206	59	in	in	ADP
admet-1078	206	60	infected	infected	ADJ
admet-1078	206	61	epithelial	epithelial	ADJ
admet-1078	206	62	cells	cell	NOUN
admet-1078	206	63	and	and	CCONJ
admet-1078	206	64	mouse	mouse	NOUN
admet-1078	206	65	placenta	placenta	PROPN
admet-1078	206	66	.	.	PUNCT
admet-1078	207	1	plos	plos	PROPN
admet-1078	207	2	one	one	NUM
admet-1078	207	3	7(6	7(6	NUM
admet-1078	207	4	)	)	PUNCT
admet-1078	207	5	(	(	PUNCT
admet-1078	207	6	2012	2012	NUM
admet-1078	207	7	)	)	PUNCT
admet-1078	207	8	e39080	e39080	NOUN
admet-1078	207	9	.	.	PUNCT
admet-1078	208	1	https://doi.org/10.1371/journal.pone.0039080	https://doi.org/10.1371/journal.pone.0039080	NOUN
admet-1078	208	2	.	.	PUNCT
admet-1078	209	1	[	[	X
admet-1078	209	2	15	15	NUM
admet-1078	209	3	]	]	X
admet-1078	209	4	l.	l.	PROPN
admet-1078	209	5	desvignes	desvignes	PROPN
admet-1078	209	6	,	,	PUNCT
admet-1078	209	7	a.j	a.j	PROPN
admet-1078	209	8	.	.	PROPN
admet-1078	209	9	wolf	wolf	PROPN
admet-1078	209	10	,	,	PUNCT
admet-1078	209	11	j.d	j.d	PROPN
admet-1078	209	12	.	.	PROPN
admet-1078	209	13	ernst	ernst	PROPN
admet-1078	209	14	.	.	PUNCT
admet-1078	210	1	dynamic	dynamic	ADJ
admet-1078	210	2	roles	role	NOUN
admet-1078	210	3	of	of	ADP
admet-1078	210	4	type	type	NOUN
admet-1078	210	5	i	i	PRON
admet-1078	210	6	and	and	CCONJ
admet-1078	210	7	type	type	NOUN
admet-1078	210	8	ii	ii	PROPN
admet-1078	210	9	interferons	interferon	NOUN
admet-1078	210	10	in	in	ADP
admet-1078	210	11	early	early	ADJ
admet-1078	210	12	infection	infection	NOUN
admet-1078	210	13	with	with	ADP
admet-1078	210	14	mycobacterium	mycobacterium	NOUN
admet-1078	210	15	tuberculosis	tuberculosis	NOUN
admet-1078	210	16	.	.	PUNCT
admet-1078	211	1	journal	journal	NOUN
admet-1078	211	2	of	of	ADP
admet-1078	211	3	immunology	immunology	NOUN
admet-1078	211	4	.	.	PUNCT
admet-1078	212	1	188(12	188(12	NUM
admet-1078	212	2	)	)	PUNCT
admet-1078	212	3	(	(	PUNCT
admet-1078	212	4	2012	2012	NUM
admet-1078	212	5	)	)	PUNCT
admet-1078	212	6	6205–6215	6205–6215	NUM
admet-1078	212	7	.	.	PUNCT
admet-1078	213	1	https://doi.org/10.4049/jimmunol.1200255	https://doi.org/10.4049/jimmunol.1200255	NOUN
admet-1078	213	2	.	.	PUNCT
admet-1078	214	1	[	[	X
admet-1078	214	2	16	16	NUM
admet-1078	214	3	]	]	X
admet-1078	214	4	s.v	s.v	PROPN
admet-1078	214	5	.	.	PROPN
admet-1078	214	6	jamwal	jamwal	PROPN
admet-1078	214	7	,	,	PUNCT
admet-1078	214	8	p.	p.	PROPN
admet-1078	214	9	mehrotra	mehrotra	PROPN
admet-1078	214	10	,	,	PUNCT
admet-1078	214	11	a.	a.	PROPN
admet-1078	214	12	singh	singh	PROPN
admet-1078	214	13	,	,	PUNCT
admet-1078	214	14	z.	z.	PROPN
admet-1078	214	15	siddiqui	siddiqui	PROPN
admet-1078	214	16	,	,	PUNCT
admet-1078	214	17	a.	a.	PROPN
admet-1078	214	18	basu	basu	PROPN
admet-1078	214	19	,	,	PUNCT
admet-1078	214	20	k.v	k.v	PROPN
admet-1078	214	21	.	.	PROPN
admet-1078	214	22	rao	rao	PROPN
admet-1078	214	23	.	.	PUNCT
admet-1078	215	1	mycobacterial	mycobacterial	ADJ
admet-1078	215	2	escape	escape	NOUN
admet-1078	215	3	from	from	ADP
admet-1078	215	4	macrophage	macrophage	ADJ
admet-1078	215	5	phagosomes	phagosome	NOUN
admet-1078	215	6	to	to	ADP
admet-1078	215	7	the	the	DET
admet-1078	215	8	cytoplasm	cytoplasm	NOUN
admet-1078	215	9	represents	represent	VERB
admet-1078	215	10	an	an	DET
admet-1078	215	11	alternate	alternate	ADJ
admet-1078	215	12	adaptation	adaptation	NOUN
admet-1078	215	13	mechanism	mechanism	NOUN
admet-1078	215	14	.	.	PUNCT
admet-1078	216	1	scientific	scientific	ADJ
admet-1078	216	2	reports	report	NOUN
admet-1078	216	3	6	6	NUM
admet-1078	216	4	(	(	PUNCT
admet-1078	216	5	2016	2016	NUM
admet-1078	216	6	)	)	PUNCT
admet-1078	216	7	23089	23089	NUM
admet-1078	216	8	.	.	PUNCT
admet-1078	217	1	https://doi.org/10.1038/srep23089	https://doi.org/10.1038/srep23089	NOUN
admet-1078	217	2	.	.	PUNCT
admet-1078	218	1	[	[	X
admet-1078	218	2	17	17	NUM
admet-1078	218	3	]	]	X
admet-1078	218	4	t.n	t.n	PROPN
admet-1078	218	5	.	.	PROPN
admet-1078	218	6	ottenhoff	ottenhoff	PROPN
admet-1078	218	7	,	,	PUNCT
admet-1078	218	8	r.h	r.h	PROPN
admet-1078	218	9	.	.	PROPN
admet-1078	218	10	dass	dass	PROPN
admet-1078	218	11	,	,	PUNCT
admet-1078	218	12	n.	n.	PROPN
admet-1078	218	13	yang	yang	PROPN
admet-1078	218	14	,	,	PUNCT
admet-1078	218	15	et	et	PROPN
admet-1078	218	16	al	al	PROPN
admet-1078	218	17	.	.	PUNCT
admet-1078	218	18	genome	genome	NOUN
admet-1078	218	19	-	-	PUNCT
admet-1078	218	20	wide	wide	ADJ
admet-1078	218	21	expression	expression	NOUN
admet-1078	218	22	profiling	profiling	NOUN
admet-1078	218	23	identifies	identifie	NOUN
admet-1078	218	24	type	type	NOUN
admet-1078	218	25	1	1	NUM
admet-1078	218	26	interferon	interferon	ADJ
admet-1078	218	27	response	response	NOUN
admet-1078	218	28	pathways	pathway	NOUN
admet-1078	218	29	in	in	ADP
admet-1078	218	30	active	active	ADJ
admet-1078	218	31	tuberculosis	tuberculosis	NOUN
admet-1078	218	32	.	.	PUNCT
admet-1078	219	1	plos	plos	PROPN
admet-1078	219	2	one	one	NUM
admet-1078	219	3	7(9	7(9	NUM
admet-1078	219	4	)	)	PUNCT
admet-1078	219	5	(	(	PUNCT
admet-1078	219	6	2012	2012	NUM
admet-1078	219	7	)	)	PUNCT
admet-1078	219	8	e45839	e45839	NOUN
admet-1078	219	9	.	.	PUNCT
admet-1078	220	1	https://doi.org/10.1371/journal.pone.0045839	https://doi.org/10.1371/journal.pone.0045839	PROPN
admet-1078	221	1	[	[	X
admet-1078	221	2	18	18	NUM
admet-1078	221	3	]	]	PUNCT
admet-1078	221	4	m.	m.	NOUN
admet-1078	221	5	travar	travar	NOUN
admet-1078	221	6	,	,	PUNCT
admet-1078	221	7	m.	m.	NOUN
admet-1078	221	8	petkovic	petkovic	PROPN
admet-1078	221	9	,	,	PUNCT
admet-1078	221	10	a.	a.	NOUN
admet-1078	221	11	verhaz	verhaz	NOUN
admet-1078	221	12	.	.	PUNCT
admet-1078	222	1	type	type	NOUN
admet-1078	222	2	i	i	PROPN
admet-1078	222	3	,	,	PUNCT
admet-1078	222	4	ii	ii	PROPN
admet-1078	222	5	,	,	PUNCT
admet-1078	222	6	and	and	CCONJ
admet-1078	222	7	iii	iii	NUM
admet-1078	222	8	interferons	interferon	NOUN
admet-1078	222	9	:	:	PUNCT
admet-1078	222	10	regulating	regulate	VERB
admet-1078	222	11	immunity	immunity	NOUN
admet-1078	222	12	to	to	ADP
admet-1078	222	13	mycobacterium	mycobacterium	NOUN
admet-1078	222	14	tuberculosis	tuberculosis	NOUN
admet-1078	222	15	infection	infection	NOUN
admet-1078	222	16	.	.	PUNCT
admet-1078	223	1	archivum	archivum	PROPN
admet-1078	223	2	immunologiae	immunologiae	ADJ
admet-1078	223	3	et	et	PROPN
admet-1078	223	4	therapiae	therapiae	NOUN
admet-1078	223	5	experimentalis	experimentalis	PROPN
admet-1078	223	6	(	(	PUNCT
admet-1078	223	7	warsz	warsz	NOUN
admet-1078	223	8	)	)	PUNCT
admet-1078	223	9	64(1	64(1	NUM
admet-1078	223	10	)	)	PUNCT
admet-1078	223	11	(	(	PUNCT
admet-1078	223	12	2016	2016	NUM
admet-1078	223	13	)	)	PUNCT
admet-1078	223	14	19–31	19–31	NUM
admet-1078	223	15	.	.	PUNCT
admet-1078	224	1	doi	doi	NOUN
admet-1078	224	2	:	:	PUNCT
admet-1078	224	3	https://doi.org/10.1007/s00005-015-0365-7	https://doi.org/10.1007/s00005-015-0365-7	NUM
admet-1078	224	4	.	.	PUNCT
admet-1078	225	1	[	[	X
admet-1078	225	2	19	19	NUM
admet-1078	225	3	]	]	X
admet-1078	225	4	m.a	m.a	PROPN
admet-1078	225	5	.	.	PROPN
admet-1078	225	6	huaman	huaman	PROPN
admet-1078	225	7	,	,	PUNCT
admet-1078	225	8	d.	d.	PROPN
admet-1078	225	9	henson	henson	PROPN
admet-1078	225	10	,	,	PUNCT
admet-1078	225	11	p.l	p.l	PROPN
admet-1078	225	12	.	.	PROPN
admet-1078	225	13	rondan	rondan	PROPN
admet-1078	225	14	,	,	PUNCT
admet-1078	225	15	et	et	PROPN
admet-1078	225	16	al	al	PROPN
admet-1078	225	17	.	.	PROPN
admet-1078	225	18	latent	latent	PROPN
admet-1078	225	19	tuberculosis	tuberculosis	NOUN
admet-1078	225	20	infection	infection	NOUN
admet-1078	225	21	is	be	AUX
admet-1078	225	22	associated	associate	VERB
admet-1078	225	23	with	with	ADP
admet-1078	225	24	increased	increase	VERB
admet-1078	225	25	unstimulated	unstimulated	ADJ
admet-1078	225	26	levels	level	NOUN
admet-1078	225	27	of	of	ADP
admet-1078	225	28	interferon	interferon	ADJ
admet-1078	225	29	-	-	PUNCT
admet-1078	225	30	gamma	gamma	NOUN
admet-1078	225	31	in	in	ADP
admet-1078	225	32	lima	lima	PROPN
admet-1078	225	33	,	,	PUNCT
admet-1078	225	34	peru	peru	PROPN
admet-1078	225	35	.	.	PUNCT
admet-1078	226	1	plos	plos	PROPN
admet-1078	226	2	one	one	NUM
admet-1078	226	3	13(9	13(9	NUM
admet-1078	226	4	)	)	PUNCT
admet-1078	226	5	(	(	PUNCT
admet-1078	226	6	2018	2018	NUM
admet-1078	226	7	)	)	PUNCT
admet-1078	227	1	e0202191	e0202191	PROPN
admet-1078	227	2	.	.	PUNCT
admet-1078	228	1	https://doi.org/10.1371/journal.pone.0202191	https://doi.org/10.1371/journal.pone.0202191	NOUN
admet-1078	228	2	.	.	PUNCT
admet-1078	229	1	[	[	X
admet-1078	229	2	20	20	NUM
admet-1078	229	3	]	]	X
admet-1078	229	4	e.	e.	PROPN
admet-1078	229	5	petruccioli	petruccioli	PROPN
admet-1078	229	6	,	,	PUNCT
admet-1078	229	7	t.j	t.j	PROPN
admet-1078	229	8	.	.	PROPN
admet-1078	229	9	scriba	scriba	PROPN
admet-1078	229	10	,	,	PUNCT
admet-1078	229	11	l.	l.	PROPN
admet-1078	229	12	petrone	petrone	PROPN
admet-1078	229	13	,	,	PUNCT
admet-1078	229	14	et	et	PROPN
admet-1078	229	15	al	al	PROPN
admet-1078	229	16	.	.	PROPN
admet-1078	229	17	correlates	correlate	VERB
admet-1078	229	18	of	of	ADP
admet-1078	229	19	tuberculosis	tuberculosis	NOUN
admet-1078	229	20	risk	risk	NOUN
admet-1078	229	21	:	:	PUNCT
admet-1078	229	22	predictive	predictive	ADJ
admet-1078	229	23	biomarkers	biomarker	NOUN
admet-1078	229	24	for	for	ADP
admet-1078	229	25	progression	progression	NOUN
admet-1078	229	26	to	to	ADP
admet-1078	229	27	active	active	ADJ
admet-1078	229	28	tuberculosis	tuberculosis	NOUN
admet-1078	229	29	.	.	PUNCT
admet-1078	230	1	the	the	DET
admet-1078	230	2	european	european	ADJ
admet-1078	230	3	respiratory	respiratory	ADJ
admet-1078	230	4	journal	journal	PROPN
admet-1078	230	5	48(6	48(6	NOUN
admet-1078	230	6	)	)	PUNCT
admet-1078	230	7	(	(	PUNCT
admet-1078	230	8	2016	2016	NUM
admet-1078	230	9	)	)	PUNCT
admet-1078	230	10	1751	1751	NUM
admet-1078	230	11	-	-	SYM
admet-1078	230	12	1763	1763	NUM
admet-1078	230	13	.	.	PUNCT
admet-1078	231	1	https://doi.org/10.1183/13993003.01012-2016	https://doi.org/10.1183/13993003.01012-2016	X
admet-1078	231	2	.	.	PUNCT
admet-1078	232	1	[	[	X
admet-1078	232	2	21	21	NUM
admet-1078	232	3	]	]	X
admet-1078	232	4	v.n	v.n	PROPN
admet-1078	232	5	.	.	PROPN
admet-1078	232	6	zimina	zimina	PROPN
admet-1078	232	7	,	,	PUNCT
admet-1078	232	8	i.a	i.a	PROPN
admet-1078	232	9	.	.	PROPN
admet-1078	232	10	vasilieva	vasilieva	PROPN
admet-1078	232	11	,	,	PUNCT
admet-1078	232	12	a.v	a.v	PROPN
admet-1078	232	13	.	.	PROPN
admet-1078	232	14	kravchenko	kravchenko	PROPN
admet-1078	232	15	,	,	PUNCT
admet-1078	232	16	f.a	f.a	PROPN
admet-1078	232	17	.	.	PUNCT
admet-1078	232	18	batyrov	batyrov	PROPN
admet-1078	232	19	.	.	PUNCT
admet-1078	233	1	generalized	generalize	VERB
admet-1078	233	2	tuberculosis	tuberculosis	NOUN
admet-1078	233	3	in	in	ADP
admet-1078	233	4	hiv	hiv	PROPN
admet-1078	233	5	-	-	PUNCT
admet-1078	233	6	infected	infect	VERB
admet-1078	233	7	patients	patient	NOUN
admet-1078	233	8	with	with	ADP
admet-1078	233	9	aids	aids	PROPN
admet-1078	233	10	.	.	PUNCT
admet-1078	234	1	journal	journal	NOUN
admet-1078	234	2	of	of	ADP
admet-1078	234	3	the	the	DET
admet-1078	234	4	international	international	ADJ
admet-1078	234	5	aids	aids	PROPN
admet-1078	234	6	society	society	PROPN
admet-1078	234	7	13(4	13(4	NUM
admet-1078	234	8	)	)	PUNCT
admet-1078	234	9	(	(	PUNCT
admet-1078	234	10	2010	2010	NUM
admet-1078	234	11	)	)	PUNCT
admet-1078	235	1	p195	p195	PROPN
admet-1078	235	2	.	.	NOUN
admet-1078	235	3	https://doi.org/10.1186/1758-2652-13-s4-p195	https://doi.org/10.1186/1758-2652-13-s4-p195	NOUN
admet-1078	235	4	.	.	PUNCT
admet-1078	236	1	[	[	X
admet-1078	236	2	22	22	NUM
admet-1078	236	3	]	]	X
admet-1078	236	4	e.	e.	PROPN
admet-1078	236	5	van	van	PROPN
admet-1078	236	6	de	de	PROPN
admet-1078	236	7	vosse	vosse	PROPN
admet-1078	236	8	,	,	PUNCT
admet-1078	236	9	m.a	m.a	PROPN
admet-1078	236	10	.	.	PROPN
admet-1078	236	11	hoeve	hoeve	NOUN
admet-1078	236	12	,	,	PUNCT
admet-1078	236	13	t.n	t.n	PROPN
admet-1078	236	14	.	.	PROPN
admet-1078	236	15	ottenhoff	ottenhoff	PROPN
admet-1078	236	16	.	.	PUNCT
admet-1078	237	1	human	human	ADJ
admet-1078	237	2	genetics	genetic	NOUN
admet-1078	237	3	of	of	ADP
admet-1078	237	4	intracellular	intracellular	ADJ
admet-1078	237	5	infectious	infectious	ADJ
admet-1078	237	6	diseases	disease	NOUN
admet-1078	237	7	:	:	PUNCT
admet-1078	237	8	molecular	molecular	ADJ
admet-1078	237	9	and	and	CCONJ
admet-1078	237	10	cellular	cellular	ADJ
admet-1078	237	11	immunity	immunity	NOUN
admet-1078	237	12	against	against	ADP
admet-1078	237	13	mycobacteria	mycobacteria	NOUN
admet-1078	237	14	and	and	CCONJ
admet-1078	237	15	salmonellae	salmonellae	PROPN
admet-1078	237	16	.	.	PUNCT
admet-1078	238	1	lancet	lancet	PROPN
admet-1078	238	2	infect	infect	PROPN
admet-1078	238	3	.	.	PUNCT
admet-1078	239	1	dis	dis	INTJ
admet-1078	239	2	.	.	PUNCT
admet-1078	240	1	4	4	NUM
admet-1078	240	2	(	(	PUNCT
admet-1078	240	3	2004	2004	NUM
admet-1078	240	4	)	)	PUNCT
admet-1078	241	1	739–749	739–749	NUM
admet-1078	241	2	.	.	PUNCT
admet-1078	242	1	https://doi.org/10.1016/s1473-3099(04)01203-4	https://doi.org/10.1016/s1473-3099(04)01203-4	NOUN
admet-1078	242	2	.	.	PUNCT
admet-1078	243	1	[	[	X
admet-1078	243	2	23	23	NUM
admet-1078	243	3	]	]	X
admet-1078	243	4	l.c	l.c	PROPN
admet-1078	243	5	.	.	PROPN
admet-1078	243	6	platanias	platania	NOUN
admet-1078	243	7	.	.	PUNCT
admet-1078	244	1	mechanisms	mechanism	NOUN
admet-1078	244	2	of	of	ADP
admet-1078	244	3	type	type	NOUN
admet-1078	244	4	-	-	PUNCT
admet-1078	244	5	iand	iand	NOUN
admet-1078	244	6	type	type	NOUN
admet-1078	244	7	-	-	PUNCT
admet-1078	244	8	ii	ii	NOUN
admet-1078	244	9	-	-	PUNCT
admet-1078	244	10	interferon	interferon	ADJ
admet-1078	244	11	-	-	PUNCT
admet-1078	244	12	mediated	mediate	VERB
admet-1078	244	13	signalling	signalling	NOUN
admet-1078	244	14	.	.	PUNCT
admet-1078	245	1	nature	nature	NOUN
admet-1078	245	2	reviews	review	NOUN
admet-1078	245	3	.	.	PUNCT
admet-1078	246	1	immunology	immunology	NOUN
admet-1078	246	2	5(5	5(5	NUM
admet-1078	246	3	)	)	PUNCT
admet-1078	246	4	(	(	PUNCT
admet-1078	246	5	2005	2005	NUM
admet-1078	246	6	)	)	PUNCT
admet-1078	246	7	375–386	375–386	NUM
admet-1078	246	8	.	.	PUNCT
admet-1078	247	1	https://doi.org/10.1038/nri1604	https://doi.org/10.1038/nri1604	PROPN
admet-1078	247	2	.	.	PUNCT
admet-1078	248	1	[	[	X
admet-1078	248	2	24	24	NUM
admet-1078	248	3	]	]	X
admet-1078	248	4	b.h	b.h	PROPN
admet-1078	248	5	.	.	PROPN
admet-1078	248	6	salt	salt	NOUN
admet-1078	248	7	,	,	PUNCT
admet-1078	248	8	j.e	j.e	PROPN
admet-1078	248	9	.	.	PROPN
admet-1078	248	10	niemela	niemela	PROPN
admet-1078	248	11	,	,	PUNCT
admet-1078	248	12	r.	r.	PROPN
admet-1078	248	13	pandey	pandey	PROPN
admet-1078	248	14	,	,	PUNCT
admet-1078	248	15	e.p	e.p	PROPN
admet-1078	248	16	.	.	PROPN
admet-1078	248	17	hanson	hanson	PROPN
admet-1078	248	18	,	,	PUNCT
admet-1078	248	19	r.p	r.p	PROPN
admet-1078	248	20	.	.	PROPN
admet-1078	248	21	deering	deering	PROPN
admet-1078	248	22	,	,	PUNCT
admet-1078	248	23	r.	r.	PROPN
admet-1078	248	24	quinones	quinone	NOUN
admet-1078	248	25	,	,	PUNCT
admet-1078	248	26	a.	a.	NOUN
admet-1078	248	27	jain	jain	PROPN
admet-1078	248	28	,	,	PUNCT
admet-1078	248	29	j.s	j.s	PROPN
admet-1078	248	30	.	.	PROPN
admet-1078	248	31	orange	orange	PROPN
admet-1078	248	32	,	,	PUNCT
admet-1078	248	33	e.w	e.w	PROPN
admet-1078	248	34	.	.	PROPN
admet-1078	248	35	gelfand	gelfand	PROPN
admet-1078	248	36	.	.	PUNCT
admet-1078	249	1	ikbkg	ikbkg	NOUN
admet-1078	249	2	(	(	PUNCT
admet-1078	249	3	nuclear	nuclear	ADJ
admet-1078	249	4	factor	factor	NOUN
admet-1078	249	5	-	-	PUNCT
admet-1078	249	6	kappa	kappa	PROPN
admet-1078	249	7	b	b	PROPN
admet-1078	249	8	essential	essential	ADJ
admet-1078	249	9	modulator	modulator	NOUN
admet-1078	249	10	)	)	PUNCT
admet-1078	249	11	mutation	mutation	NOUN
admet-1078	249	12	can	can	AUX
admet-1078	249	13	be	be	AUX
admet-1078	249	14	associated	associate	VERB
admet-1078	249	15	with	with	ADP
admet-1078	249	16	opportunistic	opportunistic	ADJ
admet-1078	249	17	infection	infection	NOUN
admet-1078	249	18	without	without	ADP
admet-1078	249	19	impairing	impair	VERB
admet-1078	249	20	toll	toll	NOUN
admet-1078	249	21	-	-	PUNCT
admet-1078	249	22	like	like	ADJ
admet-1078	249	23	receptor	receptor	NOUN
admet-1078	249	24	function	function	NOUN
admet-1078	249	25	.	.	PUNCT
admet-1078	250	1	the	the	DET
admet-1078	250	2	journal	journal	PROPN
admet-1078	250	3	of	of	ADP
admet-1078	250	4	allergy	allergy	PROPN
admet-1078	250	5	and	and	CCONJ
admet-1078	250	6	clinical	clinical	ADJ
admet-1078	250	7	immunology	immunology	NOUN
admet-1078	250	8	121	121	NUM
admet-1078	250	9	(	(	PUNCT
admet-1078	250	10	2008	2008	NUM
admet-1078	250	11	)	)	PUNCT
admet-1078	251	1	976–982	976–982	NUM
admet-1078	251	2	.	.	PUNCT
admet-1078	251	3	https://doi.org/10.1016/j.jaci.2007.11.014	https://doi.org/10.1016/j.jaci.2007.11.014	NOUN
admet-1078	251	4	.	.	PUNCT
admet-1078	252	1	[	[	X
admet-1078	252	2	25	25	NUM
admet-1078	252	3	]	]	PUNCT
admet-1078	252	4	j.	j.	PROPN
admet-1078	252	5	bustamante	bustamante	PROPN
admet-1078	252	6	,	,	PUNCT
admet-1078	252	7	a.a	a.a	PROPN
admet-1078	252	8	.	.	PROPN
admet-1078	252	9	arias	arias	PROPN
admet-1078	252	10	,	,	PUNCT
admet-1078	252	11	g.	g.	PROPN
admet-1078	252	12	vogt	vogt	PROPN
admet-1078	252	13	,	,	PUNCT
admet-1078	252	14	c.	c.	PROPN
admet-1078	252	15	picard	picard	PROPN
admet-1078	252	16	,	,	PUNCT
admet-1078	252	17	l.b	l.b	PROPN
admet-1078	252	18	.	.	PROPN
admet-1078	252	19	galicia	galicia	PROPN
admet-1078	252	20	,	,	PUNCT
admet-1078	252	21	et	et	PROPN
admet-1078	252	22	al	al	PROPN
admet-1078	252	23	.	.	PROPN
admet-1078	252	24	germline	germline	PROPN
admet-1078	252	25	cybb	cybb	PROPN
admet-1078	252	26	mutations	mutation	NOUN
admet-1078	252	27	that	that	PRON
admet-1078	252	28	selectively	selectively	ADV
admet-1078	252	29	affect	affect	VERB
admet-1078	252	30	macrophages	macrophage	NOUN
admet-1078	252	31	in	in	ADP
admet-1078	252	32	kindreds	kindred	NOUN
admet-1078	252	33	with	with	ADP
admet-1078	252	34	x	x	VERB
admet-1078	252	35	-	-	ADJ
admet-1078	252	36	linked	link	VERB
admet-1078	252	37	predisposition	predisposition	NOUN
admet-1078	252	38	to	to	ADP
admet-1078	252	39	tuberculous	tuberculous	ADJ
admet-1078	252	40	mycobacterial	mycobacterial	ADJ
admet-1078	252	41	disease	disease	NOUN
admet-1078	252	42	.	.	PUNCT
admet-1078	253	1	nature	nature	NOUN
admet-1078	253	2	immunology	immunology	NOUN
admet-1078	253	3	12	12	NUM
admet-1078	253	4	(	(	PUNCT
admet-1078	253	5	2011	2011	NUM
admet-1078	253	6	)	)	PUNCT
admet-1078	253	7	213–221	213–221	NUM
admet-1078	253	8	.	.	PUNCT
admet-1078	254	1	https://doi.org/10.1038/ni.1992	https://doi.org/10.1038/ni.1992	AUX
admet-1078	254	2	.	.	PUNCT
admet-1078	255	1	[	[	X
admet-1078	255	2	26	26	NUM
admet-1078	255	3	]	]	X
admet-1078	255	4	j.d	j.d	PROPN
admet-1078	255	5	.	.	PROPN
admet-1078	255	6	ernst	ernst	PROPN
admet-1078	255	7	.	.	PUNCT
admet-1078	256	1	the	the	DET
admet-1078	256	2	immunological	immunological	ADJ
admet-1078	256	3	life	life	NOUN
admet-1078	256	4	cycle	cycle	NOUN
admet-1078	256	5	of	of	ADP
admet-1078	256	6	tuberculosis	tuberculosis	NOUN
admet-1078	256	7	.	.	PUNCT
admet-1078	257	1	nature	nature	NOUN
admet-1078	257	2	reviews	review	VERB
admet-1078	257	3	immunology	immunology	NOUN
admet-1078	257	4	12	12	NUM
admet-1078	257	5	(	(	PUNCT
admet-1078	257	6	2012	2012	NUM
admet-1078	257	7	)	)	PUNCT
admet-1078	257	8	581	581	NUM
admet-1078	257	9	–	–	PUNCT
admet-1078	257	10	591	591	NUM
admet-1078	257	11	.	.	PUNCT
admet-1078	258	1	https://doi.org/10.1038/nri3259	https://doi.org/10.1038/nri3259	NOUN
admet-1078	258	2	.	.	PUNCT
admet-1078	259	1	[	[	X
admet-1078	259	2	27	27	NUM
admet-1078	259	3	]	]	X
admet-1078	259	4	o.	o.	PROPN
admet-1078	259	5	filipe	filipe	PROPN
admet-1078	259	6	-	-	PUNCT
admet-1078	259	7	santos	santos	PROPN
admet-1078	259	8	,	,	PUNCT
admet-1078	259	9	j.	j.	PROPN
admet-1078	259	10	bustamante	bustamante	PROPN
admet-1078	259	11	,	,	PUNCT
admet-1078	259	12	a.	a.	NOUN
admet-1078	259	13	chapgier	chapgier	NOUN
admet-1078	259	14	,	,	PUNCT
admet-1078	259	15	g.	g.	PROPN
admet-1078	259	16	vogt	vogt	PROPN
admet-1078	259	17	,	,	PUNCT
admet-1078	259	18	l.	l.	PROPN
admet-1078	259	19	de	de	PROPN
admet-1078	259	20	beaucoudrey	beaucoudrey	PROPN
admet-1078	259	21	,	,	PUNCT
admet-1078	259	22	j.	j.	PROPN
admet-1078	259	23	feinberg	feinberg	PROPN
admet-1078	259	24	,	,	PUNCT
admet-1078	259	25	e.	e.	PROPN
admet-1078	259	26	jouanguy	jouanguy	PROPN
admet-1078	259	27	,	,	PUNCT
admet-1078	259	28	s.	s.	PROPN
admet-1078	259	29	boisson	boisson	PROPN
admet-1078	259	30	-	-	PUNCT
admet-1078	259	31	dupuis	dupuis	PROPN
admet-1078	259	32	,	,	PUNCT
admet-1078	259	33	c.	c.	PROPN
admet-1078	259	34	fieschi	fieschi	PROPN
admet-1078	259	35	,	,	PUNCT
admet-1078	259	36	c.	c.	PROPN
admet-1078	259	37	picard	picard	PROPN
admet-1078	259	38	,	,	PUNCT
admet-1078	259	39	j.l	j.l	PROPN
admet-1078	259	40	.	.	PROPN
admet-1078	259	41	casanova	casanova	PROPN
admet-1078	259	42	.	.	PUNCT
admet-1078	260	1	inborn	inborn	ADJ
admet-1078	260	2	errors	error	NOUN
admet-1078	260	3	of	of	ADP
admet-1078	260	4	il-12/23and	il-12/23and	NOUN
admet-1078	260	5	ifn	ifn	PROPN
admet-1078	260	6	-	-	PUNCT
admet-1078	260	7	γ	γ	NOUN
admet-1078	260	8	-	-	PUNCT
admet-1078	260	9	mediated	mediate	VERB
admet-1078	260	10	immunity	immunity	NOUN
admet-1078	260	11	:	:	PUNCT
admet-1078	260	12	molecular	molecular	ADJ
admet-1078	260	13	,	,	PUNCT
admet-1078	260	14	cellular	cellular	ADJ
admet-1078	260	15	,	,	PUNCT
admet-1078	260	16	and	and	CCONJ
admet-1078	260	17	clinical	clinical	ADJ
admet-1078	260	18	features	feature	NOUN
admet-1078	260	19	.	.	PUNCT
admet-1078	261	1	seminars	seminar	NOUN
admet-1078	261	2	in	in	ADP
admet-1078	261	3	immunology	immunology	NOUN
admet-1078	261	4	18	18	NUM
admet-1078	261	5	(	(	PUNCT
admet-1078	261	6	2006	2006	NUM
admet-1078	261	7	)	)	PUNCT
admet-1078	261	8	347–361	347–361	PROPN
admet-1078	261	9	.	.	PUNCT
admet-1078	262	1	https://doi.org/10.1016/j.smim.2006.07.010	https://doi.org/10.1016/j.smim.2006.07.010	PROPN
admet-1078	262	2	.	.	PUNCT
admet-1078	263	1	[	[	X
admet-1078	263	2	28	28	NUM
admet-1078	263	3	]	]	X
admet-1078	263	4	s.	s.	PROPN
admet-1078	263	5	al	al	PROPN
admet-1078	263	6	-	-	PUNCT
admet-1078	263	7	muhsen	muhsen	PROPN
admet-1078	263	8	,	,	PUNCT
admet-1078	263	9	j.l	j.l	PROPN
admet-1078	263	10	.	.	PROPN
admet-1078	263	11	casanova	casanova	PROPN
admet-1078	263	12	.	.	PUNCT
admet-1078	264	1	the	the	DET
admet-1078	264	2	genetic	genetic	ADJ
admet-1078	264	3	heterogeneity	heterogeneity	NOUN
admet-1078	264	4	of	of	ADP
admet-1078	264	5	mendelian	mendelian	ADJ
admet-1078	264	6	susceptibility	susceptibility	NOUN
admet-1078	264	7	to	to	ADP
admet-1078	264	8	mycobacterial	mycobacterial	ADJ
admet-1078	264	9	diseases	disease	NOUN
admet-1078	264	10	.	.	PUNCT
admet-1078	265	1	journal	journal	PROPN
admet-1078	265	2	of	of	ADP
admet-1078	265	3	allergy	allergy	PROPN
admet-1078	265	4	and	and	CCONJ
admet-1078	265	5	clinical	clinical	ADJ
admet-1078	265	6	immunology	immunology	NOUN
admet-1078	265	7	122	122	NUM
admet-1078	265	8	(	(	PUNCT
admet-1078	265	9	2008	2008	NUM
admet-1078	265	10	)	)	PUNCT
admet-1078	265	11	1043–1051	1043–1051	NUM
admet-1078	265	12	.	.	PUNCT
admet-1078	266	1	https://doi.org/10.1016/j.jaci.2008.10.037	https://doi.org/10.1016/j.jaci.2008.10.037	PROPN
admet-1078	266	2	.	.	PUNCT
admet-1078	267	1	[	[	X
admet-1078	267	2	29	29	NUM
admet-1078	267	3	]	]	X
admet-1078	267	4	s.d	s.d	PROPN
admet-1078	267	5	.	.	PROPN
admet-1078	267	6	rosenzweig	rosenzweig	PROPN
admet-1078	267	7	,	,	PUNCT
admet-1078	267	8	s.e	s.e	PROPN
admet-1078	267	9	.	.	PROPN
admet-1078	267	10	dorman	dorman	PROPN
admet-1078	267	11	,	,	PUNCT
admet-1078	267	12	g.	g.	PROPN
admet-1078	267	13	uzel	uzel	PROPN
admet-1078	267	14	,	,	PUNCT
admet-1078	267	15	s.	s.	PROPN
admet-1078	267	16	shaw	shaw	PROPN
admet-1078	267	17	,	,	PUNCT
admet-1078	267	18	a.	a.	NOUN
admet-1078	267	19	scurlock	scurlock	PROPN
admet-1078	267	20	,	,	PUNCT
admet-1078	267	21	m.r	m.r	PROPN
admet-1078	267	22	.	.	PROPN
admet-1078	267	23	brown	brown	PROPN
admet-1078	267	24	,	,	PUNCT
admet-1078	267	25	r.h	r.h	PROPN
admet-1078	267	26	.	.	PROPN
admet-1078	267	27	buckley	buckley	PROPN
admet-1078	267	28	,	,	PUNCT
admet-1078	267	29	s.m	s.m	PROPN
admet-1078	267	30	.	.	PROPN
admet-1078	267	31	holland	holland	PROPN
admet-1078	267	32	.	.	PUNCT
admet-1078	268	1	a	a	DET
admet-1078	268	2	novel	novel	ADJ
admet-1078	268	3	mutation	mutation	NOUN
admet-1078	268	4	in	in	ADP
admet-1078	268	5	ifn	ifn	PROPN
admet-1078	268	6	-	-	PUNCT
admet-1078	268	7	γ	γ	NOUN
admet-1078	268	8	receptor	receptor	NOUN
admet-1078	268	9	2	2	NUM
admet-1078	268	10	with	with	ADP
admet-1078	268	11	dominant	dominant	ADJ
admet-1078	268	12	negative	negative	ADJ
admet-1078	268	13	activity	activity	NOUN
admet-1078	268	14	:	:	PUNCT
admet-1078	268	15	biological	biological	ADJ
admet-1078	268	16	consequences	consequence	NOUN
admet-1078	268	17	of	of	ADP
admet-1078	268	18	homozygous	homozygous	ADJ
admet-1078	268	19	and	and	CCONJ
admet-1078	268	20	heterozygous	heterozygous	ADJ
admet-1078	268	21	states	state	NOUN
admet-1078	268	22	.	.	PUNCT
admet-1078	269	1	journal	journal	NOUN
admet-1078	269	2	of	of	ADP
admet-1078	269	3	immunology	immunology	NOUN
admet-1078	269	4	173	173	NUM
admet-1078	269	5	(	(	PUNCT
admet-1078	269	6	2004	2004	NUM
admet-1078	269	7	)	)	PUNCT
admet-1078	269	8	4000–4008	4000–4008	NOUN
admet-1078	269	9	.	.	PUNCT
admet-1078	270	1	https://doi.org/10.4049/jimmunol.173.6.4000	https://doi.org/10.4049/jimmunol.173.6.4000	PROPN
admet-1078	270	2	.	.	PUNCT
admet-1078	271	1	http://dx.doi.org/10.5599/admet.1078	http://dx.doi.org/10.5599/admet.1078	PROPN
admet-1078	271	2	https://doi.org/10.1371/journal.pone.0039080	https://doi.org/10.1371/journal.pone.0039080	NOUN
admet-1078	271	3	https://doi.org/10.1371/journal.pone.0039080	https://doi.org/10.1371/journal.pone.0039080	NOUN
admet-1078	271	4	https://doi.org/10.4049/jimmunol.1200255	https://doi.org/10.4049/jimmunol.1200255	NOUN
admet-1078	271	5	https://dx.doi.org/10.1038%2fsrep23089	https://dx.doi.org/10.1038%2fsrep23089	NOUN
admet-1078	271	6	https://doi.org/10.1371/journal.pone.0045839	https://doi.org/10.1371/journal.pone.0045839	VERB
admet-1078	271	7	https://doi.org/10.1007/s00005-015-0365-7	https://doi.org/10.1007/s00005-015-0365-7	NUM
admet-1078	271	8	https://doi.org/10.1371/journal.pone.0202191	https://doi.org/10.1371/journal.pone.0202191	NOUN
admet-1078	271	9	https://doi.org/10.1183/13993003.01012-2016	https://doi.org/10.1183/13993003.01012-2016	PROPN
admet-1078	271	10	https://doi.org/10.1186/1758-2652-13-s4-p195	https://doi.org/10.1186/1758-2652-13-s4-p195	NOUN
admet-1078	271	11	https://doi.org/10.1016/s1473-3099(04)01203-4	https://doi.org/10.1016/s1473-3099(04)01203-4	X
admet-1078	271	12	https://doi.org/10.1038/nri1604	https://doi.org/10.1038/nri1604	PRON
admet-1078	271	13	https://doi.org/10.1016/j.jaci.2007.11.014	https://doi.org/10.1016/j.jaci.2007.11.014	PROPN
admet-1078	271	14	https://doi.org/10.1038/ni.1992	https://doi.org/10.1038/ni.1992	ADP
admet-1078	271	15	https://doi.org/10.1038/ni.1992	https://doi.org/10.1038/ni.1992	VERB
admet-1078	271	16	https://doi.org/10.1038/nri3259	https://doi.org/10.1038/nri3259	NOUN
admet-1078	271	17	https://doi.org/10.1016/j.smim.2006.07.010	https://doi.org/10.1016/j.smim.2006.07.010	PROPN
admet-1078	271	18	https://doi.org/10.1016/j.jaci.2008.10.037	https://doi.org/10.1016/j.jaci.2008.10.037	PROPN
admet-1078	271	19	https://doi.org/10.1016/j.jaci.2008.10.037	https://doi.org/10.1016/j.jaci.2008.10.037	PROPN
admet-1078	271	20	https://doi.org/10.4049/jimmunol.173.6.4000	https://doi.org/10.4049/jimmunol.173.6.4000	PROPN
admet-1078	271	21	https://doi.org/10.4049/jimmunol.173.6.4000	https://doi.org/10.4049/jimmunol.173.6.4000	PROPN
admet-1078	272	1	svetlana	svetlana	PROPN
admet-1078	272	2	a.	a.	PROPN
admet-1078	272	3	berns	berns	PROPN
admet-1078	272	4	et	et	PROPN
admet-1078	272	5	al	al	PROPN
admet-1078	272	6	.	.	PROPN
admet-1078	272	7	admet	admet	PROPN
admet-1078	272	8	&	&	CCONJ
admet-1078	272	9	dmpk	dmpk	PROPN
admet-1078	272	10	10(1	10(1	NUM
admet-1078	272	11	)	)	PUNCT
admet-1078	272	12	(	(	PUNCT
admet-1078	272	13	2022	2022	NUM
admet-1078	272	14	)	)	PUNCT
admet-1078	272	15	63	63	NUM
admet-1078	272	16	-	-	SYM
admet-1078	272	17	73	73	NUM
admet-1078	272	18	72	72	NUM
admet-1078	272	19	[	[	X
admet-1078	272	20	30	30	NUM
admet-1078	272	21	]	]	X
admet-1078	272	22	j.f	j.f	PROPN
admet-1078	272	23	.	.	PROPN
admet-1078	272	24	emile	emile	PROPN
admet-1078	272	25	,	,	PUNCT
admet-1078	272	26	n.	n.	PROPN
admet-1078	272	27	patey	patey	PROPN
admet-1078	272	28	,	,	PUNCT
admet-1078	272	29	f.	f.	PROPN
admet-1078	272	30	altare	altare	PROPN
admet-1078	272	31	,	,	PUNCT
admet-1078	272	32	s.	s.	PROPN
admet-1078	272	33	lamhamedi	lamhamedi	PROPN
admet-1078	272	34	,	,	PUNCT
admet-1078	272	35	e.	e.	PROPN
admet-1078	272	36	jouanguy	jouanguy	PROPN
admet-1078	272	37	,	,	PUNCT
admet-1078	272	38	f.	f.	PROPN
admet-1078	272	39	boman	boman	PROPN
admet-1078	272	40	,	,	PUNCT
admet-1078	272	41	j.	j.	PROPN
admet-1078	272	42	quillard	quillard	PROPN
admet-1078	272	43	,	,	PUNCT
admet-1078	272	44	m.	m.	NOUN
admet-1078	272	45	lecomte	lecomte	PROPN
admet-1078	272	46	-	-	PUNCT
admet-1078	272	47	houcke	houcke	PROPN
admet-1078	272	48	,	,	PUNCT
admet-1078	272	49	o.	o.	PROPN
admet-1078	272	50	verola	verola	PROPN
admet-1078	272	51	,	,	PUNCT
admet-1078	272	52	j.f	j.f	PROPN
admet-1078	272	53	.	.	PROPN
admet-1078	272	54	mousnier	mousnier	PROPN
admet-1078	272	55	,	,	PUNCT
admet-1078	272	56	f.	f.	PROPN
admet-1078	272	57	dijoud	dijoud	PROPN
admet-1078	272	58	,	,	PUNCT
admet-1078	272	59	s.	s.	PROPN
admet-1078	272	60	blanche	blanche	PROPN
admet-1078	272	61	,	,	PUNCT
admet-1078	272	62	a.	a.	NOUN
admet-1078	272	63	fischer	fischer	PROPN
admet-1078	272	64	,	,	PUNCT
admet-1078	272	65	n.	n.	PROPN
admet-1078	272	66	brousse	brousse	PROPN
admet-1078	272	67	,	,	PUNCT
admet-1078	272	68	j.l	j.l	PROPN
admet-1078	272	69	.	.	PROPN
admet-1078	272	70	casanova	casanova	PROPN
admet-1078	272	71	.	.	PUNCT
admet-1078	273	1	correlation	correlation	NOUN
admet-1078	273	2	of	of	ADP
admet-1078	273	3	granuloma	granuloma	ADJ
admet-1078	273	4	structure	structure	NOUN
admet-1078	273	5	with	with	ADP
admet-1078	273	6	clinical	clinical	ADJ
admet-1078	273	7	outcome	outcome	NOUN
admet-1078	273	8	defines	define	VERB
admet-1078	273	9	two	two	NUM
admet-1078	273	10	types	type	NOUN
admet-1078	273	11	of	of	ADP
admet-1078	273	12	idiopathic	idiopathic	ADJ
admet-1078	273	13	disseminated	disseminate	VERB
admet-1078	273	14	bcg	bcg	NOUN
admet-1078	273	15	infection	infection	NOUN
admet-1078	273	16	.	.	PUNCT
admet-1078	274	1	j	j	PROPN
admet-1078	274	2	pathol	pathol	NOUN
admet-1078	274	3	.	.	PUNCT
admet-1078	275	1	181	181	NUM
admet-1078	275	2	(	(	PUNCT
admet-1078	275	3	1997	1997	NUM
admet-1078	275	4	)	)	PUNCT
admet-1078	275	5	25–30	25–30	NUM
admet-1078	275	6	.	.	PUNCT
admet-1078	275	7	https://doi.org/10.1002/(sici)1096-9896(199701)181:1<25::aid-path747>3.0.co;2-z	https://doi.org/10.1002/(sici)1096-9896(199701)181:1<25::aid-path747>3.0.co;2-z	PUNCT
admet-1078	275	8	.	.	PUNCT
admet-1078	276	1	[	[	X
admet-1078	276	2	31	31	NUM
admet-1078	276	3	]	]	SYM
admet-1078	276	4	s.n	s.n	PROPN
admet-1078	276	5	.	.	PROPN
admet-1078	276	6	kozlov	kozlov	PROPN
admet-1078	276	7	,	,	PUNCT
admet-1078	276	8	r.s	r.s	PROPN
admet-1078	276	9	.	.	PROPN
admet-1078	276	10	kozlov	kozlov	PROPN
admet-1078	276	11	.	.	PUNCT
admet-1078	277	1	modern	modern	ADJ
admet-1078	277	2	antimicrobial	antimicrobial	ADJ
admet-1078	277	3	chemotherapy	chemotherapy	NOUN
admet-1078	277	4	.	.	PUNCT
admet-1078	278	1	a	a	DET
admet-1078	278	2	guide	guide	NOUN
admet-1078	278	3	for	for	ADP
admet-1078	278	4	doctors	doctor	NOUN
admet-1078	278	5	.	.	PUNCT
admet-1078	279	1	3rd	3rd	ADJ
admet-1078	279	2	edition	edition	NOUN
admet-1078	279	3	revised	revise	VERB
admet-1078	279	4	and	and	CCONJ
admet-1078	279	5	enlarged	enlarge	VERB
admet-1078	279	6	.	.	PUNCT
admet-1078	280	1	medicinskoe	medicinskoe	PROPN
admet-1078	280	2	informacionnoe	informacionnoe	ADJ
admet-1078	280	3	agentstvo	agentstvo	NOUN
admet-1078	280	4	(	(	PUNCT
admet-1078	280	5	2017	2017	NUM
admet-1078	280	6	)	)	PUNCT
admet-1078	280	7	400	400	NUM
admet-1078	280	8	с	с	NOUN
admet-1078	280	9	.	.	PUNCT
admet-1078	281	1	[	[	X
admet-1078	281	2	32	32	NUM
admet-1078	281	3	]	]	PUNCT
admet-1078	281	4	t.	t.	PROPN
admet-1078	281	5	eddens	eddens	PROPN
admet-1078	281	6	,	,	PUNCT
admet-1078	281	7	j.k	j.k	PROPN
admet-1078	281	8	.	.	PROPN
admet-1078	281	9	kolls	kolls	PROPN
admet-1078	281	10	.	.	PUNCT
admet-1078	282	1	host	host	NOUN
admet-1078	282	2	defenses	defense	NOUN
admet-1078	282	3	against	against	ADP
admet-1078	282	4	bacterial	bacterial	ADJ
admet-1078	282	5	lower	low	ADJ
admet-1078	282	6	respiratory	respiratory	ADJ
admet-1078	282	7	tract	tract	NOUN
admet-1078	282	8	infection	infection	NOUN
admet-1078	282	9	.	.	PUNCT
admet-1078	283	1	curr	curr	PROPN
admet-1078	283	2	.	.	PUNCT
admet-1078	284	1	opin	opin	NOUN
admet-1078	284	2	.	.	PUNCT
admet-1078	285	1	immunol	immunol	NOUN
admet-1078	285	2	.	.	PUNCT
admet-1078	286	1	24(4	24(4	NOUN
admet-1078	286	2	)	)	PUNCT
admet-1078	286	3	(	(	PUNCT
admet-1078	286	4	2012	2012	NUM
admet-1078	286	5	)	)	PUNCT
admet-1078	287	1	424–430	424–430	NUM
admet-1078	287	2	.	.	PUNCT
admet-1078	288	1	https://doi.org/10.1016/j.coi.2012.07.005	https://doi.org/10.1016/j.coi.2012.07.005	PROPN
admet-1078	288	2	.	.	PUNCT
admet-1078	289	1	[	[	X
admet-1078	289	2	33	33	NUM
admet-1078	289	3	]	]	X
admet-1078	289	4	c.v	c.v	PROPN
admet-1078	289	5	.	.	PROPN
admet-1078	289	6	harding	harding	PROPN
admet-1078	289	7	,	,	PUNCT
admet-1078	289	8	w.h	w.h	PROPN
admet-1078	289	9	.	.	PROPN
admet-1078	289	10	boom	boom	NOUN
admet-1078	289	11	.	.	PUNCT
admet-1078	290	1	regulation	regulation	NOUN
admet-1078	290	2	of	of	ADP
admet-1078	290	3	antigen	antigen	ADJ
admet-1078	290	4	presentation	presentation	NOUN
admet-1078	290	5	by	by	ADP
admet-1078	290	6	mycobacterium	mycobacterium	NOUN
admet-1078	290	7	tuberculosis	tuberculosis	NOUN
admet-1078	290	8	:	:	PUNCT
admet-1078	290	9	a	a	DET
admet-1078	290	10	role	role	NOUN
admet-1078	290	11	for	for	ADP
admet-1078	290	12	toll	toll	NOUN
admet-1078	290	13	-	-	PUNCT
admet-1078	290	14	like	like	ADJ
admet-1078	290	15	receptors	receptor	NOUN
admet-1078	290	16	.	.	PUNCT
admet-1078	291	1	nat	nat	PROPN
admet-1078	291	2	.	.	PUNCT
admet-1078	292	1	rev	rev	PROPN
admet-1078	292	2	.	.	PROPN
admet-1078	292	3	microbiol	microbiol	PROPN
admet-1078	292	4	.	.	PUNCT
admet-1078	293	1	8	8	NUM
admet-1078	293	2	(	(	PUNCT
admet-1078	293	3	2010	2010	NUM
admet-1078	293	4	)	)	PUNCT
admet-1078	294	1	296–307	296–307	NUM
admet-1078	294	2	.	.	PUNCT
admet-1078	294	3	https://doi.org/10.1038/nrmicro2321	https://doi.org/10.1038/nrmicro2321	PROPN
admet-1078	294	4	.	.	PUNCT
admet-1078	295	1	[	[	X
admet-1078	295	2	34	34	NUM
admet-1078	295	3	]	]	PUNCT
admet-1078	295	4	a.	a.	NOUN
admet-1078	295	5	razaghi	razaghi	PROPN
admet-1078	295	6	,	,	PUNCT
admet-1078	295	7	l.	l.	PROPN
admet-1078	295	8	owens	owens	PROPN
admet-1078	295	9	,	,	PUNCT
admet-1078	295	10	k.	k.	PROPN
admet-1078	295	11	heimann	heimann	PROPN
admet-1078	295	12	.	.	PUNCT
admet-1078	296	1	review	review	NOUN
admet-1078	296	2	of	of	ADP
admet-1078	296	3	the	the	DET
admet-1078	296	4	recombinant	recombinant	ADJ
admet-1078	296	5	human	human	ADJ
admet-1078	296	6	interferon	interferon	PROPN
admet-1078	296	7	gamma	gamma	NOUN
admet-1078	296	8	as	as	ADP
admet-1078	296	9	an	an	DET
admet-1078	296	10	immunotherapeutic	immunotherapeutic	ADJ
admet-1078	296	11	:	:	PUNCT
admet-1078	296	12	impacts	impact	NOUN
admet-1078	296	13	of	of	ADP
admet-1078	296	14	production	production	NOUN
admet-1078	296	15	platforms	platform	NOUN
admet-1078	296	16	and	and	CCONJ
admet-1078	296	17	glycosylation	glycosylation	NOUN
admet-1078	296	18	.	.	PUNCT
admet-1078	297	1	journal	journal	PROPN
admet-1078	297	2	of	of	ADP
admet-1078	297	3	biotechnology	biotechnology	NOUN
admet-1078	297	4	240	240	NUM
admet-1078	297	5	(	(	PUNCT
admet-1078	297	6	2016	2016	NUM
admet-1078	297	7	)	)	PUNCT
admet-1078	297	8	48–60	48–60	PROPN
admet-1078	297	9	.	.	PUNCT
admet-1078	298	1	https://doi.org/10.1016/j.jbiotec.2016.10.022	https://doi.org/10.1016/j.jbiotec.2016.10.022	NOUN
admet-1078	298	2	.	.	PUNCT
admet-1078	299	1	[	[	X
admet-1078	299	2	35	35	NUM
admet-1078	299	3	]	]	X
admet-1078	299	4	f.c	f.c	PROPN
admet-1078	299	5	.	.	PROPN
admet-1078	299	6	fang	fang	PROPN
admet-1078	299	7	.	.	PUNCT
admet-1078	300	1	antimicrobial	antimicrobial	ADJ
admet-1078	300	2	reactive	reactive	ADJ
admet-1078	300	3	oxygen	oxygen	NOUN
admet-1078	300	4	and	and	CCONJ
admet-1078	300	5	nitrogen	nitrogen	NOUN
admet-1078	300	6	species	specie	NOUN
admet-1078	300	7	:	:	PUNCT
admet-1078	300	8	concepts	concept	NOUN
admet-1078	300	9	and	and	CCONJ
admet-1078	300	10	controversies	controversy	NOUN
admet-1078	300	11	.	.	PUNCT
admet-1078	301	1	nat	nat	PROPN
admet-1078	301	2	.	.	PUNCT
admet-1078	302	1	rev	rev	PROPN
admet-1078	302	2	.	.	PROPN
admet-1078	302	3	microbiol	microbiol	PROPN
admet-1078	302	4	.	.	PUNCT
admet-1078	303	1	2(10	2(10	NUM
admet-1078	303	2	)	)	PUNCT
admet-1078	303	3	(	(	PUNCT
admet-1078	303	4	2004	2004	NUM
admet-1078	303	5	)	)	PUNCT
admet-1078	303	6	820	820	NUM
admet-1078	303	7	-	-	SYM
admet-1078	303	8	32	32	NUM
admet-1078	303	9	.	.	PUNCT
admet-1078	303	10	https://doi.org/10.1038/nrmicro1004	https://doi.org/10.1038/nrmicro1004	NOUN
admet-1078	303	11	.	.	PUNCT
admet-1078	304	1	[	[	X
admet-1078	304	2	36	36	NUM
admet-1078	304	3	]	]	X
admet-1078	304	4	e.	e.	PROPN
admet-1078	304	5	pashkov	pashkov	PROPN
admet-1078	304	6	,	,	PUNCT
admet-1078	304	7	a.	a.	PROPN
admet-1078	304	8	karaulov	karaulov	PROPN
admet-1078	304	9	,	,	PUNCT
admet-1078	304	10	s.	s.	PROPN
admet-1078	304	11	bykov	bykov	PROPN
admet-1078	304	12	,	,	PUNCT
admet-1078	304	13	m.	m.	PROPN
admet-1078	304	14	korn	korn	PROPN
admet-1078	304	15	,	,	PUNCT
admet-1078	304	16	a.	a.	NOUN
admet-1078	304	17	bykov	bykov	PROPN
admet-1078	304	18	,	,	PUNCT
admet-1078	304	19	a.	a.	NOUN
admet-1078	304	20	vorob'ev	vorob'ev	NOUN
admet-1078	304	21	,	,	PUNCT
admet-1078	304	22	v.	v.	PROPN
admet-1078	304	23	zverev	zverev	X
admet-1078	304	24	.	.	PUNCT
admet-1078	305	1	atlas	atlas	PROPN
admet-1078	305	2	of	of	ADP
admet-1078	305	3	medical	medical	ADJ
admet-1078	305	4	microbiology	microbiology	NOUN
admet-1078	305	5	,	,	PUNCT
admet-1078	305	6	virology	virology	NOUN
admet-1078	305	7	and	and	CCONJ
admet-1078	305	8	immunology	immunology	NOUN
admet-1078	305	9	.	.	PUNCT
admet-1078	306	1	m.	m.	NOUN
admet-1078	306	2	:	:	PUNCT
admet-1078	306	3	medicinskoe	medicinskoe	PROPN
admet-1078	306	4	informacionnoe	informacionnoe	ADJ
admet-1078	306	5	agentstvo	agentstvo	NOUN
admet-1078	306	6	(	(	PUNCT
admet-1078	306	7	2008	2008	NUM
admet-1078	306	8	)	)	PUNCT
admet-1078	306	9	272	272	NUM
admet-1078	306	10	с	с	NOUN
admet-1078	306	11	.	.	PUNCT
admet-1078	307	1	[	[	X
admet-1078	307	2	37	37	NUM
admet-1078	307	3	]	]	X
admet-1078	307	4	r.s	r.s	PROPN
admet-1078	307	5	.	.	PROPN
admet-1078	307	6	orlov	orlov	PROPN
admet-1078	307	7	,	,	PUNCT
admet-1078	307	8	a.d	a.d	PROPN
admet-1078	307	9	.	.	PROPN
admet-1078	307	10	nozdrachev	nozdrachev	PROPN
admet-1078	307	11	.	.	PUNCT
admet-1078	308	1	normal	normal	ADJ
admet-1078	308	2	physiology	physiology	NOUN
admet-1078	308	3	:	:	PUNCT
admet-1078	308	4	textbook	textbook	NOUN
admet-1078	308	5	.	.	PUNCT
admet-1078	309	1	second	second	ADJ
admet-1078	309	2	edition	edition	NOUN
admet-1078	309	3	,	,	PUNCT
admet-1078	309	4	revised	revise	VERB
admet-1078	309	5	and	and	CCONJ
admet-1078	309	6	enlarged	enlarge	VERB
admet-1078	309	7	m.	m.	NOUN
admet-1078	309	8	gjeotar	gjeotar	PROPN
admet-1078	309	9	-	-	PUNCT
admet-1078	309	10	media	medium	NOUN
admet-1078	309	11	(	(	PUNCT
admet-1078	309	12	2010	2010	NUM
admet-1078	309	13	)	)	PUNCT
admet-1078	309	14	832	832	NUM
admet-1078	310	1	p.	p.	NOUN
admet-1078	311	1	[	[	X
admet-1078	311	2	38	38	NUM
admet-1078	311	3	]	]	X
admet-1078	311	4	e.l	e.l	PROPN
admet-1078	311	5	.	.	PROPN
admet-1078	311	6	lousberg	lousberg	PROPN
admet-1078	311	7	,	,	PUNCT
admet-1078	311	8	c.k	c.k	PROPN
admet-1078	311	9	.	.	PROPN
admet-1078	311	10	fraser	fraser	PROPN
admet-1078	311	11	,	,	PUNCT
admet-1078	311	12	m.g	m.g	PROPN
admet-1078	311	13	.	.	PROPN
admet-1078	311	14	tovey	tovey	PROPN
admet-1078	311	15	,	,	PUNCT
admet-1078	311	16	k.r	k.r	PROPN
admet-1078	311	17	.	.	PROPN
admet-1078	311	18	diener	diener	PROPN
admet-1078	311	19	,	,	PUNCT
admet-1078	311	20	j.d	j.d	PROPN
admet-1078	311	21	.	.	PROPN
admet-1078	311	22	hayball	hayball	NOUN
admet-1078	311	23	.	.	PUNCT
admet-1078	312	1	type	type	NOUN
admet-1078	312	2	i	i	PRON
admet-1078	312	3	interferons	interferon	NOUN
admet-1078	312	4	mediate	mediate	VERB
admet-1078	312	5	the	the	DET
admet-1078	312	6	innate	innate	ADJ
admet-1078	312	7	cytokine	cytokine	ADJ
admet-1078	312	8	response	response	NOUN
admet-1078	312	9	to	to	ADP
admet-1078	312	10	recombinant	recombinant	ADJ
admet-1078	312	11	fowlpox	fowlpox	ADJ
admet-1078	312	12	virus	virus	NOUN
admet-1078	312	13	but	but	CCONJ
admet-1078	312	14	not	not	PART
admet-1078	312	15	the	the	DET
admet-1078	312	16	induction	induction	NOUN
admet-1078	312	17	of	of	ADP
admet-1078	312	18	plasmacytoid	plasmacytoid	ADJ
admet-1078	312	19	dendritic	dendritic	ADJ
admet-1078	312	20	celldependent	celldependent	NOUN
admet-1078	312	21	adaptive	adaptive	ADJ
admet-1078	312	22	immunity	immunity	NOUN
admet-1078	312	23	.	.	PUNCT
admet-1078	313	1	journal	journal	NOUN
admet-1078	313	2	of	of	ADP
admet-1078	313	3	virology	virology	NOUN
admet-1078	313	4	84(13	84(13	NUM
admet-1078	313	5	)	)	PUNCT
admet-1078	313	6	(	(	PUNCT
admet-1078	313	7	2010	2010	NUM
admet-1078	313	8	)	)	PUNCT
admet-1078	313	9	6549–6563	6549–6563	NOUN
admet-1078	313	10	.	.	PUNCT
admet-1078	314	1	https://doi.org/10.1128/jvi.02618-09	https://doi.org/10.1128/jvi.02618-09	PROPN
admet-1078	314	2	.	.	PUNCT
admet-1078	315	1	[	[	X
admet-1078	315	2	39	39	NUM
admet-1078	315	3	]	]	X
admet-1078	315	4	p.o	p.o	PROPN
admet-1078	315	5	.	.	PROPN
admet-1078	315	6	pinheiro	pinheiro	PROPN
admet-1078	315	7	,	,	PUNCT
admet-1078	315	8	e.b	e.b	PROPN
admet-1078	315	9	.	.	PROPN
admet-1078	315	10	oliveira	oliveira	PROPN
admet-1078	315	11	,	,	PUNCT
admet-1078	315	12	g.	g.	PROPN
admet-1078	315	13	santos	santos	PROPN
admet-1078	315	14	,	,	PUNCT
admet-1078	315	15	g.m	g.m	PROPN
admet-1078	315	16	.	.	PROPN
admet-1078	315	17	sperandio	sperandio	PROPN
admet-1078	315	18	da	da	PROPN
admet-1078	315	19	silva	silva	PROPN
admet-1078	315	20	,	,	PUNCT
admet-1078	315	21	b.j	b.j	PROPN
admet-1078	315	22	.	.	PROPN
admet-1078	315	23	andrade	andrade	PROPN
admet-1078	315	24	silva	silva	PROPN
admet-1078	315	25	,	,	PUNCT
admet-1078	315	26	r.m.b	r.m.b	NOUN
admet-1078	315	27	.	.	PUNCT
admet-1078	316	1	teles	tele	NOUN
admet-1078	316	2	,	,	PUNCT
admet-1078	316	3	a.	a.	NOUN
admet-1078	316	4	milagres	milagres	PROPN
admet-1078	316	5	,	,	PUNCT
admet-1078	316	6	e.n	e.n	PROPN
admet-1078	316	7	.	.	PROPN
admet-1078	316	8	sarno	sarno	PROPN
admet-1078	316	9	,	,	PUNCT
admet-1078	316	10	m.p	m.p	PROPN
admet-1078	316	11	.	.	PROPN
admet-1078	316	12	dalcolmo	dalcolmo	PROPN
admet-1078	316	13	,	,	PUNCT
admet-1078	316	14	e.p	e.p	PROPN
admet-1078	316	15	.	.	PROPN
admet-1078	316	16	sampaio	sampaio	PROPN
admet-1078	316	17	.	.	PUNCT
admet-1078	317	1	different	different	ADJ
admet-1078	317	2	immunosuppressive	immunosuppressive	ADJ
admet-1078	317	3	mechanisms	mechanism	NOUN
admet-1078	317	4	in	in	ADP
admet-1078	317	5	multi	multi	ADJ
admet-1078	317	6	-	-	ADJ
admet-1078	317	7	drug	drug	NOUN
admet-1078	317	8	-	-	PUNCT
admet-1078	317	9	resistant	resistant	ADJ
admet-1078	317	10	tuberculosis	tuberculosis	NOUN
admet-1078	317	11	and	and	CCONJ
admet-1078	317	12	non	non	ADJ
admet-1078	317	13	-	-	ADJ
admet-1078	317	14	tuberculous	tuberculous	ADJ
admet-1078	317	15	mycobacteria	mycobacteria	NOUN
admet-1078	317	16	patients	patient	NOUN
admet-1078	317	17	.	.	PUNCT
admet-1078	318	1	clinical	clinical	ADJ
admet-1078	318	2	and	and	CCONJ
admet-1078	318	3	experimental	experimental	ADJ
admet-1078	318	4	immunology	immunology	NOUN
admet-1078	318	5	171(2	171(2	NUM
admet-1078	318	6	)	)	PUNCT
admet-1078	318	7	(	(	PUNCT
admet-1078	318	8	2013	2013	NUM
admet-1078	318	9	)	)	PUNCT
admet-1078	318	10	210–219	210–219	NUM
admet-1078	318	11	.	.	PUNCT
admet-1078	319	1	https://doi.org/10.1111/cei.12007	https://doi.org/10.1111/cei.12007	ADJ
admet-1078	319	2	.	.	PUNCT
admet-1078	320	1	[	[	X
admet-1078	320	2	40	40	NUM
admet-1078	320	3	]	]	PUNCT
admet-1078	320	4	a.	a.	NOUN
admet-1078	320	5	fortes	fortes	PROPN
admet-1078	320	6	,	,	PUNCT
admet-1078	320	7	k.	k.	PROPN
admet-1078	320	8	pereira	pereira	PROPN
admet-1078	320	9	,	,	PUNCT
admet-1078	320	10	p.r.z	p.r.z	PROPN
admet-1078	320	11	.	.	PUNCT
admet-1078	320	12	antas	antas	PROPN
admet-1078	320	13	,	,	PUNCT
admet-1078	320	14	c.l.m.c	c.l.m.c	PROPN
admet-1078	320	15	.	.	PROPN
admet-1078	320	16	franken	franken	PROPN
admet-1078	320	17	,	,	PUNCT
admet-1078	320	18	m.	m.	PROPN
admet-1078	320	19	dalcolmo	dalcolmo	PROPN
admet-1078	320	20	,	,	PUNCT
admet-1078	320	21	m.m	m.m	PROPN
admet-1078	320	22	.	.	PROPN
admet-1078	320	23	ribeiro	ribeiro	PROPN
admet-1078	320	24	-	-	PUNCT
admet-1078	320	25	carvalho	carvalho	PROPN
admet-1078	320	26	,	,	PUNCT
admet-1078	320	27	k.s	k.s	PROPN
admet-1078	320	28	.	.	PROPN
admet-1078	320	29	cunha	cunha	PROPN
admet-1078	320	30	,	,	PUNCT
admet-1078	320	31	a.	a.	PROPN
admet-1078	320	32	geluk	geluk	PROPN
admet-1078	320	33	,	,	PUNCT
admet-1078	320	34	a.	a.	NOUN
admet-1078	320	35	kritski	kritski	PROPN
admet-1078	320	36	,	,	PUNCT
admet-1078	320	37	a.	a.	NOUN
admet-1078	320	38	kolk	kolk	PROPN
admet-1078	320	39	,	,	PUNCT
admet-1078	320	40	p.	p.	NOUN
admet-1078	320	41	klatser	klatser	PROPN
admet-1078	320	42	,	,	PUNCT
admet-1078	320	43	e.n	e.n	PROPN
admet-1078	320	44	.	.	PROPN
admet-1078	320	45	sarno	sarno	PROPN
admet-1078	320	46	,	,	PUNCT
admet-1078	320	47	t.h.m	t.h.m	PROPN
admet-1078	320	48	.	.	PROPN
admet-1078	320	49	ottenhoff	ottenhoff	PROPN
admet-1078	320	50	,	,	PUNCT
admet-1078	320	51	e.p	e.p	PROPN
admet-1078	320	52	.	.	PROPN
admet-1078	320	53	sampaio	sampaio	PROPN
admet-1078	320	54	.	.	PUNCT
admet-1078	321	1	detection	detection	NOUN
admet-1078	321	2	of	of	ADP
admet-1078	321	3	in	in	ADP
admet-1078	321	4	vitro	vitro	X
admet-1078	321	5	interferon	interferon	ADJ
admet-1078	321	6	-	-	PUNCT
admet-1078	321	7	γ	γ	NOUN
admet-1078	321	8	and	and	CCONJ
admet-1078	321	9	serum	serum	VERB
admet-1078	321	10	tumour	tumour	NOUN
admet-1078	321	11	necrosis	necrosis	NOUN
admet-1078	321	12	factor	factor	NOUN
admet-1078	321	13	-	-	PUNCT
admet-1078	321	14	α	α	NOUN
admet-1078	321	15	in	in	ADP
admet-1078	321	16	multidrug	multidrug	NOUN
admet-1078	321	17	-	-	PUNCT
admet-1078	321	18	resistant	resistant	ADJ
admet-1078	321	19	tuberculosis	tuberculosis	NOUN
admet-1078	321	20	patients	patient	NOUN
admet-1078	321	21	.	.	PUNCT
admet-1078	322	1	clinical	clinical	ADJ
admet-1078	322	2	and	and	CCONJ
admet-1078	322	3	experimental	experimental	ADJ
admet-1078	322	4	immunology	immunology	NOUN
admet-1078	322	5	141(3	141(3	NUM
admet-1078	322	6	)	)	PUNCT
admet-1078	322	7	(	(	PUNCT
admet-1078	322	8	2005	2005	NUM
admet-1078	322	9	)	)	PUNCT
admet-1078	322	10	541–548	541–548	NUM
admet-1078	322	11	.	.	PUNCT
admet-1078	323	1	https://doi.org/10.1111/j.13652249.2005.02872.x	https://doi.org/10.1111/j.13652249.2005.02872.x	X
admet-1078	323	2	.	.	PUNCT
admet-1078	324	1	[	[	X
admet-1078	324	2	41	41	NUM
admet-1078	324	3	]	]	X
admet-1078	324	4	b.m	b.m	PROPN
admet-1078	324	5	.	.	PROPN
admet-1078	324	6	brooks	brooks	PROPN
admet-1078	324	7	,	,	PUNCT
admet-1078	324	8	c.a	c.a	PROPN
admet-1078	324	9	.	.	PROPN
admet-1078	324	10	hart	hart	PROPN
admet-1078	324	11	,	,	PUNCT
admet-1078	324	12	j.w	j.w	PROPN
admet-1078	324	13	.	.	PROPN
admet-1078	324	14	coleman	coleman	PROPN
admet-1078	324	15	.	.	PUNCT
admet-1078	325	1	2005	2005	NUM
admet-1078	325	2	.	.	PUNCT
admet-1078	326	1	differential	differential	ADJ
admet-1078	326	2	effects	effect	NOUN
admet-1078	326	3	of	of	ADP
admet-1078	326	4	beta	beta	NOUN
admet-1078	326	5	-	-	PUNCT
admet-1078	326	6	lactams	lactam	NOUN
admet-1078	326	7	on	on	ADP
admet-1078	326	8	human	human	ADJ
admet-1078	326	9	ifngamma	ifngamma	PROPN
admet-1078	326	10	activity	activity	NOUN
admet-1078	326	11	.	.	PUNCT
admet-1078	327	1	the	the	DET
admet-1078	327	2	journal	journal	NOUN
admet-1078	327	3	of	of	ADP
admet-1078	327	4	antimicrobial	antimicrobial	ADJ
admet-1078	327	5	chemotherapy	chemotherapy	NOUN
admet-1078	327	6	56(6	56(6	NUM
admet-1078	327	7	)	)	PUNCT
admet-1078	327	8	(	(	PUNCT
admet-1078	327	9	2005	2005	NUM
admet-1078	327	10	)	)	PUNCT
admet-1078	327	11	1122	1122	NUM
admet-1078	327	12	-	-	SYM
admet-1078	327	13	1125	1125	NUM
admet-1078	327	14	.	.	PUNCT
admet-1078	328	1	https://doi.org/10.1093/jac/dki373	https://doi.org/10.1093/jac/dki373	NOUN
admet-1078	328	2	.	.	PUNCT
admet-1078	329	1	[	[	X
admet-1078	329	2	42	42	NUM
admet-1078	329	3	]	]	X
admet-1078	329	4	https://clinicaltrials.gov	https://clinicaltrials.gov	PROPN
admet-1078	329	5	(	(	PUNCT
admet-1078	329	6	date	date	NOUN
admet-1078	329	7	accessed	access	VERB
admet-1078	329	8	10.06.2021	10.06.2021	NUM
admet-1078	329	9	)	)	PUNCT
admet-1078	329	10	.	.	PUNCT
admet-1078	330	1	[	[	X
admet-1078	330	2	43	43	NUM
admet-1078	330	3	]	]	X
admet-1078	330	4	x.f	x.f	PROPN
admet-1078	330	5	.	.	PUNCT
admet-1078	331	1	gao	gao	PROPN
admet-1078	331	2	,	,	PUNCT
admet-1078	331	3	z.w	z.w	PROPN
admet-1078	331	4	.	.	PROPN
admet-1078	331	5	yang	yang	PROPN
admet-1078	331	6	,	,	PUNCT
admet-1078	331	7	j.	j.	PROPN
admet-1078	331	8	li	li	PROPN
admet-1078	331	9	.	.	PROPN
admet-1078	331	10	adjunctive	adjunctive	ADJ
admet-1078	331	11	therapy	therapy	NOUN
admet-1078	331	12	with	with	ADP
admet-1078	331	13	interferon	interferon	ADJ
admet-1078	331	14	-	-	PUNCT
admet-1078	331	15	gamma	gamma	NOUN
admet-1078	331	16	for	for	ADP
admet-1078	331	17	the	the	DET
admet-1078	331	18	treatment	treatment	NOUN
admet-1078	331	19	of	of	ADP
admet-1078	331	20	pulmonary	pulmonary	ADJ
admet-1078	331	21	tuberculosis	tuberculosis	NOUN
admet-1078	331	22	:	:	PUNCT
admet-1078	331	23	a	a	DET
admet-1078	331	24	systematic	systematic	ADJ
admet-1078	331	25	review	review	NOUN
admet-1078	331	26	.	.	PUNCT
admet-1078	332	1	international	international	ADJ
admet-1078	332	2	journal	journal	NOUN
admet-1078	332	3	of	of	ADP
admet-1078	332	4	infectious	infectious	ADJ
admet-1078	332	5	diseases	disease	NOUN
admet-1078	332	6	15	15	NUM
admet-1078	332	7	(	(	PUNCT
admet-1078	332	8	2011	2011	NUM
admet-1078	332	9	)	)	PUNCT
admet-1078	332	10	e594	e594	PROPN
admet-1078	332	11	–	–	PUNCT
admet-1078	332	12	e600	e600	PROPN
admet-1078	332	13	.	.	PUNCT
admet-1078	333	1	https://doi.org/10.1016/j.ijid.2011.05.002	https://doi.org/10.1016/j.ijid.2011.05.002	NOUN
admet-1078	333	2	.	.	PUNCT
admet-1078	334	1	[	[	X
admet-1078	334	2	44	44	NUM
admet-1078	334	3	]	]	PUNCT
admet-1078	334	4	r.	r.	NOUN
admet-1078	334	5	condos	condo	NOUN
admet-1078	334	6	,	,	PUNCT
admet-1078	334	7	w.	w.	PROPN
admet-1078	334	8	n.	n.	PROPN
admet-1078	334	9	rom	rom	PROPN
admet-1078	334	10	,	,	PUNCT
admet-1078	334	11	and	and	CCONJ
admet-1078	334	12	n.	n.	PROPN
admet-1078	334	13	w.	w.	PROPN
admet-1078	334	14	schluger	schluger	PROPN
admet-1078	334	15	.	.	PUNCT
admet-1078	335	1	treatment	treatment	NOUN
admet-1078	335	2	of	of	ADP
admet-1078	335	3	multidrug	multidrug	NOUN
admet-1078	335	4	-	-	PUNCT
admet-1078	335	5	resistant	resistant	ADJ
admet-1078	335	6	pulmonary	pulmonary	ADJ
admet-1078	335	7	tuberculosis	tuberculosis	NOUN
admet-1078	335	8	with	with	ADP
admet-1078	335	9	interferon	interferon	ADJ
admet-1078	335	10	-	-	PUNCT
admet-1078	335	11	gamma	gamma	NOUN
admet-1078	335	12	via	via	ADP
admet-1078	335	13	aerosol	aerosol	NOUN
admet-1078	335	14	.	.	PUNCT
admet-1078	336	1	lancet	lancet	PROPN
admet-1078	336	2	349(9064	349(9064	NUM
admet-1078	336	3	)	)	PUNCT
admet-1078	336	4	(	(	PUNCT
admet-1078	336	5	1997	1997	NUM
admet-1078	336	6	)	)	PUNCT
admet-1078	336	7	1513–1515	1513–1515	NUM
admet-1078	336	8	.	.	PUNCT
admet-1078	337	1	https://doi.org/10.1016/s0140-6736(96)12273-x	https://doi.org/10.1016/s0140-6736(96)12273-x	PROPN
admet-1078	338	1	[	[	X
admet-1078	338	2	45	45	NUM
admet-1078	338	3	]	]	PUNCT
admet-1078	338	4	r.	r.	PROPN
admet-1078	338	5	suarez	suarez	PROPN
admet-1078	338	6	-	-	PUNCT
admet-1078	338	7	mendez	mendez	PROPN
admet-1078	338	8	,	,	PUNCT
admet-1078	338	9	i.	i.	NOUN
admet-1078	338	10	garcía	garcía	NOUN
admet-1078	338	11	-	-	PUNCT
admet-1078	338	12	garcía	garcía	ADJ
admet-1078	338	13	,	,	PUNCT
admet-1078	338	14	n.	n.	PROPN
admet-1078	338	15	fernández	fernández	PROPN
admet-1078	338	16	-	-	PUNCT
admet-1078	338	17	olivera	olivera	PROPN
admet-1078	338	18	et	et	PROPN
admet-1078	338	19	al	al	PROPN
admet-1078	338	20	.	.	PROPN
admet-1078	338	21	adjuvant	adjuvant	PROPN
admet-1078	338	22	interferon	interferon	PROPN
admet-1078	338	23	gamma	gamma	NOUN
admet-1078	338	24	in	in	ADP
admet-1078	338	25	patients	patient	NOUN
admet-1078	338	26	with	with	ADP
admet-1078	338	27	drug	drug	NOUN
admet-1078	338	28	resistant	resistant	ADJ
admet-1078	338	29	pulmonary	pulmonary	ADJ
admet-1078	338	30	tuberculosis	tuberculosis	NOUN
admet-1078	338	31	:	:	PUNCT
admet-1078	338	32	a	a	DET
admet-1078	338	33	pilot	pilot	NOUN
admet-1078	338	34	study	study	NOUN
admet-1078	338	35	.	.	PUNCT
admet-1078	339	1	bmc	bmc	ADJ
admet-1078	339	2	infectious	infectious	ADJ
admet-1078	339	3	diseases	disease	NOUN
admet-1078	339	4	4	4	NUM
admet-1078	339	5	(	(	PUNCT
admet-1078	339	6	2004	2004	NUM
admet-1078	339	7	)	)	PUNCT
admet-1078	339	8	44	44	NUM
admet-1078	339	9	.	.	PUNCT
admet-1078	339	10	https://doi.org/10.1186/1471-2334-4-44	https://doi.org/10.1186/1471-2334-4-44	X
admet-1078	339	11	.	.	PUNCT
admet-1078	340	1	[	[	X
admet-1078	340	2	46	46	NUM
admet-1078	340	3	]	]	PUNCT
admet-1078	340	4	s.	s.	PROPN
admet-1078	340	5	k.	k.	PROPN
admet-1078	340	6	park	park	PROPN
admet-1078	340	7	,	,	PUNCT
admet-1078	340	8	s.	s.	PROPN
admet-1078	340	9	cho	cho	PROPN
admet-1078	340	10	,	,	PUNCT
admet-1078	340	11	i.	i.	PROPN
admet-1078	340	12	h.	h.	PROPN
admet-1078	340	13	lee	lee	PROPN
admet-1078	340	14	et	et	PROPN
admet-1078	340	15	al	al	PROPN
admet-1078	340	16	.	.	PROPN
admet-1078	340	17	subcutaneously	subcutaneously	ADV
admet-1078	340	18	administered	administer	VERB
admet-1078	340	19	interferon	interferon	ADJ
admet-1078	340	20	-	-	PUNCT
admet-1078	340	21	gamma	gamma	NOUN
admet-1078	340	22	for	for	ADP
admet-1078	340	23	the	the	DET
admet-1078	340	24	treatment	treatment	NOUN
admet-1078	340	25	of	of	ADP
admet-1078	340	26	multidrugresistant	multidrugresistant	ADJ
admet-1078	340	27	pulmonary	pulmonary	ADJ
admet-1078	340	28	tuberculosis	tuberculosis	NOUN
admet-1078	340	29	.	.	PUNCT
admet-1078	341	1	international	international	ADJ
admet-1078	341	2	journal	journal	NOUN
admet-1078	341	3	of	of	ADP
admet-1078	341	4	infectious	infectious	ADJ
admet-1078	341	5	diseases	disease	NOUN
admet-1078	341	6	11(5	11(5	NUM
admet-1078	341	7	)	)	PUNCT
admet-1078	341	8	(	(	PUNCT
admet-1078	341	9	2007	2007	NUM
admet-1078	341	10	)	)	PUNCT
admet-1078	342	1	434–440	434–440	NUM
admet-1078	342	2	.	.	PUNCT
admet-1078	342	3	https://doi.org/10.1016/j.ijid.2006.12.004	https://doi.org/10.1016/j.ijid.2006.12.004	PROPN
admet-1078	342	4	.	.	PUNCT
admet-1078	343	1	https://doi.org/10.1002/(sici)1096-9896(199701)181:1%3c25::aid-path747%3e3.0.co;2-z	https://doi.org/10.1002/(sici)1096-9896(199701)181:1%3c25::aid-path747%3e3.0.co;2-z	NOUN
admet-1078	343	2	https://doi.org/10.1002/(sici)1096-9896(199701)181:1%3c25::aid-path747%3e3.0.co;2-z	https://doi.org/10.1002/(sici)1096-9896(199701)181:1%3c25::aid-path747%3e3.0.co;2-z	PROPN
admet-1078	343	3	https://doi.org/10.1016/j.coi.2012.07.005	https://doi.org/10.1016/j.coi.2012.07.005	PROPN
admet-1078	343	4	https://doi.org/10.1038/nrmicro2321	https://doi.org/10.1038/nrmicro2321	PROPN
admet-1078	343	5	https://doi.org/10.1016/j.jbiotec.2016.10.022	https://doi.org/10.1016/j.jbiotec.2016.10.022	NOUN
admet-1078	343	6	https://doi.org/10.1038/nrmicro1004	https://doi.org/10.1038/nrmicro1004	NOUN
admet-1078	344	1	https://doi.org/10.1128/jvi.02618-09	https://doi.org/10.1128/jvi.02618-09	PROPN
admet-1078	344	2	https://doi.org/10.1128/jvi.02618-09	https://doi.org/10.1128/jvi.02618-09	PROPN
admet-1078	344	3	https://doi.org/10.1111/cei.12007	https://doi.org/10.1111/cei.12007	VERB
admet-1078	344	4	https://doi.org/10.1111/j.1365-2249.2005.02872.x	https://doi.org/10.1111/j.1365-2249.2005.02872.x	NOUN
admet-1078	344	5	https://doi.org/10.1111/j.1365-2249.2005.02872.x	https://doi.org/10.1111/j.1365-2249.2005.02872.x	PROPN
admet-1078	344	6	https://doi.org/10.1093/jac/dki373	https://doi.org/10.1093/jac/dki373	VERB
admet-1078	344	7	https://clinicaltrials.gov/	https://clinicaltrials.gov/	ADJ
admet-1078	344	8	https://doi.org/10.1016/j.ijid.2011.05.002	https://doi.org/10.1016/j.ijid.2011.05.002	NOUN
admet-1078	344	9	https://doi.org/10.1016/s0140-6736(96)12273-x	https://doi.org/10.1016/s0140-6736(96)12273-x	ADV
admet-1078	344	10	https://doi.org/10.1016/s0140-6736(96)12273-x	https://doi.org/10.1016/s0140-6736(96)12273-x	PROPN
admet-1078	344	11	https://doi.org/10.1186/1471-2334-4-44	https://doi.org/10.1186/1471-2334-4-44	PROPN
admet-1078	344	12	https://doi.org/10.1016/j.ijid.2006.12.004	https://doi.org/10.1016/j.ijid.2006.12.004	PROPN
admet-1078	344	13	admet	admet	X
admet-1078	344	14	&	&	CCONJ
admet-1078	344	15	dmpk	dmpk	PROPN
admet-1078	344	16	10(1	10(1	NUM
admet-1078	344	17	)	)	PUNCT
admet-1078	344	18	(	(	PUNCT
admet-1078	344	19	2022	2022	NUM
admet-1078	344	20	)	)	PUNCT
admet-1078	344	21	63	63	NUM
admet-1078	344	22	-	-	SYM
admet-1078	344	23	73	73	NUM
admet-1078	344	24	therapeutic	therapeutic	ADJ
admet-1078	344	25	potential	potential	NOUN
admet-1078	344	26	of	of	ADP
admet-1078	344	27	interferon	interferon	ADJ
admet-1078	344	28	-	-	PUNCT
admet-1078	344	29	gamma	gamma	NOUN
admet-1078	344	30	in	in	ADP
admet-1078	344	31	tuberculosis	tuberculosis	NOUN
admet-1078	344	32	doi	doi	NOUN
admet-1078	344	33	:	:	PUNCT
admet-1078	344	34	http://dx.doi.org/10.5599/admet.1078	http://dx.doi.org/10.5599/admet.1078	PROPN
admet-1078	344	35	73	73	NUM
admet-1078	345	1	[	[	X
admet-1078	345	2	47	47	NUM
admet-1078	345	3	]	]	PUNCT
admet-1078	345	4	i.	i.	PROPN
admet-1078	345	5	raad	raad	PROPN
admet-1078	345	6	,	,	PUNCT
admet-1078	345	7	r.	r.	PROPN
admet-1078	345	8	hachem	hachem	PROPN
admet-1078	345	9	,	,	PUNCT
admet-1078	345	10	n.	n.	PROPN
admet-1078	345	11	leeds	leeds	PROPN
admet-1078	345	12	,	,	PUNCT
admet-1078	345	13	r.	r.	PROPN
admet-1078	345	14	sawaya	sawaya	PROPN
admet-1078	345	15	,	,	PUNCT
admet-1078	345	16	z.	z.	PROPN
admet-1078	345	17	salem	salem	PROPN
admet-1078	345	18	,	,	PUNCT
admet-1078	345	19	and	and	CCONJ
admet-1078	345	20	s.	s.	PROPN
admet-1078	345	21	atweh	atweh	PROPN
admet-1078	345	22	.	.	PUNCT
admet-1078	346	1	use	use	NOUN
admet-1078	346	2	of	of	ADP
admet-1078	346	3	adjunctive	adjunctive	ADJ
admet-1078	346	4	treatment	treatment	NOUN
admet-1078	346	5	with	with	ADP
admet-1078	346	6	interferon	interferon	ADJ
admet-1078	346	7	-	-	PUNCT
admet-1078	346	8	gamma	gamma	NOUN
admet-1078	346	9	in	in	ADP
admet-1078	346	10	an	an	DET
admet-1078	346	11	immunocompromised	immunocompromise	VERB
admet-1078	346	12	patient	patient	NOUN
admet-1078	346	13	who	who	PRON
admet-1078	346	14	had	have	VERB
admet-1078	346	15	refractory	refractory	NOUN
admet-1078	346	16	multidrug	multidrug	NOUN
admet-1078	346	17	-	-	PUNCT
admet-1078	346	18	resistant	resistant	ADJ
admet-1078	346	19	tuberculosis	tuberculosis	NOUN
admet-1078	346	20	of	of	ADP
admet-1078	346	21	the	the	DET
admet-1078	346	22	brain	brain	NOUN
admet-1078	346	23	.	.	PUNCT
admet-1078	347	1	clinical	clinical	ADJ
admet-1078	347	2	infectious	infectious	ADJ
admet-1078	347	3	diseases	disease	NOUN
admet-1078	347	4	22(3	22(3	NOUN
admet-1078	347	5	)	)	PUNCT
admet-1078	347	6	1996	1996	NUM
admet-1078	347	7	572–574	572–574	NUM
admet-1078	347	8	.	.	PUNCT
admet-1078	348	1	https://doi.org/10.1093/clinids/22.3.572	https://doi.org/10.1093/clinids/22.3.572	NUM
admet-1078	348	2	.	.	PUNCT
admet-1078	349	1	[	[	X
admet-1078	349	2	48	48	NUM
admet-1078	349	3	]	]	SYM
admet-1078	349	4	a.a	a.a	PROPN
admet-1078	349	5	.	.	PROPN
admet-1078	349	6	maslennikov	maslennikov	PROPN
admet-1078	349	7	,	,	PUNCT
admet-1078	349	8	n.i	n.i	PROPN
admet-1078	349	9	.	.	PROPN
admet-1078	349	10	obolonkova	obolonkova	PROPN
admet-1078	349	11	.	.	PUNCT
admet-1078	350	1	efficiency	efficiency	NOUN
admet-1078	350	2	of	of	ADP
admet-1078	350	3	ingaron	ingaron	NOUN
admet-1078	350	4	in	in	ADP
admet-1078	350	5	the	the	DET
admet-1078	350	6	treatment	treatment	NOUN
admet-1078	350	7	of	of	ADP
admet-1078	350	8	patients	patient	NOUN
admet-1078	350	9	with	with	ADP
admet-1078	350	10	destructive	destructive	ADJ
admet-1078	350	11	pulmonary	pulmonary	NOUN
admet-1078	350	12	bacteriologicaly	bacteriologicaly	PROPN
admet-1078	350	13	proven	prove	VERB
admet-1078	350	14	tuberculosis	tuberculosis	NOUN
admet-1078	350	15	.	.	PUNCT
admet-1078	351	1	research	research	NOUN
admet-1078	351	2	result	result	NOUN
admet-1078	351	3	.	.	PUNCT
admet-1078	352	1	medicine	medicine	NOUN
admet-1078	352	2	and	and	CCONJ
admet-1078	352	3	pharmacy	pharmacy	NOUN
admet-1078	352	4	series	serie	NOUN
admet-1078	352	5	1(7	1(7	NUM
admet-1078	352	6	)	)	PUNCT
admet-1078	352	7	2016	2016	NUM
admet-1078	352	8	.	.	PUNCT
admet-1078	353	1	https://doi.org/10.18413/2313-8955-2016-2-1-10-16	https://doi.org/10.18413/2313-8955-2016-2-1-10-16	NOUN
admet-1078	353	2	.	.	PUNCT
admet-1078	354	1	[	[	X
admet-1078	354	2	49	49	NUM
admet-1078	354	3	]	]	PUNCT
admet-1078	354	4	r.	r.	PROPN
admet-1078	354	5	dawson	dawson	PROPN
admet-1078	354	6	,	,	PUNCT
admet-1078	354	7	r.	r.	PROPN
admet-1078	354	8	condos	condos	PROPN
admet-1078	354	9	,	,	PUNCT
admet-1078	354	10	d.	d.	PROPN
admet-1078	354	11	tse	tse	PROPN
admet-1078	354	12	,	,	PUNCT
admet-1078	354	13	et	et	PROPN
admet-1078	354	14	al	al	PROPN
admet-1078	354	15	.	.	PROPN
admet-1078	354	16	immunomodulation	immunomodulation	PROPN
admet-1078	354	17	with	with	ADP
admet-1078	354	18	recombinant	recombinant	ADJ
admet-1078	354	19	interferon	interferon	ADJ
admet-1078	354	20	-	-	PUNCT
admet-1078	354	21	gamma1b	gamma1b	NOUN
admet-1078	354	22	in	in	ADP
admet-1078	354	23	pulmonary	pulmonary	ADJ
admet-1078	354	24	tuberculosis	tuberculosis	NOUN
admet-1078	354	25	.	.	PUNCT
admet-1078	355	1	plos	plos	PROPN
admet-1078	355	2	one	one	NUM
admet-1078	355	3	4(9	4(9	NUM
admet-1078	355	4	)	)	PUNCT
admet-1078	355	5	(	(	PUNCT
admet-1078	355	6	2009	2009	NUM
admet-1078	355	7	)	)	PUNCT
admet-1078	356	1	e6984	e6984	PROPN
admet-1078	356	2	.	.	PUNCT
admet-1078	357	1	https://doi.org/10.1371/journal.pone.0006984	https://doi.org/10.1371/journal.pone.0006984	NOUN
admet-1078	357	2	.	.	PUNCT
admet-1078	358	1	[	[	X
admet-1078	358	2	50	50	NUM
admet-1078	358	3	]	]	X
admet-1078	358	4	m.s	m.s	PROPN
admet-1078	358	5	.	.	PROPN
admet-1078	358	6	pisarenko	pisarenko	PROPN
admet-1078	358	7	.	.	PUNCT
admet-1078	359	1	pecularities	pecularitie	NOUN
admet-1078	359	2	of	of	ADP
admet-1078	359	3	ifn	ifn	PROPN
admet-1078	359	4	-	-	PUNCT
admet-1078	359	5	g	g	NOUN
admet-1078	359	6	secretion	secretion	NOUN
admet-1078	359	7	in	in	ADP
admet-1078	359	8	drug	drug	NOUN
admet-1078	359	9	-	-	PUNCT
admet-1078	359	10	resistant	resistant	ADJ
admet-1078	359	11	pulmonary	pulmonary	ADJ
admet-1078	359	12	tuberculosis	tuberculosis	NOUN
admet-1078	359	13	.	.	PUNCT
admet-1078	360	1	fundamental	fundamental	ADJ
admet-1078	360	2	research	research	NOUN
admet-1078	360	3	9	9	NUM
admet-1078	360	4	(	(	PUNCT
admet-1078	360	5	2013	2013	NUM
admet-1078	360	6	)	)	PUNCT
admet-1078	360	7	444	444	NUM
admet-1078	360	8	-	-	SYM
admet-1078	360	9	447	447	NUM
admet-1078	360	10	.	.	PUNCT
admet-1078	361	1	[	[	X
admet-1078	361	2	51	51	NUM
admet-1078	361	3	]	]	X
admet-1078	361	4	i.a	i.a	PROPN
admet-1078	361	5	.	.	PROPN
admet-1078	361	6	vasilyeva	vasilyeva	PROPN
admet-1078	361	7	,	,	PUNCT
admet-1078	361	8	e.m	e.m	PROPN
admet-1078	361	9	.	.	PROPN
admet-1078	361	10	belilovsky	belilovsky	PROPN
admet-1078	361	11	,	,	PUNCT
admet-1078	361	12	s.e	s.e	PROPN
admet-1078	361	13	.	.	PROPN
admet-1078	361	14	borisov	borisov	PROPN
admet-1078	361	15	,	,	PUNCT
admet-1078	361	16	s.a	s.a	PROPN
admet-1078	361	17	.	.	PROPN
admet-1078	361	18	sterlikov	sterlikov	PROPN
admet-1078	361	19	.	.	PUNCT
admet-1078	362	1	incidence	incidence	NOUN
admet-1078	362	2	,	,	PUNCT
admet-1078	362	3	mortality	mortality	NOUN
admet-1078	362	4	and	and	CCONJ
admet-1078	362	5	prevalence	prevalence	NOUN
admet-1078	362	6	as	as	ADP
admet-1078	362	7	indicators	indicator	NOUN
admet-1078	362	8	of	of	ADP
admet-1078	362	9	tuberculosis	tuberculosis	NOUN
admet-1078	362	10	burden	burden	NOUN
admet-1078	362	11	in	in	ADP
admet-1078	362	12	who	who	PRON
admet-1078	362	13	regions	region	NOUN
admet-1078	362	14	,	,	PUNCT
admet-1078	362	15	countries	country	NOUN
admet-1078	362	16	of	of	ADP
admet-1078	362	17	the	the	DET
admet-1078	362	18	world	world	NOUN
admet-1078	362	19	and	and	CCONJ
admet-1078	362	20	the	the	DET
admet-1078	362	21	russian	russian	PROPN
admet-1078	362	22	federation	federation	PROPN
admet-1078	362	23	.	.	PUNCT
admet-1078	363	1	part	part	NOUN
admet-1078	363	2	2	2	NUM
admet-1078	363	3	.	.	NOUN
admet-1078	364	1	tuberculosis	tuberculosis	NOUN
admet-1078	364	2	mortality	mortality	NOUN
admet-1078	364	3	.	.	PUNCT
admet-1078	365	1	tuberculosis	tuberculosis	NOUN
admet-1078	365	2	and	and	CCONJ
admet-1078	365	3	lung	lung	NOUN
admet-1078	365	4	diseases	disease	NOUN
admet-1078	365	5	95(7	95(7	NUM
admet-1078	365	6	)	)	PUNCT
admet-1078	365	7	(	(	PUNCT
admet-1078	365	8	2017	2017	NUM
admet-1078	365	9	)	)	PUNCT
admet-1078	365	10	8	8	NUM
admet-1078	365	11	-	-	SYM
admet-1078	365	12	16	16	NUM
admet-1078	365	13	.	.	PUNCT
admet-1078	366	1	https://doi.org/10.21292/2075-1230-2017-95-6-9-21	https://doi.org/10.21292/2075-1230-2017-95-6-9-21	NOUN
admet-1078	366	2	.	.	PUNCT
admet-1078	367	1	[	[	X
admet-1078	367	2	52	52	NUM
admet-1078	367	3	]	]	PUNCT
admet-1078	367	4	t.	t.	PROPN
admet-1078	367	5	tanimura	tanimura	PROPN
admet-1078	367	6	,	,	PUNCT
admet-1078	367	7	e.	e.	PROPN
admet-1078	367	8	jaramillo	jaramillo	PROPN
admet-1078	367	9	,	,	PUNCT
admet-1078	367	10	d.	d.	PROPN
admet-1078	367	11	weil	weil	PROPN
admet-1078	367	12	,	,	PUNCT
admet-1078	367	13	m.	m.	NOUN
admet-1078	367	14	raviglione	raviglione	PROPN
admet-1078	367	15	,	,	PUNCT
admet-1078	367	16	k.	k.	PROPN
admet-1078	367	17	lönnroth	lönnroth	PROPN
admet-1078	367	18	.	.	PUNCT
admet-1078	368	1	financial	financial	ADJ
admet-1078	368	2	burden	burden	NOUN
admet-1078	368	3	for	for	ADP
admet-1078	368	4	tuberculosis	tuberculosis	NOUN
admet-1078	368	5	patients	patient	NOUN
admet-1078	368	6	in	in	ADP
admet-1078	368	7	lowand	lowand	ADJ
admet-1078	368	8	middle	middle	ADJ
admet-1078	368	9	-	-	PUNCT
admet-1078	368	10	income	income	NOUN
admet-1078	368	11	countries	country	NOUN
admet-1078	368	12	:	:	PUNCT
admet-1078	368	13	a	a	DET
admet-1078	368	14	systematic	systematic	ADJ
admet-1078	368	15	review	review	NOUN
admet-1078	368	16	.	.	PUNCT
admet-1078	369	1	the	the	DET
admet-1078	369	2	european	european	ADJ
admet-1078	369	3	respiratory	respiratory	ADJ
admet-1078	369	4	journal	journal	PROPN
admet-1078	369	5	43(6	43(6	PROPN
admet-1078	369	6	)	)	PUNCT
admet-1078	369	7	(	(	PUNCT
admet-1078	369	8	2014	2014	NUM
admet-1078	369	9	)	)	PUNCT
admet-1078	369	10	1763	1763	NUM
admet-1078	369	11	-	-	SYM
admet-1078	369	12	1775	1775	NUM
admet-1078	369	13	.	.	PUNCT
admet-1078	370	1	https://doi.org/10.1183/09031936.00193413	https://doi.org/10.1183/09031936.00193413	PROPN
admet-1078	370	2	.	.	PUNCT
admet-1078	371	1	[	[	X
admet-1078	371	2	53	53	NUM
admet-1078	371	3	]	]	X
admet-1078	371	4	s.l	s.l	PROPN
admet-1078	371	5	.	.	NOUN
admet-1078	371	6	plavinskiy	plavinskiy	NOUN
admet-1078	371	7	,	,	PUNCT
admet-1078	371	8	p.i	p.i	PROPN
admet-1078	371	9	.	.	PROPN
admet-1078	371	10	shabalkin	shabalkin	PROPN
admet-1078	371	11	.	.	PUNCT
admet-1078	372	1	evaluation	evaluation	NOUN
admet-1078	372	2	of	of	ADP
admet-1078	372	3	the	the	DET
admet-1078	372	4	clinical	clinical	ADJ
admet-1078	372	5	and	and	CCONJ
admet-1078	372	6	economic	economic	ADJ
admet-1078	372	7	effectiveness	effectiveness	NOUN
admet-1078	372	8	of	of	ADP
admet-1078	372	9	interferongamma	interferongamma	PROPN
admet-1078	372	10	in	in	ADP
admet-1078	372	11	the	the	DET
admet-1078	372	12	treatment	treatment	NOUN
admet-1078	372	13	of	of	ADP
admet-1078	372	14	tuberculosis	tuberculosis	NOUN
admet-1078	372	15	.	.	PUNCT
admet-1078	373	1	epidemiology	epidemiology	NOUN
admet-1078	373	2	and	and	CCONJ
admet-1078	373	3	infectious	infectious	ADJ
admet-1078	373	4	diseases	disease	NOUN
admet-1078	373	5	.	.	PUNCT
admet-1078	374	1	russian	russian	ADJ
admet-1078	374	2	journal	journal	PROPN
admet-1078	374	3	22(6	22(6	NUM
admet-1078	374	4	)	)	PUNCT
admet-1078	374	5	(	(	PUNCT
admet-1078	374	6	2017	2017	NUM
admet-1078	374	7	)	)	PUNCT
admet-1078	374	8	276	276	NUM
admet-1078	374	9	-	-	SYM
admet-1078	374	10	280	280	NUM
admet-1078	374	11	.	.	PUNCT
admet-1078	374	12	https://doi.org/10.17816/eid40981	https://doi.org/10.17816/eid40981	NOUN
admet-1078	374	13	.	.	PUNCT
admet-1078	375	1	[	[	X
admet-1078	375	2	54	54	NUM
admet-1078	375	3	]	]	X
admet-1078	375	4	k.l	k.l	PROPN
admet-1078	375	5	.	.	PROPN
admet-1078	375	6	chin	chin	PROPN
admet-1078	375	7	,	,	PUNCT
admet-1078	375	8	f.z	f.z	PROPN
admet-1078	375	9	.	.	PROPN
admet-1078	375	10	anis	anis	PROPN
admet-1078	375	11	,	,	PUNCT
admet-1078	375	12	m.e	m.e	PROPN
admet-1078	375	13	.	.	PROPN
admet-1078	375	14	sarmiento	sarmiento	PROPN
admet-1078	375	15	,	,	PUNCT
admet-1078	375	16	m.n	m.n	PROPN
admet-1078	375	17	.	.	PROPN
admet-1078	375	18	norazmi	norazmi	PROPN
admet-1078	375	19	,	,	PUNCT
admet-1078	375	20	a.	a.	NOUN
admet-1078	375	21	acosta	acosta	PROPN
admet-1078	375	22	.	.	PUNCT
admet-1078	376	1	role	role	NOUN
admet-1078	376	2	of	of	ADP
admet-1078	376	3	interferons	interferon	NOUN
admet-1078	376	4	in	in	ADP
admet-1078	376	5	the	the	DET
admet-1078	376	6	development	development	NOUN
admet-1078	376	7	of	of	ADP
admet-1078	376	8	diagnostics	diagnostic	NOUN
admet-1078	376	9	,	,	PUNCT
admet-1078	376	10	vaccines	vaccine	NOUN
admet-1078	376	11	,	,	PUNCT
admet-1078	376	12	and	and	CCONJ
admet-1078	376	13	therapy	therapy	NOUN
admet-1078	376	14	for	for	ADP
admet-1078	376	15	tuberculosis	tuberculosis	NOUN
admet-1078	376	16	.	.	PUNCT
admet-1078	377	1	journal	journal	NOUN
admet-1078	377	2	of	of	ADP
admet-1078	377	3	immunology	immunology	NOUN
admet-1078	377	4	research	research	NOUN
admet-1078	377	5	2017	2017	NUM
admet-1078	377	6	(	(	PUNCT
admet-1078	377	7	2017	2017	NUM
admet-1078	377	8	)	)	PUNCT
admet-1078	377	9	5212910	5212910	NUM
admet-1078	377	10	.	.	PUNCT
admet-1078	378	1	https://doi.org/10.1155/2017/5212910	https://doi.org/10.1155/2017/5212910	NOUN
admet-1078	378	2	.	.	PUNCT
admet-1078	379	1	[	[	X
admet-1078	379	2	55	55	NUM
admet-1078	379	3	]	]	PUNCT
admet-1078	379	4	s.	s.	PROPN
admet-1078	379	5	anderson	anderson	PROPN
admet-1078	379	6	,	,	PUNCT
admet-1078	379	7	v.	v.	PROPN
admet-1078	379	8	ansdell	ansdell	PROPN
admet-1078	379	9	,	,	PUNCT
admet-1078	379	10	p.m.	p.m.	NOUN
admet-1078	379	11	arguin	arguin	NOUN
admet-1078	379	12	,	,	PUNCT
admet-1078	379	13	et	et	PROPN
admet-1078	379	14	al	al	PROPN
admet-1078	379	15	..	..	PUNCT
admet-1078	379	16	the	the	DET
admet-1078	379	17	travel	travel	NOUN
admet-1078	379	18	and	and	CCONJ
admet-1078	379	19	tropical	tropical	ADJ
admet-1078	379	20	medicine	medicine	NOUN
admet-1078	379	21	manual	manual	NOUN
admet-1078	379	22	(	(	PUNCT
admet-1078	379	23	fifth	fifth	ADJ
admet-1078	379	24	edition	edition	NOUN
admet-1078	379	25	)	)	PUNCT
admet-1078	379	26	.	.	PUNCT
admet-1078	380	1	elsevier	elsevier	NOUN
admet-1078	380	2	(	(	PUNCT
admet-1078	380	3	2017	2017	NUM
admet-1078	380	4	)	)	PUNCT
admet-1078	380	5	646p	646p	PROPN
admet-1078	380	6	.	.	PUNCT
admet-1078	381	1	https://doi.org/10.1016/b978-0-323-37506-1.00061-1	https://doi.org/10.1016/b978-0-323-37506-1.00061-1	NOUN
admet-1078	381	2	.	.	PUNCT
admet-1078	382	1	[	[	X
admet-1078	382	2	56	56	NUM
admet-1078	382	3	]	]	X
admet-1078	382	4	p.	p.	NOUN
admet-1078	382	5	c.	c.	PROPN
admet-1078	382	6	hopewell	hopewell	PROPN
admet-1078	382	7	,	,	PUNCT
admet-1078	382	8	m.	m.	PROPN
admet-1078	382	9	kato	kato	PROPN
admet-1078	382	10	-	-	PUNCT
admet-1078	382	11	maeda	maeda	PROPN
admet-1078	382	12	,	,	PUNCT
admet-1078	382	13	j.	j.	PROPN
admet-1078	382	14	d.	d.	PROPN
admet-1078	382	15	ernst	ernst	PROPN
admet-1078	382	16	.	.	PROPN
admet-1078	382	17	murray	murray	PROPN
admet-1078	382	18	and	and	CCONJ
admet-1078	382	19	nadel	nadel	PROPN
admet-1078	382	20	's	's	PART
admet-1078	382	21	textbook	textbook	NOUN
admet-1078	382	22	of	of	ADP
admet-1078	382	23	respiratory	respiratory	ADJ
admet-1078	382	24	medicine	medicine	NOUN
admet-1078	382	25	(	(	PUNCT
admet-1078	382	26	sixth	sixth	ADJ
admet-1078	382	27	edition	edition	NOUN
admet-1078	382	28	)	)	PUNCT
admet-1078	382	29	.	.	PUNCT
admet-1078	383	1	elsevier	elsevier	NOUN
admet-1078	383	2	(	(	PUNCT
admet-1078	383	3	2016	2016	NUM
admet-1078	383	4	)	)	PUNCT
admet-1078	383	5	.	.	PUNCT
admet-1078	384	1	https://doi.org/10.1016/b978-1-4557-3383-5.00035-x	https://doi.org/10.1016/b978-1-4557-3383-5.00035-x	PROPN
admet-1078	384	2	.	.	PUNCT
admet-1078	385	1	[	[	X
admet-1078	385	2	57	57	NUM
admet-1078	385	3	]	]	PUNCT
admet-1078	385	4	t.	t.	NOUN
admet-1078	385	5	togun	togun	PROPN
admet-1078	385	6	,	,	PUNCT
admet-1078	385	7	b.	b.	PROPN
admet-1078	385	8	kampmann	kampmann	PROPN
admet-1078	385	9	,	,	PUNCT
admet-1078	385	10	m.	m.	PROPN
admet-1078	385	11	pai	pai	PROPN
admet-1078	385	12	.	.	PUNCT
admet-1078	386	1	diagnosis	diagnosis	NOUN
admet-1078	386	2	of	of	ADP
admet-1078	386	3	childhood	childhood	NOUN
admet-1078	386	4	tuberculosis	tuberculosis	NOUN
admet-1078	386	5	,	,	PUNCT
admet-1078	386	6	reference	reference	NOUN
admet-1078	386	7	module	module	NOUN
admet-1078	386	8	in	in	ADP
admet-1078	386	9	biomedical	biomedical	ADJ
admet-1078	386	10	sciences	science	NOUN
admet-1078	386	11	.	.	PUNCT
admet-1078	387	1	elsevier	elsevier	NOUN
admet-1078	387	2	(	(	PUNCT
admet-1078	387	3	2017	2017	NUM
admet-1078	387	4	)	)	PUNCT
admet-1078	387	5	.	.	PUNCT
admet-1078	388	1	https://doi.org/10.1016/b978-0-12-801238-3.64157-0	https://doi.org/10.1016/b978-0-12-801238-3.64157-0	NOUN
admet-1078	388	2	.	.	PUNCT
admet-1078	389	1	[	[	X
admet-1078	389	2	58	58	X
admet-1078	389	3	]	]	X
admet-1078	389	4	y.	y.	PROPN
admet-1078	389	5	xu	xu	PROPN
admet-1078	389	6	,	,	PUNCT
admet-1078	389	7	b.	b.	PROPN
admet-1078	389	8	zhu	zhu	PROPN
admet-1078	389	9	,	,	PUNCT
admet-1078	389	10	q.	q.	PROPN
admet-1078	389	11	wang	wang	PROPN
admet-1078	389	12	,	,	PUNCT
admet-1078	389	13	et	et	PROPN
admet-1078	389	14	al	al	PROPN
admet-1078	389	15	.	.	PROPN
admet-1078	389	16	recombinant	recombinant	ADJ
admet-1078	389	17	bcg	bcg	PROPN
admet-1078	389	18	coexpressing	coexpresse	VERB
admet-1078	389	19	ag85b	ag85b	ADP
admet-1078	389	20	,	,	PUNCT
admet-1078	389	21	esat-6	esat-6	NUM
admet-1078	389	22	and	and	CCONJ
admet-1078	389	23	mouse	mouse	NOUN
admet-1078	389	24	-	-	PUNCT
admet-1078	389	25	ifn	ifn	NOUN
admet-1078	389	26	-	-	PUNCT
admet-1078	389	27	gamma	gamma	NOUN
admet-1078	389	28	confers	confer	NOUN
admet-1078	389	29	effective	effective	ADJ
admet-1078	389	30	protection	protection	NOUN
admet-1078	389	31	against	against	ADP
admet-1078	389	32	mycobacterium	mycobacterium	NOUN
admet-1078	389	33	tuberculosis	tuberculosis	NOUN
admet-1078	389	34	in	in	ADP
admet-1078	389	35	c57bl/6	c57bl/6	NOUN
admet-1078	389	36	mice	mouse	NOUN
admet-1078	389	37	.	.	PUNCT
admet-1078	390	1	fems	fems	PROPN
admet-1078	390	2	immunology	immunology	NOUN
admet-1078	390	3	and	and	CCONJ
admet-1078	390	4	medical	medical	ADJ
admet-1078	390	5	microbiology	microbiology	NOUN
admet-1078	390	6	51(3	51(3	NUM
admet-1078	390	7	)	)	PUNCT
admet-1078	390	8	(	(	PUNCT
admet-1078	390	9	2007	2007	NUM
admet-1078	390	10	)	)	PUNCT
admet-1078	391	1	480–487	480–487	NUM
admet-1078	391	2	.	.	PUNCT
admet-1078	392	1	https://doi.org/10.1111/j.1574-695x.2007.00322.x	https://doi.org/10.1111/j.1574-695x.2007.00322.x	PROPN
admet-1078	392	2	.	.	PUNCT
admet-1078	393	1	[	[	X
admet-1078	393	2	59	59	NUM
admet-1078	393	3	]	]	X
admet-1078	393	4	g.	g.	PROPN
admet-1078	393	5	c.	c.	PROPN
admet-1078	393	6	k.	k.	PROPN
admet-1078	393	7	w.	w.	PROPN
admet-1078	393	8	koh	koh	PROPN
admet-1078	393	9	,	,	PUNCT
admet-1078	393	10	m.f	m.f	PROPN
admet-1078	393	11	.	.	PROPN
admet-1078	393	12	schreiber	schreiber	PROPN
admet-1078	393	13	,	,	PUNCT
admet-1078	393	14	r.	r.	PROPN
admet-1078	393	15	bautista	bautista	PROPN
admet-1078	393	16	,	,	PUNCT
admet-1078	393	17	et	et	PROPN
admet-1078	393	18	al	al	PROPN
admet-1078	393	19	.	.	PUNCT
admet-1078	394	1	host	host	NOUN
admet-1078	394	2	responses	response	NOUN
admet-1078	394	3	to	to	ADP
admet-1078	394	4	melioidosis	melioidosis	NOUN
admet-1078	394	5	and	and	CCONJ
admet-1078	394	6	tuberculosis	tuberculosis	NOUN
admet-1078	394	7	are	be	AUX
admet-1078	394	8	both	both	PRON
admet-1078	394	9	dominated	dominate	VERB
admet-1078	394	10	by	by	ADP
admet-1078	394	11	interferon	interferon	ADJ
admet-1078	394	12	-	-	PUNCT
admet-1078	394	13	mediated	mediate	VERB
admet-1078	394	14	signaling	signaling	NOUN
admet-1078	394	15	.	.	PUNCT
admet-1078	395	1	plos	plos	PROPN
admet-1078	395	2	one	one	NUM
admet-1078	395	3	8(1	8(1	NOUN
admet-1078	395	4	)	)	PUNCT
admet-1078	395	5	(	(	PUNCT
admet-1078	395	6	2013	2013	NUM
admet-1078	395	7	)	)	PUNCT
admet-1078	396	1	e54961	e54961	PROPN
admet-1078	396	2	.	.	PUNCT
admet-1078	397	1	https://doi.org/10.1371/journal.pone.0054961	https://doi.org/10.1371/journal.pone.0054961	PROPN
admet-1078	397	2	.	.	PUNCT
admet-1078	398	1	[	[	X
admet-1078	398	2	60	60	NUM
admet-1078	398	3	]	]	X
admet-1078	398	4	s.h	s.h	PROPN
admet-1078	398	5	.	.	PROPN
admet-1078	398	6	kaufmann	kaufmann	PROPN
admet-1078	398	7	,	,	PUNCT
admet-1078	398	8	c.	c.	PROPN
admet-1078	398	9	lange	lange	PROPN
admet-1078	398	10	,	,	PUNCT
admet-1078	398	11	m.	m.	NOUN
admet-1078	398	12	rao	rao	PROPN
admet-1078	398	13	,	,	PUNCT
admet-1078	398	14	et	et	PROPN
admet-1078	398	15	al	al	PROPN
admet-1078	398	16	.	.	PROPN
admet-1078	398	17	progress	progress	NOUN
admet-1078	398	18	in	in	ADP
admet-1078	398	19	tuberculosis	tuberculosis	NOUN
admet-1078	398	20	vaccine	vaccine	NOUN
admet-1078	398	21	development	development	NOUN
admet-1078	398	22	and	and	CCONJ
admet-1078	398	23	hostdirected	hostdirected	ADJ
admet-1078	398	24	therapies	therapy	NOUN
admet-1078	398	25	–	–	PUNCT
admet-1078	398	26	a	a	DET
admet-1078	398	27	state	state	NOUN
admet-1078	398	28	of	of	ADP
admet-1078	398	29	the	the	DET
admet-1078	398	30	art	art	NOUN
admet-1078	398	31	review	review	NOUN
admet-1078	398	32	.	.	PUNCT
admet-1078	399	1	the	the	DET
admet-1078	399	2	lancet	lancet	NOUN
admet-1078	399	3	.	.	PUNCT
admet-1078	400	1	respiratory	respiratory	ADJ
admet-1078	400	2	medicine	medicine	NOUN
admet-1078	400	3	2(4	2(4	NUM
admet-1078	400	4	)	)	PUNCT
admet-1078	400	5	(	(	PUNCT
admet-1078	400	6	2014	2014	NUM
admet-1078	400	7	)	)	PUNCT
admet-1078	400	8	301	301	NUM
admet-1078	400	9	-	-	SYM
admet-1078	400	10	320	320	NUM
admet-1078	400	11	.	.	PUNCT
admet-1078	400	12	https://doi.org/10.1016/s2213-2600(14)70033-5	https://doi.org/10.1016/s2213-2600(14)70033-5	PROPN
admet-1078	400	13	.	.	PUNCT
admet-1078	401	1	©	©	NOUN
admet-1078	401	2	2022	2022	NUM
admet-1078	401	3	by	by	ADP
admet-1078	401	4	the	the	DET
admet-1078	401	5	authors	author	NOUN
admet-1078	401	6	;	;	PUNCT
admet-1078	401	7	licensee	licensee	PROPN
admet-1078	401	8	iapc	iapc	PROPN
admet-1078	401	9	,	,	PUNCT
admet-1078	401	10	zagreb	zagreb	PROPN
admet-1078	401	11	,	,	PUNCT
admet-1078	401	12	croatia	croatia	PROPN
admet-1078	401	13	.	.	PUNCT
admet-1078	402	1	this	this	DET
admet-1078	402	2	article	article	NOUN
admet-1078	402	3	is	be	AUX
admet-1078	402	4	an	an	DET
admet-1078	402	5	open	open	ADJ
admet-1078	402	6	-	-	PUNCT
admet-1078	402	7	access	access	NOUN
admet-1078	402	8	article	article	NOUN
admet-1078	402	9	distributed	distribute	VERB
admet-1078	402	10	under	under	ADP
admet-1078	402	11	the	the	DET
admet-1078	402	12	terms	term	NOUN
admet-1078	402	13	and	and	CCONJ
admet-1078	402	14	conditions	condition	NOUN
admet-1078	402	15	of	of	ADP
admet-1078	402	16	the	the	DET
admet-1078	402	17	creative	creative	ADJ
admet-1078	402	18	commons	common	NOUN
admet-1078	402	19	attribution	attribution	NOUN
admet-1078	402	20	license	license	NOUN
admet-1078	402	21	(	(	PUNCT
admet-1078	402	22	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
admet-1078	402	23	)	)	PUNCT
admet-1078	402	24	http://dx.doi.org/10.5599/admet.1078	http://dx.doi.org/10.5599/admet.1078	VERB
admet-1078	402	25	https://doi.org/10.1093/clinids/22.3.572	https://doi.org/10.1093/clinids/22.3.572	NUM
admet-1078	402	26	https://doi.org/10.1093/clinids/22.3.572	https://doi.org/10.1093/clinids/22.3.572	NUM
admet-1078	402	27	https://doi.org/10.18413/2313-8955-2016-2-1-10-16	https://doi.org/10.18413/2313-8955-2016-2-1-10-16	NUM
admet-1078	402	28	https://doi.org/10.1371/journal.pone.0006984	https://doi.org/10.1371/journal.pone.0006984	NOUN
admet-1078	402	29	https://doi.org/10.21292/2075-1230-2017-95-6-9-21	https://doi.org/10.21292/2075-1230-2017-95-6-9-21	NOUN
admet-1078	402	30	https://doi.org/10.1183/09031936.00193413	https://doi.org/10.1183/09031936.00193413	VERB
admet-1078	402	31	http://www.medlit.ru/journalsview/infections/main/	http://www.medlit.ru/journalsview/infections/main/	NOUN
admet-1078	402	32	http://www.medlit.ru/journalsview/infections/view/journal/en/2017/issue-6/	http://www.medlit.ru/journalsview/infections/view/journal/en/2017/issue-6/	X
admet-1078	402	33	http://www.medlit.ru/journalsview/infections/view/journal/en/2017/issue-6/	http://www.medlit.ru/journalsview/infections/view/journal/en/2017/issue-6/	X
admet-1078	402	34	https://doi.org/10.17816/eid40981	https://doi.org/10.17816/eid40981	VERB
admet-1078	402	35	https://doi.org/10.1155/2017/5212910	https://doi.org/10.1155/2017/5212910	NOUN
admet-1078	402	36	https://www.sciencedirect.com/book/9780323375061/the-travel-and-tropical-medicine-manual	https://www.sciencedirect.com/book/9780323375061/the-travel-and-tropical-medicine-manual	ADJ
admet-1078	402	37	https://doi.org/10.1016/b978-0-323-37506-1.00061-1	https://doi.org/10.1016/b978-0-323-37506-1.00061-1	PROPN
admet-1078	402	38	https://doi.org/10.1016/b978-1-4557-3383-5.00035-x	https://doi.org/10.1016/b978-1-4557-3383-5.00035-x	VERB
admet-1078	402	39	https://doi.org/10.1016/b978-0-12-801238-3.64157-0	https://doi.org/10.1016/b978-0-12-801238-3.64157-0	NOUN
admet-1078	402	40	https://doi.org/10.1111/j.1574-695x.2007.00322.x	https://doi.org/10.1111/j.1574-695x.2007.00322.x	PROPN
admet-1078	402	41	https://doi.org/10.1371/journal.pone.0054961	https://doi.org/10.1371/journal.pone.0054961	ADJ
admet-1078	402	42	https://doi.org/10.1371/journal.pone.0054961	https://doi.org/10.1371/journal.pone.0054961	ADJ
admet-1078	402	43	https://doi.org/10.1016/s2213-2600(14)70033-5	https://doi.org/10.1016/s2213-2600(14)70033-5	NOUN
admet-1078	402	44	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN